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Abstract 
 
Notch is highly conserved signaling pathway that regulates the development 
and differentiation of many types of tissues and influences major cellular 
processes such as cell proliferation, differentiation and apoptosis. Mutations in 
several Notch signaling components have been associated with a number of 
congenital heart defects, demonstrating an essential role for Notch both in 
cardiovascular system development and its maintenance during postnatal life. In 
particular, mutations in NOTCH1 have been linked to congenital abnormalities of 
aortic valve and aorta, such as bicuspid aortic valve, increasing risk of aortic 
dilatation and valve calcification. Therapeutic agents that may influence these 
disorders are absent to date and the only therapeutic decision is elective surgical 
intervention. Thus, understanding the mechanisms underlying left ventricular 
outflow tract malformations become especially important. 
This study aimed to investigate the role of Notch-dependent cellular and 
molecular mechanisms in development of aortic and aortic valve pathologies. 
Using primary cells, first, we sought to compare the cellular functions of 
endothelial and smooth muscle cells in patients with thoracic aortic aneurysm and 
healthy donors. Second, since Notch signaling pathway is key regulator of 
endothelial-to-mesenchymal transition, the process underlying valve formation, 
we explored whether Notch-dependent endothelial-to-mesenchymal transition is 
affected in aortic endothelial cells from patients with thoracic aortic aneurysm, 
associated with bicuspid aortic valve – common congenital heart malformation. 
Third, although vascular smooth muscle cells have been considered as the main 
target of degeneration in the aortic wall, endothelial dysfunction might also be 
responsible for thoracic aortic aneurysm formation. Therefore, we addressed the 
role of Notch and Notch-related signaling pathways in shear stress response in 
endothelial cells from aortic aneurysm and healthy controls. Forth, the 
involvement of dysregulated Notch pathway in calcification is evident. In this 
work we sought to reveal early Notch-dependent mechanisms of valve 
calcification in patients with bicuspid- or tricuspid aortic valve associated 
calcified stenosis. 
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Our data demonstrate downregulation of smooth muscle as well as 
endothelial cell specific markers in the patient cells. Cellular proliferation, 
migration, and synthesis of extracellular matrix proteins are attenuated in the cells 
of the patients with thoracic aortic aneurysm compared to healthy controls. We 
show that endothelial cells from persons with aortic aneurysm and bicuspid aortic 
valve have downregulated Notch signaling and fail to activate Notch-dependent 
endothelial-to-mesenchymal transition in response to its stimulation by different 
Notch components. Activity of Wnt and BMP pathways was significantly 
elevated in endothelial cells from aneurysms. Furthermore, activation of DLL4, 
SNAIL1, DKK1, TCF4 and BMP2 was attenuated in cells of patients in response 
to shear stress, implying dysregulated Notch/BMP/WNT cross-talk.  
We report that the expression pattern of Notch genes is altered in the aortic 
valve interstitial cells of patients with calcific aortic stenosis compared to those of 
healthy persons. Interstitial cells from bicuspid calcified valves demonstrated 
significantly higher sensitivity to stimuli at early stages of induced proosteogenic 
differentiation and were significantly more sensitive to the activation of 
proosteogenic OPN, ALP and POSTIN expression by Notch activation. Notch-
dependent endothelial-to-mesenchymal transition was also more prominent in 
bicuspid valve derived endothelial cells compared to the cells from calcified 
tricuspid and healthy valves. 
This study provides the first direct functional evidence that primary aortic 
and valvular cells from patients with left ventricle outflow tract pathologies have 
impaired Notch signaling pathway comparing to healthy donors. In conclusion: 1 
- both endothelial and smooth muscle cells of aneurysmal aortic wall have 
downregulated specific cellular markers and altered functional properties, such as 
growth rate, apoptosis induction, and extracellular matrix synthesis; 2 – Notch-
dependent endothelial-to-mesenhymal transition is attenuated in endothelial cells 
of patients with thoracic aortic aneurysm and bicuspid aortic valve; 3 - shear-
stress response is impaired in endothelial cells of the patients with thoracic aortic 
aneurysm due to altered Notch/BMP/WNT/β-catenin network; 4 - early events of 
aortic valve calcification are Notch-dependent and differ in bicuspid and tricuspid 
aortic valves.       
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TAA           thoracic aortic aneurysm 
TAV           tricuspid aortic valve 
BAV           bicuspid aortic valve 
SMC           smooth muscle cells 
ECs              endothelial cells 
HAEC        human aortic endothelial cells 
HUVEC     human umbilical vein endothelial cells 
VEC           valve endothelial cells 
VIC            valve interstitial cells 
ECM          extracellular matrix 
OFT           outflow tract 
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NICD         Notch Intracellular Domain 
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 1. Introduction 
Notch signaling is an evolutionary conserved pathway regulating a vast 
range of crucial developmental process. Notch pathway is a key signaling in cell-
cell communications, determining cell fate and differentiation of many types of 
tissues. Deceptively simple molecular design of the core pathway is in apparent 
contrast to multiple Notch effects. The canonical Notch signaling is at its core a 
straightforward signaling mechanism, which is extremely dose-sensitive due to 
lack of signal amplification step or utilization of secondary messengers to transmit 
the signal from the cell surface to the nucleus. 
In accordance with a variety of cellular events that Notch pathway controls, 
many data are accumulated on pathogenic role of the Notch signaling cascade in a 
wide spectrum of human diseases including cardiovascular disorders. In the last 
decade it became clear that this signaling pathway plays an important role in 
postnatal maintenance of tissues homeostasis as well as in response to stress. 
Apparently, damage in intercellular Notch signaling could lead to abnormalities in 
tissues homeostasis, in particular in cardiovascular system and thus lead to the 
pathologies associated with a shift of cell differentiation. 
       
1.1 The core of Notch pathway. 
In mammals Notch family constitutes of four receptors (Notch 1, -2, -3, -4) 
and five ligands (Delta-like 1, -3, -4, Jagged (Serrate) 1, -2). The Notch receptors 
are type I single-pass transmembrane proteins with large extracellular ligand-
binding region (NECD), membrane-spanning part and intercellular domain 
(NICD), containing among other motifs, a transcriptional activation domain 
(Figure 1). The Notch receptors are synthesized as 300-350 kDa single precursor 
proteins that during maturation in the Golgi proteolitically processed by furin-like 
convertase at the site called S1, giving two non-covalently associated subunits 
(Logeat et al., 1998). The resulting two associated subunits compose the mature 
heterodimeric form of the protein present at the cell surface (Kopan and Ilagan, 
2009; Kopan et al., 1996). The extracellular domain composed of 29-36 N-
terminal-epidermal growth factor (EGF)-like repeats that are available to interact 
with ligands. O-linked glycosylation of these EGF repeats, including modification 
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by O-fucose, Fringe and Rumi glycosyltransferases, also modulate the activity of 
Notch receptors in response to different ligands (Kovall and Blacklow, 2010). For 
instance, modifications of EGF6 and 36 by Manic Fringe specifically inhibited 
Notch1 activation by Jagged 1 and enhances activation from Delta-like 1 (Kakuda 
and Haltiwanger, 2017). Many EGF repeats bind calcium ions that also can affect 
signaling efficiency (Raya et al., 2004). Within the extracellular domain structure, 
the EGF repeats are followed by unique negative regulatory region (NRR), which 
is composed of three cysteine-rich Lin12/Notch repeats (LNR) and 
heterodimerization domain. The NRR participates in preventing receptor 
activation in the absence of ligands (Rand et al., 2000; Sanchez-Irizarry et al., 
2004). 
The intercellular domain of Notch receptors consists of a recombination 
signal binding prtotein-1 for Jk (RBPjk)-associated molecule (RAM) domain, 
seven ankyrin repeats (ANK), edged by two nuclear localization signals (NLS), a 
transactivation domain (TAD), present in Notch 1, -2, -3, and a PEST region that 
participates in protein degradation (Rechsteiner and Rogers, 1996).  
Notch ligands are divided into two general classes, depending on their 
homology to Drosophila prototypes Delta and Serrate, and collectively referred to 
as DSL family (Delta/Serrate/LAG-2). They also are type I transmembrane 
proteins with domain organization. The extracellular domain comprises 7-16 
EGF-like repeats and DSL domain, which is unique to Notch ligands. Serrate 
family ligands differ from Delta-like ligands by larger number of EGF repeats and 
by the presence of additional cysteine-rich domain and a von Willebrand factor 
type C domain in the extracellular region (Fleming, 1998). 
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Figure 1. Notch receptors and ligands organization (Niessen and Karsan, 
2007). 
 
Transduction of Notch signal mediated by a sequence of proteolytic events 
and requires three key steps: 1 – ligand recognition; 2 – conformational changes 
and exposure of the cleavage site; 3 – assembly of nuclear transcriptional 
activation complexes (Bray, 2006; Kovall and Blacklow, 2010). Because both 
receptors and ligands are transmembrane proteins, Notch activation depends on 
direct cell-cell contact. Interaction between the Notch receptor of one cell and the 
Notch ligand of another cell (trans-interaction) results in conformational changes 
of the extracellular domain exposing a motif that is recognized and cleaved by 
ADAM metalloproteases at the S2 cleavage site (Brou et al., 2000). Binding of 
receptor and ligand in the same cell in cis generally leads to the inhibition of 
signaling (Bray, 1997; Sprinzak et al., 2010). Efficiency of ligand-receptor 
interaction depends on ubiquitylation and endocytosis of ligand in signaling cell 
promoted by E3 ubiquitin ligases such as Mindbomb-1 (Mib1). This event causes 
mechanical force on the receptor pulling protective NRR away to promote 
exposure of S2 site (Itoh et al., 2003; Kopan and Ilagan, 2009; Meloty-Kapella et 
al., 2012). S2 cleavage creates membrane-tethered intermediate called Notch 
extracellular truncation (NEXT) that is substrate for "-secretase protease complex, 
containing presenilin1, presenilin2, Pen-2, Aph-1 and nicastrin (Fischer et al., 
2007; Selkoe and Wolfe, 2007; Struhl and Greenwald, 2001). "-Secretase 
complex cleaves the Notch receptor at the two distinct sites S3/S4 and releases 
 14 
intercellular domain of Notch, which translocates to the nucleus to regulate gene 
transcription.  
All Notch signals cause changes in gene transcription mediated by nuclear 
effector CSL (CBF1 in humans, Suppressor of Hairless in Drosophila, RBPjk in 
mice). In the absence of NICD CSL is bound by corepressor proteins, such as 
SMRT (NcoR) and SHRP (MINT/SPEN), and inhibits transcription of target 
genes, recruiting histone deacetylases to its promoters (Morel et al., 2001). NICD-
CSL binding displaces corepressor complexes from CSL and allows recruitment 
of the transcriptional coactivator Mastermind-Like-1 (MAML) and histone 
acetyltransferases such as p300 (Wallberg et al., 2002). Formation of 
CSL/NICD/MAML complex results in direct transcriptional activation of target 
genes (Figure 2). 
 
    
Figure 2. Schematic representation of Notch signaling pathway (de la Pompa, 
2009).   
 
The best characterized Notch target genes are members of the basic helix-
loop-helix (bHLH) hairy/enchancer of split (HESR) family and the Hes-related 
repressor protein (HRT/Hey/Herp with YRPW motif) transcription factor family 
(Iso et al., 2003; Kokubo et al., 2005). Nevertheless, the spectrum of Notch targets 
is larger and numerous genes may be activated in parallel with HESR, including 
SNAIL1, p21, MYC, Ephrin B2, Cyclin D1, platelet-derived growth factor receptor 
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β (PDGFR β) and smooth muscle α-actin (ACTA2) (Andersson et al., 2011; Cohen 
et al., 2010; Morimoto et al., 2010; Sahlgren et al., 2008; Timmerman, 2004). The 
nuclear kinase CycC:CDK8 negatively regulates NICD activity, recruited by 
MAML it hyperphosphorylates the TAD and PEST domains of NICD resulting in 
ubiquitin-mediated proteasome degradation (Fryer et al., 2004). Altogether, it has 
been suggested that versatility of Notch signaling functions is ensured by 
numerous posttranslational modifications of both receptors and ligands, amount of 
receptors and ligands expressed in distinct cell context, and via coactivators and 
inhibitors that operate at every level of the signaling cascade.  
 
1.2 Notch pathway in cardiac development. 
The heart development initiates from formation of the cardiac crescent by 
bilateral precardiac mesoderm cells. The crescent contains two populations of 
precardiac cells - the first and second heart fields (FHF and SHF) that include 
progenitors of the first cardiac tissues, the myocardium and endocardium 
(Buckingham et al., 2005; Kelly et al., 2014). At this stage Notch ligand Jag1 is 
expressed in endocardium, labeling the presumptive valve area of the 
atrioventricular channel (AVC) and throughout the myocardium, while NICD and 
Dll4 are expressed in the endocardium (Luxán et al., 2016). These observations 
suggest early Notch signaling activity in heart development. The crescent fuses at 
the embryonic midline to form a single primary heart tube consisting of an inner 
endocardial layer and an outer myocardial layer separated by an extracellular 
matrix named cardiac jelly. At this stage Jag1 expression is maintained in the 
endocardium and is activated in myocardium, while restricted endocardial 
expression is exhibited by Dll4, Notch2, NICD and Notch4 (Del Monte et al., 
2007; Luxán et al., 2016; Timmerman, 2004). The heart tube grows by addition of 
SHF progenitors into its anterior (arterial) and posterior (venous) poles and 
undergoes rightward looping morphogenesis. The initial anterior-posterior 
polarity changes into right-left patterning. At this stage NICD expression is 
relatively uniform in presumptive valve endocardium (the endocardium lining the 
AVC and the outflow tract (OFT)), but restricted to the endocardium at the base 
of the developing trabeculae in the ventricules. Jag1 is expressed in AVC 
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endocardium and myocardium, Notch2 is detected in chamber endocardium 
(Loomes et al., 2002). The FHF will give rise to the left ventricle (LV) and other 
parts of the heart, except the OFT, whereas the SHF will give rise to OFT and 
other parts except the LV.  
A third cardiac tissue covering the myocardium, epicardium, develops from 
proepicardium, which arises from cells of splanchnic mesoderm, located at the 
venous pole of the embryonic heart. These cells, which express Dll4, Jag1, 
Notch1, NICD, Notch3 and HEY, migrate to cover myocardium (Grieskamp et al., 
2011; del Monte et al., 2011). Epicardial cells then undergo epithelial-to-
mesenchymal transition and generate a population of epicardium-derived cells, 
expressing Dll4, Jag1 and NICD , that contribute coronary vessel formation (Cai 
et al., 2009).  
In late gestation Jag1 is expressed in smooth muscle cells around the valve 
and in chamber myocardium, Dll4 in developing coronary vessels and Notch1 in 
valve and chamber endocardium (Luxán et al., 2016). Epicardium, myocardium 
and endocardium are tightly associated and their interactions during cardiogenesis 
ensure highly regulated cardiac pattern, proper cell differentiation and tissue 
morphogenesis, resulting in formation of fully functional heart at birth.   
 
1.2.1 Role of Notch pathway in ventricular trabeculation. 
During ventricular chamber development the myocardium differentiates into 
two distinct layers: an outer compact zone and an inner trabecular zone. 
Trabeculae are sheets of cardiomyocytes forming muscular ridges lined by 
endocardial cells (Moorman and Christoffels, 2003). Trabecular cardiomyocytes 
and endocardium are in close interactions regulating cardiomyocyte proliferation 
and differentiation (Sedmera et al., 2000). Several signaling pathways are required 
for trabeculation, such as Bmp10, Nrg1/ErbB and EphrinB2/EphB4 (Chen, 2004). 
Notch1 activity is observed in ventricular endocardium at the base of the forming 
trabeculae. Dll4 and Jag1 are expressed in opposite manner: Dll4 is observed in 
endocardium, at the base of the developing trabeculae, whereas Jag1 is expressed 
in chamber myocardium with stronger expression in the cardiomyocytes forming 
trabeculae (D’Amato et al., 2015, 2016; Luxán et al., 2016).  
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Notch pathway is required for regulation of key pathways of trabeculae 
formation. Murine embryos lacking, systematically or in the endocardium, 
NOTCH1 or RBPjk show impaired trabeculation (Grego-Bessa et al., 2007). In the 
endocardium, EFNB2 is direct target of NICD and its expression is abrogated in 
Notch mutants. Neureguline1-ErbB signaling is essential for initiation of 
trabeculation (Meyer and Birchmeier, 1995). Neuregulin1 (NRG1) is expressed in 
endocardial cells and acts as paracrine factor for ErbB2-ErbB4 receptors 
expressed in cardiomyocytes (D’Amato et al., 2016; Meyer and Birchmeier, 
1995). Expression of NRG1 in endocardium is regulated by direct target of Notch 
– HAND2 (VanDusen et al., 2014). 
Impaired Notch pathway also affects expression of the cytokine Bmp10, a 
chamber specific bone morphogenetic protein (BMP) family member. Expression 
of Bmp10 is restricted to the trabecular myocardium. BMP10 knockout murine 
embryos dead before birth and show dramatically reduction in cardiomyocyte 
proliferative activity (Chen, 2004).  
Recent data show that heart chamber development is coordinated by 
sequential Notch1 receptor activation, regulated by glycosyltransferase Manic 
Fringe (MFng) (D’Amato et al., 2015). MFng-favoured endocardial Dll4-Notch1 
signaling promotes cardiomyocytes proliferation and differentiation resulting in 
trabeculation. Myocardial Jag1/Jag2 – Notch1 signaling, occurring after MFng 
(and Dll4) downregulation in the endocardium, supports myocardial patterning, 
maturation and compaction (D’Amato et al., 2015, 2016).  
 
1.2.2 Role of Notch pathway in atrioventricular canal development. 
The boundary between the prospective atrial and ventricular chamber 
regions of the heart tube is known as the atrioventricular canal (AVC). Formation 
of AVC is dependent on BMP2 regulated expression of T-transcription factor 2 
(TBX2), which inhibits chamber-specific gene expression within the myocardium 
of AVC (Harrelson, 2004). Cardiac-specific deletion of BMP2 results in a failure 
of AVC specification, whereas mice lacking TBX2 show defective AVC 
patterning and ectopic expression of chamber specific genes (Aanhaanen et al., 
2009; Ma, 2005). Notch signaling pathway has been shown to restrict BMP2 
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expression to AVC myocardium. Expression of Notch targets HEY1 and HEY2 is 
restricted to the atria and the ventricles, respectively, but is excluded from the 
AVC. Ectopic expression of NICD in the myocardium of mouse hearts activated 
HEY1 and HEY2 expression throughout this tissue, which in turn resulted in 
downregulation of both BMP2 and TBX2 expression and loss of AVC boundaries 
(de la Pompa and Epstein, 2012; Luna-Zurita et al., 2010; Rutenberg et al., 2006; 
Watanabe, 2006). Simultaneously, inactivation of Notch signaling in RBPjk-
targeted mutants does not affect myocardial HEY1, HEY1 and BMP2 expression 
(Luna-Zurita et al., 2010). Although these studies show apparent role of HEY1 
and HEY2 in AVC formation, precise mechanisms remain to be elucidated. 
 
1.2.3 Early valve development. 
Early valve development initiates with the formation of the endocardial 
cushions by a process of endothelial-to-mesenchymal transition (EMT) that takes 
place initially in the AVC and later in the OFT endocardium. Before the 
beginning of cushion formation, the endocardium and the myocardium lie 
adjacent to each other, separated by thick hyaluronan-rich gelatinous extracellular 
matrix named a cardiac jelly. Myocardial signals from AVC and OFT regions 
instruct adjacent endocardial cells to undergo EMT. During this process 
endocardial cells undergo phenotypic and morphological alterations, resulting in 
loss of apical-basolateral polarity and disruption of intercellular junctions, and 
acquire the ability to degrade the basement membrane and migrate away from 
endothelial sheet to invade the underlying cardiac jelly (Person et al., 2005). 
Endocardial cells exhibit abundant expression of intercellular adhesion complexes 
such as E-Cadherin and integrins. In order to acquire a mesenchymal phenotype, 
cells must lose cell adhesion by E-Cadherin downregulation and degradation. 
Completing the transition, cells activate the expression of additional mesenchymal 
genes and proteins, such as α-smooth muscle actin (αSMA, ACTA2), smooth 
muscle protein 22α (SM22α, TAGLN), collagen I and III, vimentin and fibroblast-
specific protein 1 (FSFS100A4) (Kovacic et al., 2012).  
This EMT generates mesenchymal progenitor cells that contribute to 
valvuloseptal structure and adult valve interstitial cells (VIC) (Butcher and 
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Markwald, 2007). Growth and proliferation of this newly formed mesenchymal 
cells results in fusion of endocardial cushions within the lumen of the heart tube 
and formation of the initial septa. Further remodeling of the endocardial cushions 
by condensation and elongation results in the formation of atrioventricular and 
arterial valves that ensure unidirectional blood flow in the mature heart (Hinton 
and Yutzey, 2011; Niessen and Karsan, 2007).  
Notch pathway is indispensable for early specification and initiation of 
EMT in the endocardial cells. Notch pathway genes are expressed in prospective 
valve endocardium at the beginning of EMT (Del Monte et al., 2007; 
Timmerman, 2004). Dll4 seems to be more relevant ligand at this stage, whereas 
Notch1 is a receptor with strongest endocardial expression, and the three receptors 
Notch1-3 are expressed in transforming mesenchymal cells of the AVC and the 
OFT (Timmerman, 2004). Recent data suggest sequential activation of Notch1 in 
the endocardium during valve morphogenesis and heart septation: first by Dll4 to 
induce EMT and subsequently by Jag1 to ensure proper cushion fusion and 
restrain mesenchymal cell proliferation before differentiation (MacGrogan et al., 
2016). Co-culture of HMEC-1 microvascular endothelial cell line-1 with cells 
bearing ligand Jag1 results in EMT induction (Noseda, 2004). Similar phenotypes 
between Notch1 and RPBjk mutant embryos indicates that Notch1 might be the 
most relevant Notch receptor in the endocardium (Timmerman, 2004). In murine 
model targeted inactivation of Notch1 (or RBPjk) results in severely hypoplastic 
endocardial cushions due to impaired EMT. Histological analysis of mutants 
reveals that endocardial cells remain in close association, abnormally maintain 
adherens junctions, and do not invade the cardiac jelly, despite exhibiting features 
of activated premigratory endocardial cells (Timmerman, 2004). EMT involves 
the upregulation of the Snail family of transcription factors, which are responsible 
for downregulation of the cell-adhesion molecule vascular endothelial cadherin 
(VE-cadherin, encoded by CDH5) (Nieto, 2002). The proposed mechanism is that 
NICD-RBPjk directly activates the EMT drivers SNAIL1/2, whose expression is 
severely reduced in AVC and OFT endocardium of Notch1 (or RBPjk) mutant 
mice (Timmerman, 2004). Concomitantly, CDH5 expression remains abnormally 
stabilized in the endocardium of the mutants, suggesting that loss of SNAIL1/2 
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expression prevents downregulation of cadherin-mediated endocardial cell 
adhesion, that blocks EMT (Sahlgren et al., 2008; Timmerman, 2004). These in 
vivo observations were confirmed by the defective EMT in AVC and OFT 
explants from either Notch1-deficient mice or wild-type explants treated with 
Notch signaling inhibitor and cultured in vitro onto 3D-collagen gel (Timmerman, 
2004). Numerous functional studies in mouse embryos indicate that myocardial 
paracrine and endocardial autocrine production of transforming growth factor beta 
2 (TGFβ2) and TGFβ3 are required for endocardial cushion formation 
(Camenisch et al., 2002). Moreover, Notch1 (or RBPjk)-deficient mice show 
specific reduction of transcription of TGFβ2 in AVC and OFT myocardium, 
suggesting that endocardial Notch function is needed for production of the 
myocardial TGFβ2 signal (Timmerman, 2004). Mice lacking HRT1 (HEY1) and 
HRT2 (HEY2) die during embryogenesis due to severe cardiovascular 
malformations, including impaired development of endocardial cushions (Fischer 
et al., 2007; de la Pompa, 2009).  
Gain-of-function studies support the importance on Notch signaling for 
EMT. Constitutive Notch1 activity in the endocardium enables ectopic 
noninvasive EMT of ventricular endocardial cells, conferring valvular features to 
nonvalvular, “EMT-resistant” ventricular endocardium (Luna-Zurita et al., 2010). 
In zebrafish model overexpression of NICD in heart leads to formation of 
hypertrophic atrioventricular valves (Timmerman, 2004). 
Moreover, the integration of endocardial Notch and myocardial BMP2 has 
been revealed to promote EMT. Notch1 is required for SNAIL1 expression and 
BMP2 signaling regulates SNAIL1 activation through Alk3/6 receptors in 
endocardium and inhibition of glycogen synthase kinase-3β (Gsk3β) activity 
(Luna-Zurita et al., 2010; Ma, 2005). Endocardial Notch1 induces the expression 
of WNT4, which acts as a paracrine factor to upregulate BMP2 expression in the 
adjacent AVC myocardium to signal EMT (Luxán et al., 2016; Wang et al., 
2013). The role of BMPs in initiation of EMT is supported by in vivo analysis of 
mice lacking myocardial BMP2 expression, which show no AVC endocardial 
cushion mesenchymal cell formation (Ma, 2005; Rivera-Feliciano and Tabin, 
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2006). All these findings show that Notch activity is required for endocardial 
EMT.   
 
1.2.4 Notch activity in outflow tract development and remodeling. 
The OFT is a structure at the arterial pole of the heart connecting the right 
and left ventricles with the pulmonary trunk and aorta, respectively. OFT 
development depends on coordinated interactions between multiply cell types 
originating from within and outside the heart: the endocardium, the endocardium-
derived mesenchyme, cardiac and smooth muscle precursors from the SHF, and 
cardiac neural crest (CNC) (Hutson and Kirby, 2007). During cardiogenesis the 
single vessel arised from the looped heart, truncus arteriosus, is remodeled under 
the influence of invading CNC progenitors and septates to form two vessels, the 
aorta and the pulmonary trunk. Simultaneously, the OFT rotates and aligns with 
the ventricles.  
The CNC cells are a multipotent population of progenitor cells arised from 
the dorsal neural tube that among other cell types give rise to melanocytes, nerve 
tissue, muscle, cartilage and bone. Deficient CNC contribution into the OFT 
results in persistent truncus arteriosus because of lack of mesenchymal 
contribution to the aortic-pulmonary septum (Neeb et al., 2013). In addition, CNC 
play crucial role in positioning the cushions and patterning the valve cusps within 
the developing OFT cushions (Luxán et al., 2016; Phillips et al., 2013). Cells of 
SHF and CNC are not randomly intermixed in the OFT and ascending aorta. SHF 
mesenchymal cells are dominantly located in the aortic root, while CNC cells 
populate the intimal edge of ascending aorta (Harmon and Nakano, 2013; 
Pfaltzgraff et al., 2014; Waldo et al., 2005). In the developing aortic valve CNC 
cells populate the aortic surface, whereas SHF cells populate the ventricular 
surface of the valve (Yassine et al., 2017).      
Notch elements are broadly expressed in developing OFT (High et al., 2007; 
Loomes et al., 2002). Deletion of the Notch ligand Jag1, or inhibition of Notch 
signaling within the SHF resulted in impaired development of neighboring tissue 
because of defective EMT and CNC migration (High et al., 2009). Deficient SHF 
contribution to the OFT causes a spectrum of malformations such as double outlet 
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right ventricle and over-riding aorta, which represents a set of incorrect alignment 
defects (Neeb et al., 2013). These malformations are closely to those seen in 
human with Allagile syndrome, caused by mutations in JAG1 or NOTCH2, and 
among others characterized by right-sided OFT defects (Li et al., 1997; McDaniell 
et al., 2006; Oda et al., 1997). Double heterozygous for the JAG1 null allele and 
NOTCH1 hypomorphic allele mutant mice exhibit characteristic Allagile 
syndrome abnormalities including OFT developmental defects (McCright et al., 
2002). Conditional inhibition of Notch signaling in CNC derivatives resulted in a 
spectrum of outflow tract and aortic arch malformations, associated with 
decreased differentiation and expression of smooth muscle cell (SMC) markers 
(High et al., 2007). Thus, Notch signaling seems to be an important mediator of 
interactions between SHF, CNC and OFT endocardium/endothelium.        
 
1.2.5 Notch signaling in the vasculature. 
Vasculogenesis is the de novo development of endothelial cells (ECs) from 
a dispersed population of mesodermally derived endothelial cell progenitors - 
angioblasts, whereas angiogenesis is the formation of new vessels from 
preexisting vessels. Angioblasts first differentiate and form the primary vascular 
plexus, which then is remodeled during angiogenesis, involving sprouting, 
bridging, and intussusception (vessel splitting), to generate the mature vascular 
system. Angiogenesis requires ECs to adopt specialized phenotypes and functions. 
Leading ECs, named the tip cells, are migratory and invasive, and are thought to 
guide new sprouts. Tip cells are followed by stalk cells, which elongate, 
proliferate and stabilize the nascent vessel and establish a lumen (Betz et al., 
2016; Potente et al., 2011).  
Tissue hypoxia is key trigger factor of the new vessel branches formation. It 
induces secretion of pro-angiogenic growth factors and cytokines, such as 
vascular endothelial growth factor (VEGF), which binds VEGF receptors 
(VEGFRs) on surface of ECs and promotes proliferation, migration and tip cell 
formation (Simons et al., 2016). ECs with high activation of VEGFR2 and 
VEGFR3 became tip cells and upregulate expression of DLL4 (Blanco and 
Gerhardt, 2013; Potente and Mäkinen, 2017). DLL4 induces stalk cell phenotype 
 23 
in adjacent ECs by Notch1 signaling activation, resulting in downregulation of 
VEGFR2 and VEGFR3 and activation VEGFR1 expression, that sequesters 
VEGF. Thus, Dll4-Notch1 signaling establishes differential VEGFR expression 
and VEGF sensitivity, that in turn ensure tip-stalk cell specification (Blanco and 
Gerhardt, 2013; Zarkada et al., 2015). During spouting, the levels of VEGFRs are 
permanently changed depending on ECs environment, allowing asymmetric cell 
division and reaction on new cellular neighbours (Blanco and Gerhardt, 2013; 
Costa et al., 2016). Thus, stalk cells can become tip cells and conversely, ensuring 
dynamic position changes in the growing vessels (Jakobsson et al., 2010).  
Dll4-deficient embryos as well as RBPjk mutant and HEY1/HEY2 double 
mutant embryos exhibited severe vascular defects and did not express arterial 
markers (Duarte, 2004; Fischer et al., 2004; Gale et al., 2004; Krebs, 2004). Notch 
ligand Jag1 has been shown to play antagonistic role during sprouting 
angiogenesis. JAG1 loss-of-function mutant mice have reduced sprouting 
angiogenesis in retina, while JAG1 overexpression enhanced angiogenesis and 
resulted in increased number of tip cells. Thus, Jag1 seems to act as a 
proangiogenic signal during postnatal retinal angiogenesis (Benedito et al., 2009; 
Pedrosa et al., 2015).   
Moreover, Notch signaling is among key pathways regulating arterial 
venous specification (Domenga et al., 2004). Both, Notch deficient and Notch 
gain-of-function mouse embryos develop arteriovenous malformations (Duarte, 
2004; Gale et al., 2004; Krebs, 2004). Ectopic NOTCH4 and NOTCH1 expression 
in endothelial cells resulted in development of arteriovenous malformations and 
embryonic vascular remodeling defects (Kim et al., 2008; Krebs et al., 2010). 
EphrinB2, one of key arterial markers, is direct target of Notch signaling (Grego-
Bessa et al., 2007). EphrinB2 loss-of-function mutants displayed the 
arteriovenous malformations their presented in embryos with Notch1 conditional 
activation in endothelial cells. Inducible expression of an activated NOTCH4 in 
adult mice resulted in vessel arterialization (Carlson et al., 2006; Gridley, 2010).  
 
  To support the growing network of endothelial cell tubes, mural cells are 
recruited and differentiate into smooth muscle cells (SMC) and pericytes. This 
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recruitment is largely driven by a gradient of PDGF-β secreted by endothelial 
cells (Hellstrom et al., 1999). Notch ligands expressed by endothelial cells can 
activate Notch signaling in these mural cells, which in turn ensure integrin 
adhesion to the endothelial basement membrane and induces maturation and 
differentiation (Scheppke et al., 2012). Among all Notch receptors Notch2 and 
Notch3 appear to be the most important for SMC. These two receptors affect the 
phenotype and functions of SMC (Baeten and Lilly, 2015; Liu et al., 2015). Notch 
signaling in the endothelium of the vessel is positioned to mediate differentiation 
of underlying SMC, ensuring integrity of the vessel wall (Pedrosa et al., 2015). 
Mice with an endothelial deletion of JAG1 displayed decreased SMC 
differentiation and expression of SMC markers (High et al., 2008). Moreover, 
activation of Notch signaling in SMC by endothelial-expressed Jag1 leads to 
increased expression of NOTCH3 and JAG1 (Baeten and Lilly, 2017). This 
finding suggests the lateral induction of Notch signaling within multiple SMC 
layers, ensuring the promotion of differentiation initially induced by endothelium 
signal (Hoglund and Majesky, 2012; Liu et al., 2009; Manderfield et al., 2012). 
Notch pathway has been shown to increase expression of PDGF-β receptor. Thus, 
active Notch signaling in SMC may increase migration in response to PDGF-β 
(Jin et al., 2008). Notch1 and Notch3 were shown to facilitate SMC migration in 
vitro (Sweeney et al., 2004). Notch target gene HEY2 was also demonstrated to 
promote proliferation, migration and formation of neointimal layer in a mouse 
injury model (Sakata, 2004). All these observations evidence that Notch signaling 
pathway is indispensable for recruitment of mural cells.    
SMC are not “terminally differentiated”, possessing to exist in multiple 
phenotypes allowing a wide range of functions, such as contraction, proliferation 
or synthesis and secretion of extracellular matrix (ECM). A “differentiated” SMC 
phenotype is generally determined as a quiescent cell, expressing genes encoding 
contractile proteins, such as αSMA (ACTA2), smooth muscle myosin heavy chain 
(MYH11), transgelin known as SM22α (TAGLN) and calponin (CNN1). This is 
required cell state for mature vessels to maintain physiological homeostasis. The 
effect of Notch signaling on SMC phenotype is controversial. Notch signaling has 
been linked to SMC differentiation both in vitro and in vivo (Boucher et al., 2012; 
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Doi et al., 2006; Noseda, 2006). At the same time, some data suggest Notch 
signaling to repress SMC differentiation and maintenance of the contractile SMC 
phenotype (Morrow, 2005; Proweller et al., 2005; Sweeney et al., 2004). 
The proliferation of SMC is negatively related to their differentiation status. 
Mitotically active cells are considered as “dedifferentiated” or “synthetic” 
(Owens, 2004). In several papers Notch pathway has been shown to promote 
SMC proliferation (Campos, 2002; Sweeney et al., 2004). At the same time, the 
Notch2 receptor has been shown to localize in non-proliferating regions of injured 
vessels and it inhibited proliferation through cell-cycle arrest (Baeten and Lilly, 
2017; Boucher et al., 2013). Interestingly, while both Notch2 and Notch3 promote 
contractile differentiation, they oppositely affect SMC proliferation, thereby 
underlining abundant Notch-dependent regulation of SMC phenotype. Moreover, 
Notch signaling has been involved in suppression of apoptosis and promotion of 
cell survival, apparently, with receptor specific effect and integration with other 
signal pathways (Baeten and Lilly, 2015, 2017; Liu et al., 2010; Sweeney et al., 
2004). 
SMC and their progenitors are key contributors to the ECM production. 
Notch activity has been demonstrated to promote ECM synthesis, whereas 
inhibition of Notch activity resulted in decreased expression of collagen IV and 
laminin, but increased expression of MMP2 and MMP9 (Lilly and Kennard, 2008; 
Yao et al., 2015). 
Thus, it is obvious that proper vasculature development and its further 
maintenance, including sprouting angiogenesis, endothelial cell specification, 
recruitment and differentiation of mural cells, ECM production and arteriovenous 
specification, is tightly regulated by Notch signaling pathway. 
 
1.3 Notch pathway in left ventricular outflow tract pathologies. 
Mutations in components of Notch pathway result in a spectrum of left 
ventricular outflow tract malformations. The most prevalent abnormalities are 
bicuspid aortic valve disease and calcification of the aortic valve. Bicuspid aortic 
valve describes an aortic valve with two rather three leaflets, where adjacent cusps 
fuse to form a single aberrant cusp (Figure 3).  
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Figure 3. (A) Normal tricuspid aortic valve. (B) Congenitally bicuspid aortic 
valve, one cusp (asterisk) larger than the other (Fedak et al., 2002).   
 
Bicuspid aortic valve (BAV) is the most common congenital heart 
malformation, occurring in 1% to 2% of the population (Prakash et al., 2014). The 
most frequent complication of BAV is aortic stenosis, attended by the premature 
fibrosis, stiffening and calcium deposition (Fedak et al., 2002). Although only 
<2% of the population has BAV, but they represent about 50% of the patients 
undergoing aortic valve replacement (Roberts, 2005). Calcification also occurs at 
an earlier age in BAV compared to individuals with the normal tricuspid anatomy 
(tricuspid aortic valve, TAV) (Beppu et al., 1993; Fedak et al., 2002).  
NOTCH1 mutations have been associated with BAV and have been found in 
individuals with various left ventricular outflow tract (LVOT) abnormalities, such 
as hypoplastic left heart syndrome, coarctation of the aorta and aortic valve 
stenosis (Garg et al., 2005; Koenig et al., 2017; McKellar et al., 2007). Recently it 
has been shown that NOTCH1 haploinsufficiency promotes proosteogenic and 
inflammatory gene expression and dramatically influences the capacity of human 
iPS-derived endothelial cells to resist shear stress, this may explain the aortic 
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pathology in the case of NOTCH1 mutations (Theodoris et al., 2015). It has been 
suggested that the valve defect may arise during development of the aortic 
valvular cusps and aortic media from CNC cells (Bonderman et al., 1999). 
Combined loss of NOTCH1 downstream targets, HEY1 and HEYL causes 
impaired EMT in mice (Fischer et al., 2007). Functional studies on the missense 
NOTCH1 mutations associated with LVOT malformations have shown reduced 
receptor signaling associated with defective EMT in HMEC-1 microvascular 
endothelial cell line used as a model (Riley et al., 2011). 
The mechanisms underlying heart valve calcification are not fully 
elucidated. The progressive valve fibrosis and mineralization were earlier believed 
to be a passive degenerative process, but it is now recognized as an active disease 
process driven by the cells originating to the aortic valve (Goldbarg et al., 2007; 
Pomerance, 1967; Rutkovskiy et al., 2017).  Normal aortic valve leaflets have two 
cell types: valve interstitial cells (VIC) and valve endothelial cells (VEC) 
(Rutkovskiy et al., 2017). It has been suggested that VIC are the main functional 
units of the valve that undergo mineralization (Rabkin-Aikawa et al., 2004). 
However, the VEC may also participate in the mineralization process (Cheng et 
al., 2013; Hjortnaes et al., 2015; Shapero et al., 2015; Yao et al., 2013). Ability of 
VEC to EMT may also contribute valve calcification. Human pulmonary VEC 
were capable of responding to TGFβ to produce VIC phenotype (Paruchuri et al., 
2006). In addition, mechanical strain was shown to enhance EMT of VEC through 
TGFβ/Smad and Wnt/βcatenin signaling cascade (Balachandran et al., 2011). The 
data regarding the role of Notch in aortic valve calcification are controversial. 
Notch1 can prevent osteogenic calcification, however, opposite data suggest that 
Notch1 promote osteogenic calcification in human VIC (Acharya et al., 2011; 
Nigam and Srivastava, 2009; Zeng et al., 2013). However, haploinsufficiency for 
a RBPjk predisposes to diet-induced calcific aortic valve disease in mice (Nus et 
al., 2011). Notch pathway seems to play complex role in aortic valve calcification, 
which should be interpreted with respect to the process timeline, the species and 
the end point employed in the study (Rutkovskiy et al., 2017). 
BAV patients are at increased risk for aortic dilation, aneurysm, and 
dissection (Fedak et al., 2003, 2002; Gleason, 2005). Thoracic aortic aneurysm 
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(TAA) is a life threatening condition, which is manifested by progressive 
enlargement of the thoracic aorta due to altered cellular composition and 
degeneration of the ECM in the aortic wall. The pathogenesis of aneurysm 
formation in the monogenic syndromes has been extensively studied (Lindsay and 
Dietz, 2011). However, the molecular and cellular mechanisms of the other forms, 
which constitute the majority of TAA, remain largely unknown and conservative 
therapy is currently absent for this disease (Atkins, 2014). Non-syndromic TAA 
may occur in the presence of TAV or BAV, and several lines of evidence suggest 
that the mechanism behind aneurysm development is distinct between the two 
patient groups (Balistreri et al., 2013; Folkersen et al., 2011; Ignatieva et al., 
2017; Kjellqvist et al., 2013). SMC have been considered as the main target of 
degeneration in the aortic wall, however, as endothelial cells have a substantial 
influence on smooth muscle cell differentiation via Notch pathway, recent studies 
suggest that TAA may be associated with endothelial dysfunction (Ali et al., 
2014; Baeten and Lilly, 2015; Liu et al., 2015). In addition to mutations in 
NOTCH1 (Dong et al., 2015; Freylikhman et al., 2014; Kerstjens-Frederikse et al., 
2016; McBride et al., 2008; Mohamed et al., 2006), gene GATA5 also has been 
associated with non-syndromic forms BAV/TAA (Padang et al., 2012, 2015). 
Recently, variants and mutations of NOTCH1 gene have been reported in patients 
with TAV-associated LVOT abnormalities (Ducharme et al., 2013; Irtyuga et al., 
2017).  
Altogether, it is obvious, that mutations in genes encoding components of 
the Notch pathway as well as impaired Notch signaling during cardiogenesis lead 
to a broad spectrum of LVOT disorders. 
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2. Materials and Methods 
 
2.1 Patients. 
The clinical research protocols were approved by the local Ethics 
Committee of the Almazov National Medical Research Center and were in 
accordance with the principle of the Declaration of Helsinki. All patients gave 
informed consent.  
Samples of the aneurysmal wall of the ascending aorta were harvested 
during surgery for aneurysm corrections at the Almazov National Medical 
Research Center. All samples were from aneurysms with a diameter of >5 cm 
measured by preoperative transthoracic echocardiography. Patients with 
connective tissue disorders were excluded. The patients are described in Table 1. 
Control aortic specimens were obtained during organ harvesting from organ 
transplant donors (n = 16) with the authorization of the law of Russian Federation 
and in accordance with the Declaration of Helsinki. Donors used as controls had 
no evidence of aneurysmal disease and all had TAV.  
Valve interstitial cells (VIC) and valve endothelial cells (VEC) were 
isolated from aortic valves explanted during aortic valve replacement at the 
Almazov National Medical Research Centre. Patients with known infective 
endocarditis and rheumatic disease as well as patients with left ventricular systolic 
dysfunction were excluded from the study. VIC and VEC from normal aortic 
valves were isolated from healthy valves obtained from explanted hearts from 
recipients of heart transplantation (n = 11). Due to the low incidence of BAV in 
the population all healthy valves were TAV. Clinical data regarding patients with 
aortic stenosis in BAV and TAV are shown in Table 2. 
Human umbilical vein endothelial cells (HUVEC) were harvested from 
umbilical cords after birth at the Almazov Medical Research Centre. 
 
Table 1. Clinical characteristics of TAA patients.  
Parameters TAV (n = 13) BAV (n = 22) 
Male gender (%) 46 59 
Age (years) 71.3 ± 2.53 (range 55–84) 62.1 ± 1.87 (range 42–79) 
 30 
Aortic diameter (cm) 5.6 ± 0.18* 5.9 ± 0.16*† 
Aortic CSA/h (cm2/m) 6.6 ± 0.6* 7.6 ± 0.6* 
Peak valve gradient 
(mmHg) 
83 ± 9 86 ± 11 
Mean valve gradient 
(mmHg) 
55 ± 7 59 ± 9 
Aortic valve area index 
(cm2/m2) 
0.39 ± 0.02 0.38 ± 0.02 
Hypertension (%) 84* 81* 
Medication 
 
Angiotensin receptor 
blockers (%) 
38* 18 
Statins (%) 0 41*† 
Aspirin (%) 31 14 
Values are means ± SEM. *𝑃 < 0.05 compared with donors; †P<0.05 compared 
with TAV; CSA/h, ascending aortic cross-sectional area to patient height ratio. 
 
Table 2. Clinical characteristics of patients with calcified aortic valve 
stenosis. 
Parameters 
Patients with 
BAV 
Mе (25th; 
75th percentile)  
(n=13) 
Patients with TAV 
Mе (25th; 
75th percentile)  
(n=17) 
p 
Age, years  59.0 (53.0;66.0) 63.0 (58.0;67.0) 0.133 
Gender 
F -14 (36.8%);  
M – 24 (63.2%) 
F -15 (46.8%);  
M – 17 (53.2%) 
0.472 
AV, Vmax, m/s 4.70 (4.20;5.00) 4.40 (3.95;4.90) 0.007 
AV dpmean, mm Hg 
57.00 
(48.00;66.00) 
47.00 (35.00;57.00) 0.006 
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Aortic diameter at the 
proximal ascending 
aorta, mm 
41 (35;44) 36 (32;40) 0.038 
Body mass index 
(BMI), kg/m2  
27.40 
(25.51;30.34) 
32.62 (26.79;34.94) 0.022 
Total cholesterol, 
mmol/L  
5.59 (4.42;6.25) 4.91 (4.23;6.11) 0.307 
High-density 
lipoproteins (HDL-C), 
mmol/L 
1.27 (1.08;1.41) 1.16 (1.04;1.46) 0.533 
Low-density 
lipoproteins (LDL-C), 
mmol/L 
3.50 (2.57;4.45) 3.54 (2.77;4.17) 0.758 
C-reactive protein 
(CRP), mg/L 
1.56 (1.10;3.86) 3.01 (1.06;4.70) 0.451 
BMI - body mass index; AS-aortic stenosis; HDL-C – high-density lipoprotein 
cholesterol; LDL-C – low-density lipoprotein cholesterol. 
 
 
2.2 Cell cultures.  
2.2.1 Primary cell cultures. 
Smooth muscle cells and aortic endothelial cells were isolated from tissue 
fragments of aortic wall of BAV- and TAV-associated thoracic aortic aneurysm 
patients and of healthy donors. All tissues were sampled from the outer curvature 
of the ascending aorta and the tissue was immediately dissected to separate medial 
layers followed by either freezing or enzymatic digestion. 
Valve endothelial cells and valve interstitial cells were isolated from aortic 
valve leaflets of patients with BAV- and TAV-associated calcified aortic valve 
stenosis as well as from tricuspid aortic valve of healthy donors. 
All cell cultures were maintained at 37°C in a humid 5% CO2 atmosphere.  
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2.2.2 Isolation of human aortic endothelial cells (HAEC). 
Under sterile conditions tissue fragments of aortic wall were dissected away 
from the adventitia. After washing in Phosphate-buffered Saline (PBS), the tissue 
fragments were first incubated for 30 minutes at 37°C with 0.1% collagenase 
solution (Collagenase, Type III, ≥100 units/mg, Worthington Biochemical 
Corporation, USA). Then endothelial layer was removed mechanically by scalpel 
blade, collagenase solution with endothelial cells was collected and centrifuged 
for 5 minutes at 300 g. The pellet containing endothelial cells was washed twice 
with Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen, USA) and plated 
onto 3 cm2 culture dish covered with 0.2% gelatin (Sigma-Aldrich, USA) in 
Endothelial Cell Medium (ECM) (ScienCell, USA) and incubated at 37°C. On the 
next day endothelial cells were washed with PBS and culture medium was 
changed. The cells were used in experiments at passages 2-5. 
 
2.2.3 Isolation of human smooth muscle cells. 
To obtain smooth muscle cells (SMC) cultures the cells were isolated as 
previously described (Kirschenlohr et al., 1996). Briefly, the remaining after 
HAEC isolation aortic tissue was incubated for 1 hour at 37°C in 0.1% 
collagenase solution (Collagenase, Type III, ≥100 units/mg, Worthington 
Biochemical Corporation, USA). Then aortic tissue fragments were washed with 
fresh DMEM supplemented with 20% of Fetal Calf Serum and gentamycin. Using 
scissors enzymatic digested tissue was cut into small pieces (cubes 1-2 mm on a 
side) and transferred on T-25 flask. The cells were maintained in DMEM with 
20% of Fetal Bovine Serum (FBS), 2mM L-glutamine and 100units/ml 
penicillin/streptomycin and were used in experiments between passages 2–5. 
 
2.2.4 Isolation of human valve endothelial cells. 
Valve endothelial cells (VEC) were isolated form human aortic valve 
leaflets. Valve leaflets were washed with PBS and incubated for 10 minutes at 
37°C with 0.2% collagenase solution (Collagenase type IV, ≥160 units/mg, 
Worthington Biochemical Corporation, USA). Then the valve tissue was vortexed 
for 1 min to remove endothelial cells, supernatant was collected and centrifuged 
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for 5 minutes at 300 g. The pellet of cells was washed with DMEM and plated 
onto 3 cm2 culture dish covered with 0.2% gelatin (Sigma-Aldrich, USA) in 
Endothelial Cell Medium (ECM) (ScienCell, USA) and incubated at 37°C. On the 
next day endothelial cells were washed with PBS and culture medium was 
changed. The endothelial cells between passages 2-5 were used for experiments. 
 
2.2.5 Isolation of human valve interstitial cells. 
To isolate valve interstitial cells (VIC) the remaining after VEC isolation 
valve tissue was incubated with 0.2% collagenase solution (Collagenase type IV, 
≥160 units/mg, Worthington Biochemical Corporation, USA) for 24 hours at 
37°C. Then tissue was pipetted repeatedly to break up the tissue mass and 
centrifuged for 5 minutes at 300 g. The pellet containing VIC was resuspended in 
DMEM supplemented with 15% FBS, 2mM L-glutamine and 100units/ml 
penicillin/streptomycin, and plated onto T-75 flask. The interstitial cells were 
used in experiments at passages 2-5.  
 
2.2.6 Isolation of human umbilical vein endothelial cells. 
Human umbilical vein endothelial cells (HUVEC) were harvested from 
umbilical vein by enzymatic dissociation as previously described (Baudin et al., 
2007). In brief, the vein was washed with PBS, filled by 0.1% collagenase 
solution (Collagenase, Type II, Worthington Biochemical Corporation, USA) and 
incubated in PBS at 37°C for 10 minutes. The collagenase solution containing cell 
suspension was centrifuged for 5 minutes at 300 g. The pellet of cells was twice 
washed with DMEM, resuspended and seeded onto 3 cm2 culture dish covered 
with 0.2% gelatin (Sigma-Aldrich, USA) in Endothelial Cell Medium (ECM) 
(ScienCell, USA) and incubated at 37°C. Primary cells between passages 2-5 
were used for experiments.  
 
2.2.7 Continuous cell line. 
Cell line of human embryonic kidney 293T (HEK293T) was used for 
lentiviral production. HEK293T cells were maintained in DMEM supplemented 
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with 10% FBS, 2mM L-glutamine and 100 units/ml penicillin/streptomycin on 10 
cm2 culture dish and subcultured using a 1:20 splitting ratio twice on week.   
2.3 Magnetic cell separation. 
CD31 also known as PECAM-1 (platelet endothelial cell adhesion 
molecule-1) is transmembrane glycoprotein constitutively expressed on the 
surface of endothelial cells. Endothelial cells (HAEC and VEC) were purified 
from interstitial cells using magnetic cell separation (MACS) with anti CD31+- 
conjugated microbeads (Miltenyi Biotec, Germany) according to the 
manufacturer's directions. Endothelial cells were treated with Trypsin/EDTA 
(Gibco, USA), collected and centrifuged for 5 minutes at 300 g. Then cells 
were resuspended in 60 µl of medium, mixed with 20 µl of FcR Blocking Reagent 
and 20 µl of CD31 MicroBeads. The suspension was incubated for 15 minutes at 
4°C. Then endothelial cells were loaded onto column placed in the magnetic field. 
The labeled CD31+ cells were retained on the column while unlabeled 
cells ran through. After removal of the column from the magnetic field, the 
magnetically retained CD31+ cells were eluted as the positively selected cell 
fraction and directly taken into culture. Purity of the endothelial cells was 
confirmed by immunocytochemistry staining with anti CD31 and anti vWF 
antibodies. 
2.4 Cell proliferation and migration assay.  
The cell proliferation rate was assayed with the cultured cell growth curves. 
The cells were plated at equal density and counted each two days. In these 
experiments 80×103 of SMC were seeded into 6-well plates; 20×103 of HAEC 
were seeded into 12-well plates. 
Cell migration was examined using “scratch” wound assay as described 
previously (Mathew et al., 1996). Cells were grown to confluence on 6-well 
plates; after the cells formed a monolayer the medium was exchanged for serum 
free medium containing 10 mM hydroxyurea and 10 ng/mL PDGF_BB growth 
factor to inhibit proliferation and to stimulate migration and the cell monolayer 
was scraped with a 200P pipette tip to create a cell-free zone. The number of cells 
migrated into the wounded area was counted after 6 and 24 hours.  
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Experiments were performed in duplicates and then repeated three times. 
2.5 Cell apoptosis assay. 
Hydrogene peroxide (H2O2) is the most widely used apoptosis inducer 
(Whittemore et al., 1994). Exposure to H2O2 triggers apoptosis via the 
mitochondrial pathway leading to release of cytochrome c from mitochondria and 
activation of caspases-9 and -3 (Singh et al., 2007; Xiang et al., 2016). In the 
viable cells phosphatidylserin is located on the cytoplasmic surface of the cell 
membrane. In the apoptosis, phosphatidylserin is translocated from the 
cytoplasmic face to the outer leaflet of the membrane, exposing phosphatidylserin 
to the external cellular environment where it can be detected. Annexin V is a 
cellular protein used to detect apoptotic cells by its ability to bind to 
phosphatidylserine.  
For estimation of apoptosis SMC were plated at a density 10×103 cells/cm2. 
After 48 hours 10×10-3 M hydrogen peroxide (H2O2) was added to the culture 
medium. Two hours later the cells were removed and labeled with FITC-
conjugated annexin V (Sigma-Aldrich, USA). The number of annexin V labeled 
cells was estimated by flow cytometry using Calibur II (BD, USA).  
2.6 Induction of endothelial-to-mesenchymal transition. 
Endothelial-to-mesenchymal transition (EMT) was induced in “direct” and 
“co-culture” experimental systems. For direct induction 50×103 either of HAEC 
or VEC were seeded onto 6-well plates covered with 0.2% gelatin and transduced 
overnight with saturating concentration of the lentiviral concentrate encoding 
DLL1, DLL4, JAG1, JAG2 (only for HAEC) and NICD relatively. “Direct” EMT 
was also induced by treatment with 5ng/ml of TGFβ1 in the culture media.  
For co-culture stimulation 25×103 of HUVEC were plated onto 6-well plates 
covered with 0.2% gelatin and transduced overnight with Dll1-, Dll4-, Jag1- and 
Jag2-bearing lentiviruses respectively. After 24 hours 25×103 of HAEC were 
seeded onto HUVEC with fresh ECM.  
Responsive markers of EMT such as SNAIL1, SLUG, FSPS100A4, HES1 
and HEY1 were estimated by qPCR after 72 hours and 14 days of EMT 
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stimulation. αSMA encoding by ACTA2 was late responsive and reliable marker 
of EMT measured by qPCR as well as by immunocytochemistry staining only 
after 14 days of EMT induction. Primer sequences are represented in Table 3. 
2.7 In vitro Flow model. 
Prior to flow, 75×104 of HAEC were plated on teflon-bordered cell culture 
slides (75x25x10 mm, Flexcell International Corp., Hillsborough, NC, USA) 
coated with 0.2% gelatin and cultured for 40 hours at 37°C. The culture slides 
were then inserted into a parallel-plate Streamer device (Flexcell International 
Corp., Hillsborough, NC, USA) and exposed either to laminar or oscillatory flow 
of 12 dynes/cm2 for 6 hours with 5% CO2 at 37°C. A Masterflex L/S peristaltic 
pump was used to generate flow, and the frequency was determined by the Osci-
Flow flow controller (Flexcell Internationl Corp.). The Osci-Flow regulates flow 
direction by closing and opening pinch valves that constrict or release tubing in 
the valves. For laminar flow exposure the steady flow during experimental period 
was applied to the cells. For oscillatory flow exposure, flow was regulated in 
oscillatory manner. Cells cultured the same experimental period under static 
conditions were used as controls. After flow experiments total RNA was isolated 
and expression of shear stress responsive genes was estimated by qPCR. Table 4 
presents the list of analyzed genes. Primer sequences are represented in Table 3. 
2.8 Co-culture of valve endothelial and interstitial cells. 
Within the tissue cells are closely associated and can regulate each other’s 
phenotype and activities such as proliferation, migration and apoptosis. The co-
culture experiments model the situation in vivo and provide detailed information 
about the molecular basis of cell-cell interactions, and knowledge of cellular 
events governing the differentiation. 
One day before co-culture 120×103 of VIC were plated on 12-well plates 
coated with 0.2% gelatin. At the same time HUVEC were seeded on a culture dish 
covered with 0.2% gelatin and transduced with saturating concentration of NICD-
bearing lentivirus. After 24 hours HUVEC were reseeded and 120×103 of HUVEC 
were added to VIC with fresh DMEM supplemented with 15% FBS, 2mM L-
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glutamine and 100 units/ml penicillin/streptomycin. After adhesion of 
HUVEC, the cell culture medium was replaced by osteogenic medium. The 
osteogenic medium was changed every other day.  
2.9 Induction of osteogenic differentiation. 
The osteogenic potential of cells was tested via treatment with osteogenic 
medium (DMEM supplemented with 15% FBS (HyClone), 2 mM L-glutamine, 
100 units/ml penicillin/streptomycin, 50 µg/ml ascorbic acid, 0.1 µM 
dexamethasone and 10 mM b–glycerophosphate) for 21 days. The osteogenic 
medium was changed every other day. Early assay was performed after 96 hours. 
The expression of the following proosteogenic genes was measured by qPCR: 
HEY1, BMP2, RUNX2, SPRY1, OPN, OPG, POSTIN, CTNNB1, SOX9, ALP. 
Primer sequences are represented in Table 3. After 10 days of osteogenic medium 
treatment alkaline phosphatase activity was assayed. After 21 days osteogenic 
differentiation was demonstrated by Alizarin Red. 
2.10 Alkaline phosphatase activity assay and Alizarin Red staining.  
Alkaline phosphatase staining was performed using Sigma BCIP®/NBT kit 
(Sigma-Aldrich, USA) according to the manufacturer's directions after 10 days of 
osteogenic induction. Cells were washed with PBS and incubated with alkaline 
phosphatase working solution for 10-15 minutes at room temperature. Alkaline 
phosphatase activity appeared as blue deposition and plates were photographed 
with digital camera. 
Alizarin Red staining is widely used as a reagent for calcium staining. Sites 
of calcium are covered and surrounded by an orange-red precipitate due to free 
ionic calcium forms precipitate with alizarin. After 21 days of osteogenic 
differentiation the calcium deposits were detected by Alizarin Red staining. Cells 
were washed with PBS, fixed in 70% ethanol for 1 hour, washed twice with 
distillated water and stained using Alizarin Red solution (Sigma-Aldrich, USA). 
Matrix calcification was showed with red calcium phosphate deposition. The 
images were analyzed for the ratio of differentiated and undifferentiated cell areas 
with MosaiX software (Carl Zeiss microsystems, Germany).  
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2.11 RNA isolation. 
Total RNA was extracted from the cells using Trizol reagent (Invitrogen, 
USA) according to the instructions of the manufacturer. Cells were washed with 
PBS and 1 ml of Trizol reagent was added to the culture plate to lyse the cells. 
The lysate was homogenized by pipet and incubated for 5 minutes at room 
temperature to allow complete dissociation of nucleoproteins complex. To 
separate phases 200 µl of chlorophorm were added, the sample was incubated for 
2-3 minutes at room temperature and centrifuged for 15 minutes at 12000 g at 4°C. 
The mixture separated into a lower red phenol-chloroform layer (containing the 
DNA and proteins), interphase, and a colorless upper aqueous phase containing 
RNA. The clear aqueous phase was transferred to a new tube avoiding 
transferring any of interphase or organic layer. To precipitate the RNA 500 µl of 
isopropanol was added, mixed and overnight incubated at -20°C. Then the sample 
was centrifuged for 15 minutes at 12000 g at 4°C. Total RNA precipitate forms as 
white gel-like pellet at the bottom of the tube. The pellet was resuspended in 1 ml 
of 70% ethanol, briefly vortexed and centrifuged for 5 minutes at 7500 g at 4°C. 
Pellet of RNA was dried and dissolved in 20 µl of RNase-free water. The RNA 
was stored at -80°C. The concentration and quality of RNA were estimated by 
spectrophotometr Nanodrop 3300 (ThermoScientific, USA) and 1.5% agarose gel 
electrophoresis.
2.12 Reverse transcription and qPCR assay. 
Total RNA was reverse transcribed to cDNA with MMLV RT kit (Eurogen, 
Russia). 1 µg of RNA, 20 µM of Random(dN)10 primer and RNase-free water 
were incubated for 2 minutes at 70°C. The solution of 5x first strand buffer, 10 
mM dNTP, 20 mM DTT and RNase-free water was added to previous reaction 
and mixed with 1 µl (100 units/µL) of MMLV Reverse Transcriptase. The 
synthesis reaction lasted 10 minutes at 25°C, 1 hour at 37°C, 10 minutes at 70°C 
respectively.  
Real-time PCR was performed with 1 µl of complementary DNA and 5x 
SYBRGreen PCR Mastermix in the Light Cycler system ABI 7500 (Applied 
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Biosystems, USA) using 100 nM specific forward and reverse primers for target 
genes. The thermocycling conditions were as follows: 95 °C for 5 minutes, 
followed by 45 cycles of 95 °C for 15 seconds and 60 °C for 1 minute. A final 
heating step of 65 °C to 95 °C was performed to obtain melting curves of the final 
PCR products.  
Corresponding gene expression level was normalized to housekeeping genes 
HPRT (Hypoxanthine-guanine phosphoribosyltransferase) or GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase) from the same samples. Changes in 
target genes expression levels were calculated as fold differences using the 
comparative ΔΔCT method. Primer-BLAST tool was used to design target-
specific primers. All primer sequences are presented in Table 3. 
Table 3. Primer sequences. 
Gene Primer 5’ – 3’ 
NOTCH1 
Forward GTCAACGCCGTAGATGACC 
Reverse TTGTTAGCCCCGTTCTTCAG 
NOTCH2 
Forward ATGGTGGCAGAACTGATCAAC 
Reverse TTGGCAAAATGGTCTAACAGG 
NOTCH3 
Forward GGAGCCAATAAGGACATGCAGGAT 
Reverse GGCAAAGTGGTCCAACAGCAGC 
NOTCH4 
Forward GTTGTGACAGGGTTGGGACT 
Reverse CAGCCCAGTGGGTATCTCTG 
DLL1 
Forward CTACTACGGAGAGGGCTGCT 
Reverse CCAGGGTTGCACACTTTCTC 
DLL4 
Forward AGGCCTGTTTTGTGACCAAG 
Reverse CTCCAGCTCACAGTCCACAC 
JAG1 
Forward TGCCAAGTGCCAGGAAGT 
Reverse GCCCCATCTGGTATCACACT 
HEY1 
Forward TGGATCACCTGAAAATGCTG 
Reverse CGAAATCCCAAACTCCGATA 
HES1 Forward AGCACAGAAAGTCATCAAAG 
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Reverse AGGTGCTTCACTGTCATTTC 
SNAIL1 
Forward CTCTTTCCTCGTCAGGAAGC 
Reverse GGCTGCTGGAAGGTAAACTC 
SLUG 
Forward ATGAGGAATCTGGCTGCTGT 
Reverse CAGGAGAAAATGCCTTTGGA 
ACTA2 
Forward GTTACTACTGCTGAGCGTGAG 
Reverse CAGGCAACTCGTAACTCTTC 
VIMENTIN 
Forward ACACCCTGCAATCTTTCAGACA 
Reverse GATTCCACTTTGCGTTCAAGGT 
CALPONIN 
Forward CAGCATGGCGAAGACGAAA 
Reverse GCTCCTGCTTCTCTGCGTACTT 
SM22α 
Forward AACAGCCTGTACCCTGATGG 
Reverse ATGACATGCTTTCCCTCCTG 
CDH5 
Forward TGGACAAGGACACTGGCGA 
Reverse ACAACCGATGCGTGAACACA 
FSPS100A4 
Forward AACTAAAGGAGCTGCTGACCC 
Reverse AAGTCCACCTCGTTGTCCC 
HPRT 
Forward TGACACTGGCAAAACAATGCA 
Reverse GGTCCTTTTCACCAGCAAGCT 
AXIN2 
Forward AGTGTGAGGTCCACGGAAAC  
Reverse CTGGTGCAAAGACATAGCCA  
BMP2 
Forward GCCAAGCCGAGCCAACAC 
Reverse CCCACTCGTTTCTGGTAGTTCTTC 
CDC20 
Forward CTCAGGCCATGGCTTTGCA 
Reverse GCTGCTGCGGATGCCACT 
CDCA2 
Forward TTGCCGTTCTCAGTTCTCCTAA 
Reverse CAGAAGAAATCAATTGGTCAGTGTT 
COL15A1 
Forward TGGCCACGGAGGTCAGTTCA 
Reverse CACAAGGCGGACGCCATG 
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CXCL12 
Forward AAGGTCGTGGTCGTGCTGGT 
Reverse CTCAGGCTGACGGGCTTCC 
CYP1B1 
Forward CACTATCACTGACATCTTCGGCG 
Reverse ACGACCTGATCCAATTCTGCCT 
DKK1 
Forward CGTGCAAATCTGTCTCGCCTG 
Reverse TGGTTTCCTCAATTTCTCCTCGG 
EFNB2 
Forward GCCAGACAAGAGCCATGAAGA 
Reverse TCTGGACGTCTTGTTGGATCTTT 
GREM1 
Forward GGACCCGCCGCACTGACA 
Reverse CTTCAGCAGCCGGCAGCAG 
MGP 
Forward AGAGAGGATCCGAGAACGCT 
Reverse GCGTTCGCAAAGTCTGTAGTC 
MMP10 
Forward GTGAAACAGTTTAGAAGAAAGGACA 
Reverse GGCAGAATCAACAGCATCTCT 
MMP19 
Forward GAGGCAGCCTCGTTGTGG 
Reverse GGCAGGTTCAAGATGCGG 
MMP24 
Forward GATTGGAGGAGACACCCACTTTGA 
Reverse CATGCACAGCCACCAGGAAGA 
PDE2A 
Forward GCAACAGGCCGATGGAGATG 
Reverse CGCTTTGGGGAACAGGTCCT 
POSTIN 
Forward CCCAGCAGTTTTGCCCATT 
Reverse TGTGGTGGCTCCCACGAT 
RASSF4 
Forward GCCATGTGAGAAGATCGCCA 
Reverse GTCCAGCACCGGCATTTCA 
SMAD1 
Forward GCACAGTCTGTGAACCATGGATTT 
Reverse GTAACATCCTGGCGGTGGTATTC 
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SOX7 
Forward CAAGGACGAGAGGAAACGGCT 
Reverse TCAGCGCCTTCCACGACTTT 
SOX9 
Forward GACGCTGGGCAAGCTCT  
Reverse GTAATCCGGGTGGTCCTTCT  
OPN 
Forward TCACCTGTGCCATACCAGTTAAA  
Reverse TGGGTATTTGTTGTAAAGCTGCTT  
TCF4 
Forward GGTCTGGGCTCAGGGTATGGA 
Reverse TGGTTTGGCAGAAGAGAATGGC 
THSD1 
Forward GGAGGAGTGCATGCTAATTCAGAG 
Reverse CACACTCGGCGACGCTCTC 
TXNRD1 
Forward CGATTCCGTCAAGAGATAACAACA 
Reverse GCCTTGTGTAACTTCTCCAGCATT 
vWF 
Forward GGCAGCTGTTCTTATGTCCT 
Reverse TGGAACTCATTGTTTTGTGG 
PECAM 
Forward AGACGTGCAGTACACGGAAG 
Reverse GATGTCCTTCCAGGGATGTG 
GAPDH 
Forward CAAGGTCATCCATGACAACTTTG  
Reverse GTCCACCACCCTGTTGCTGTAG  
RUNX2 
Forward TGGATCACCTGAAAATGCTG 
Reverse CGAAATCCCAAACTCCGATA 
CTNNB1 
Forward ACCACAAGCAGAGTGCTGAA 
Reverse GCTTGCATTCCACCAGCTTC 
OPG 
Forward AAACGGCAACACAGCTCACAAGAA  
Reverse GCACGCTGTTTTCACAGAGGTCAA  
ALP TaqMan Hs00740632_gH	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SMAD6 TaqMan Hs00178579_m1	  
MMP2 TaqMan Hs01548727_m1  
TIMP1 TaqMan Hs00171558_m1  
TIMP3 TaqMan Hs00165949_m1  
STAT1 TaqMan Hs01013996_m1 
STAT6 TaqMan Hs00598625_m1  
TGFBR2 TaqMan Hs00234253_m1  
2.13 Promotor activity assay. 
Firefly luciferase is widely used in cell biology as a reporter to study gene 
expression at transcriptional level and other cellular events coupled to gene 
expression, such as receptor activity, intracellular signal transduction, mRNA 
processing, etc. The enzyme firefly luciferase catalyzes the chemical reaction in 
which luciferin is converted to oxiluciferin. Some of the energy released by this 
reaction is in the form of light.  
To estimate canonical Wnt activity lentiviral TOP flash reporter construct 
based on 7TFC (Fuerer and Nusse, 2010) with following measurement of TCF 
activity were used (Addgene 24307). In the construct the expression of the firefly 
luciferase gene is regulated by seven tandem TCF binding sites upstream of a 
minimal TK promoter (Korinek et al., 1997) and the level of TCF/LEF promoter 
activity indicates the transcriptional activation of WNT/β-catenin pathway. Cell 
lysis was performed using Luciferase Assay System (Promega, USA) according to 
the manufacturer recommendations. The cells were washed with PBS and 
incubated with 5x lysis buffer for 15 minutes at room temperature. In opaque 
multiwell plate 100 µl per sample of the Luciferase Assay Reagent were 
dispensed. 20 µl of cell lysate were added to the Luciferase Assay Reagent and 
plate was placed in the luminometer. Luciferase activity was measured with 
Synergy2 (BioTek, USA). Samples were normalized by protein content using 
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Pierce BCA Protein Assay Kit (ThermoScientific, USA). 
2.14  Genetic constructs and Lentiviruses. 
Lentiviral packaging plasmids pLVTHM, psPAX2 и pMD2.G were a 
generous gift of D.Trono (École Polytechnique Fédérale de Lausanne, 
Switzerland; http://http://tcf.epfl.ch); pLVTHM was modified by the addition of 
the T7 tag and chloramphenicol resistance gene (cm), resulting in the pLVTHM-
T7-cm vector. Open reading frame for murine Notch intracellular domain (NICD) 
was amplified from reversely transcribed mouse ES cells mRNA, using the 5’-
GGCGCGCCTCTGGATCCAGTGCTGCTGTCCCGCAAG-3’ and 5’-
CCACTAGTGCGGCCGCTTATTTAAATGCCTCTGGAATGTG-3’ primers. 
cDNA of murine DLL1, DLL4, JAGGED1 and JAGGED2 were kind gift from 
Prof. Shigeru Chiba (University of Tsukuba Japan) and Dr. Katsuto Hozumi 
(Tokai University School of Medicine, Japan) (Abe et al., 2010). The NICD PCR 
fragment was cleaved with AscI and SpeI, then cloned in frame of the T7 tag, 
replacing the cm gene within pLVTHM-T7-cm. Similarly, the DLL1 was cloned 
at the AscI and SpeI restriction sites of pLVTHM-T7-cm, the DLL4 and JAG2 at 
AscI and EcoRI restriction sites of pLVTHM-T7-cm, and the JAG1 into BamHI 
and EcoRI restriction sites of the LeGO-G/BSD  (Addgene). Lentiviral production 
was performed as described previously (Malashicheva et al., 2007). The day 
before the transfection 2.5×106 of HEK293T cells were plated onto 10 cm2 culture 
dishes. After 24 hours 10 cm2 culture dishes of nonconfluent HEK293T cells were 
cotransfected with 15 µg plasmid with gene of interest, 5.27 µg pMD2.G, and 
9.73 µg packaging pCMV-dR8.74psPAX2 by calcium-phosphate method. The 
transfection mix was as follow: plasmids, 440 µl of 0.1x TE buffer pH8.0, 75.3 µl 
of 2.5 M CaCl2, sterile water up to 760 µl and 760 µl of 2x HeBS added dropwise 
under agitation. The following day the medium was changed to fresh, and the 
cells were incubated for 24 hours to obtain high-titer virus production. Produced 
lentivirus was concentrated from supernatant by ultracentrifugation for 2 hours at 
70000 g at 4°C. The pellet containing lentivirus was resuspended in 400 µl of 1% 
BSA/PBS, incubated for 1 hour on ice and frozen in aliquots at -80°C. 
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The virus titer was defined with GFP-expressing virus. For analysis, 10×104 
of HEK293T cells were plated onto 6-well plate and transduced by 1 µl, 10 µl and 
100 µl of GFP virus respectively. Cells without infection were used as control. 
After 72 hours the cells were treated with Trypsin/EDTA and resuspended in 1% 
BSA/PBS. The number of GFP-positive cells was determined by flow cytomentry 
using Calibur II (BD, USA). The efficiency of primary cells transduction was 90–
95% by GFP. 
2.15 Immunocytochemistry. 
After growing on cover slides, cells were fixed for 20 minutes in 1% 
paraformaldehyde and then for 5 minutes in methanol at -20°C. Fixed cells were 
permeabilized in 1% BSA/0.1% Triton X-100/PBS for 5 minutes and washed with 
PBS followed by blocking in 1% BSA/PBS for 1 hour. Then cells were incubated 
for 1 hour at room temperature with primary antibodies. Following primary 
antibodies were used: SMA (sc-32251, Santa Cruz, USA), SM22𝛼 (ab14106, 
Abcam, UK), vimentin (sc-6260, Santa Cruz), VE-cadherin (MAB938, RandD, 
USA), von Willebrand factor (ab20435, Abcam), CD31 (ab24590, Abcam). Then 
cells were washed with PBS three times for 5 minutes and incubated for 40 
minutes in dark at room temperature with secondary antibodies, conjugated with 
Alexa488 or Alexa546 (Invitrogen, USA). Then cells were washed with PBS 
three times for 5 minutes and DAPI was used to visualize nuclei. 
Microphotographs were taken using AxioObserver Microscope (Zeiss) at x20 
magnification with AxioVision software.  
2.16 Immunoblotting. 
Proteins were extracted from medial tissues or cells. Specimens were 
homogenized in a lysis buffer (50 mM Tris (pH 8), 150 mM NaCl, 1% Triton X-
100, 1% sodium deoxycholate, 5 mM EDTA), containing protease inhibitors 
(Roche, Germany). Protein concentration was estimated by Pierce BCA Protein 
Assay Kit (ThermoScientific, USA). Extracts were separated by 10% sodium 
dodecyl sulfate–polyacrilamide gel electrophoresis (SDS–PAGE); 20 µg of 
prepared protein sample were loaded. Primary antibodies used: SMA (Abcam), 
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vimentin (M072529, DAKO), beta-Actin (ab 6276, Abcam), calponin (Sigma-
Aldrich), SM22𝛼  (ab14106, Abcam), collagen I, fibrillin and elastin. Secondary 
antibodies were conjugated with peroxidase (BioRad, USA). Positive bands were 
quantified by densitometry using a gel documentation system Fusion Fix (Vilber 
Lourmat) and Fusion-Capt software. Bands were normalized using β-actin or 𝛼-
tubuline staining.  
2.17 Transformation of bacteria and plasmid isolation. 
Competent cells E. coli of strain Top10 were used for transformation 
(genotype: F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara leu) 7697 galU galK rpsL (StrR) endA1 nupG). 1 µg of plasmid 
was added to 50 µl of competent cells; the competent cell/DNA mixture was 
incubated on ice for 30 minutes followed by heat shock for 20 seconds at 42°C 
and 2 minutes incubation on ice. Then cells were incubated for 1 hour in 37°C 
shaking incubator with 950 µl of LB media (10 g/L NaCl, 5 g/L yeast extract, 10 
g/L tryptone) without antibiotic. After the transformation was plated onto 10 cm2 
LB/agar dish containing 100 µg/ml ampicillin and let grow overnight at 37°C.  
Plasmid DNA isolation was performed using the HiPure Plasmid Filter 
Maxiprep Kit (Invitrogen, Germany) according to the manufacturer's directions. 
The concentration and quality of DNA were estimated by spectrophotometr 
Nanodrop 3300 and 0.8% agarose gel electrophoresis. 
2.18 Statistics. 
qPCR data on gene expression were analyzed using GraphPad Prism and R 
software (version 2.12.0; R Foundation for Statistical Computing, Vienna, 
Austria). Values are expressed as means ± SEM. Groups were compared using the 
Mann–Whitney non-parametric test. A value of P≤0.05 was considered 
significant. 
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3. Results
3.1 Proliferation and migration of smooth muscle cells from patients with
thoracic aortic aneurysm and healthy donors.
Specific degenerative processes associated with reduced cell number in the 
vessel tissue are observed in the thoracic aortic aneurysm (TAA) aortic wall 
(Milewicz et al., 2008). To evaluate the possible smooth muscle cell (SMC) 
contribution to these changes, we compared the rate of SMC proliferation and 
migration in healthy donors and patients. TAA is regarded as a group of 
etiologically different diseases rather than a particular illness. Recent genetic 
studies showed that TAA accompanied and unaccompanied by bicuspid aortic 
valve (BAV) differed (Folkersen et al., 2011; Kjellqvist et al., 2013). Basing on 
these observations, we formed three experimental groups: patients (n = 9) with 
TAA without aortic valve defects (TAV-TAA), patients (n = 7) with TAA 
accompanied with aortic valve defect (BAV-TAA), and healthy donors (n = 7). 
Smooth muscle cells were isolated from tissue fragments of TAA and from the 
aortic wall of healthy donors.  
The SMC proliferation rate was assayed with the cultured cell growth 
curves. The cells were seeded at equal density and counted each two days for 
proliferation assay. The results are presented in Figure 4A. It is seen that SMC 
proliferation rate in TAA patients is lower than in healthy donors regardless of 
valve defect.  
The SMC migration rate was estimated by scratch assay. Migrated cells 
were counted after 6 hours and 24 hours (Figure 4B). It was found that the SMC 
migration rate was higher in TAV-TAA compared to healthy donors. No 
significant difference was observed in the SMC migration rate between BAV-
TAA and healthy donors. These results agree with genetic data showing that 
BAV- and TAV-associated TAA are different pathologies. Thus, SMC decreased 
proliferation may be a reason for diminished cell number in TAA aortic wall. The 
increased SMC migration rate observed in TAV-TAA patients does not affect the 
decrease in the cell number in the patient aortic tissue and may be produced by 
pro-inflammation process common for TAV-TAA (Milewicz et al., 2008).  
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Figure 4. Proliferation and migration characteristics of SMC from patients 
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with aortic aneurysm with either tricuspid aortic valve (TAV, n= 5) or 
bicuspid aortic valve (BAV, n= 5) and controls (C, n= 5). (A) SMC 
proliferation; (B) SMC migration. Groups are compared using Mann 
Whitney non-parametric test; *p<0.05. 
 
3.2 Expression of smooth muscle cell markers in smooth muscle cells from 
thoracic aortic aneurysm patients and healthy donors. 
Smooth muscle cells from aneurysms of the thoracic aorta and from control 
aortas were analyzed regarding the expression of SMC markers like !-smooth 
muscle actin (SMA), vimentin, and SM22!. Figure 5 shows typical 
immunofluorescent staining of SMC from control aortas and from aneurysms in 
patients with BAV and TAV. Both BAV- and TAV-derived SMC appeared to 
have decreased level of SMA, vimentin, and SM22!. However, there were no 
visible differences between SMC from patients with BAV and TAV-associated 
aneurysm.  
 
 
Figure 5. Expression of smooth muscle cell markers in SMC from patients 
with aortic aneurysm with either tricuspid aortic valve (TAV) or bicuspid 
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aortic valve (BAV) and controls (C) determined by immunocytochemical 
staining of α-smooth muscle actin (SMA), vimentin and SM22α. Scale bar 
corresponds to 200 µm. 
 
At protein level expression of SMA was reduced both in the BAV- and 
TAV-derived SMC and in the aortic media (Figure 6). However, although SMA 
was lower in aortic media of aneurysms from patients with BAV than in controls, 
it was still higher than in patients with TAV. mRNA level of SMA was 
significantly lower only in BAV-derived SMC. At both mRNA and protein level 
expression of vimentin was reduced in the BAV-derived SMC, however the 
protein content of vimentin in aortic media from TAV-derived SMC also was 
reduced. SM22α expression was decreased only in SMC and aortic media from 
patients with TAV. Relative mRNA content of calponin was significantly 
increased in TAV-derived SMC. 
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Figure 6. Expression of smooth muscle cell markers in SMC from patients 
with aortic aneurysm with either tricuspid aortic valve (TAV) or bicuspid 
aortic valve (BAV) and controls (C). mRNA level was determined by qPCR; 
protein level was determined by Western blot. The bands were normalized 
by "-actin. (A) Representative Western blot picture for protein level in SMC; 
(B) (a) mRNA level in SMC: (C, n= 10; TAV, n= 13; BAV, n= 11). (b) Protein 
level in SMC: (C, n= 10; TAV, n= 13; BAV, n= 11). (c) Protein level in aortic 
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media: (C, n= 11; TAV, n= 13; BAV, n= 17). Groups are compared using 
Mann-Whitney non-parametric test; *p<0.05. 
 
3.3 Apoptosis in smooth muscle cells from patients with thoracic aortic 
aneurysm and healthy donors. 
Reduced cell number has been shown in aortic tissue of thoracic aortic 
aneurysm patients and may reflect increased apoptotic level in the vessel wall 
cells. Indeed, the cell number positive for DNA double strand breaks (an 
apoptotic marker) is increased in the media of the wall of thoracic aneurysms 
(Schmid et al., 2003). It has also been suggested that oxidative stress is 
responsible for abdominal aortic aneurysm (AAA) (McCormick et al., 2007) and 
TAA (Liao et al., 2008). We have compared the cell number labeled with annexin 
V in SMC cultures derived from TAA patients and healthy donors (Figure 7A). 
The number of annexin V-positive cells was significantly higher in SMC cultures 
from patients with both BAV and TAV and did not depend on whether TAA is 
accompanied with valve defects or not. Oxidative injury might be a cause of 
increased wall weakness in both AAA and TAA (McCormick et al., 2007). The 
ability of oxidative stress to cause apoptosis might be altered in SMC from 
aneurysms. To test this hypothesis H2O2 was added to SMC. We measured 
apoptosis as a residual between the percentage of annexin V-positive cells after 
H2O2 treatment and the amount of annexin V-positive cells in normal cultures 
(“baseline”). Figure 7B shows that apoptotic induction was higher in cells 
derived from donors than from TAA patients. Reduced apoptotic induction caused 
by H2O2 was observed in cultures established from BAV- and TAV-TAA 
patients. These results show that SMC ability to enter apoptosis produced by H2O2 
is diminished in TAA patients. 
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Figure 7. Apoptosis level in cultured SMC from patients with aortic 
aneurysm with either tricuspid aortic valve (TAV) or bicuspid aortic valve 
(BAV) and controls (C). (A) The level of “baseline” SMC apoptosis in 
culture. The diagram shows the percentage of annexin V-positive SMC in 
vitro estimated by flow cytometry. The lower panel shows representative 
plots from the analysis of live SMC in culture: (C, n= 5; TAV, n= 5; BAV, n= 
5); (B) apoptosis induction by H2O2. The diagram shows the residual between 
the percentage of annexin V-positive cells after H2O2 treatment and the level 
of annexin V-positive cells in untreated cultures. The lower panel shows 
representative plots from the analysis of SMC treated with H2O2: (C, n= 5; 
TAV, n= 5; BAV, n= 5). Arrows mark annexin V-positive cells. Groups are 
compared using Mann-Whitney non-parametric test; *p<0.05. 
 
3.4 Matrix protein content in aortas of patients with thoracic aortic aneurysm 
and healthy donors.  
Degenerative processes observed in TAA tissues are accompanied by a 
modified structure and level of a number of extracellular matrix (ECM) proteins. 
To evaluate SMC contribution to ECM protein synthesis (elastin, fibrillin, and 
collagen I) in the aortic wall we estimated the protein content in aortic media 
specimens and in SMC protein extracts by Western blot. The elastin and fibrillin 
content was significantly reduced in aortic media from aneurysms in both BAV 
and TAV patients (Figure 8). The elastin content in SMC was increased in both 
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BAV- and TAV-TAA while the fibrillin level was significantly lower only in 
TAV-TAA. 
Collagen I content was higher in aortic media from both types of aneurysm 
patients but was not significantly changed in SMC from aneurysm patients. 
However, the amount of collagen I was higher in SMC of aneurysms from 
patients with TAV only (Figure 8). 
 
Figure 8. Matrix protein level in SMC from patients with aortic aneurysm 
with either tricuspid aortic valve (TAV) or bicuspid aortic valve (BAV) and 
controls (C) determined by Western blot. The diagrams represent the results 
of densitometry. The bands were normalized by !-actin. (C, n= 10; TAV, n= 
3; BAV, n= 17). Groups are compared using Mann-Whitney non-parametric 
test; *p<0.05. 
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3.5 Proliferation rate, expression of endothelial markers and matrix protein 
content in aortic endothelial cells from patients with thoracic aortic aneurysm 
and healthy donors.  
 Although SMC are considered to be the main functional unit in the aortic 
wall, endothelial cells (EC) are also involved in the function of aortic wall and 
therefore their changed function could contribute to the aortic pathology. A role of 
the endothelial cells in the developing of aneurysms is largely unknown, although 
in recent study endothelial dysfunction has been shown to affect BAV-TAA (Ali 
et al., 2014). To test if EC are also functionally changed in the aorta of TAA 
patients we compared EC cultures from TAA patients and donors. 
Since we observed significant decline of proliferation rate in diseased SMC 
we compared also proliferation of EC from BAV- and TAV-TAA patients and 
healthy donors. The cells were seeded at equal density and counted each two days 
for proliferation assay. Endothelial cells proliferation rate in both BAV and TAV 
aneurysm was lower compared to healthy donors, but endothelium from patients 
with BAV had lower proliferation rate than EC from aneurysms of patients with 
TAV (Figure 9). 
 
 
Figure 9. Proliferation characteristic of endothelial cells from patients with 
aortic aneurysm with either tricuspid aortic valve (TAV, n= 5) or bicuspid 
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aortic valve (BAV, n= 5) and controls (C, n= 5). Groups are compared using 
Mann-Whitney non-parametric test; *p<0.05. 
 
Endothelial cells from aneurysms of thoracic aorta and from control aortas 
were analyzed regarding the expression of endothelial markers like vWF (von 
Willebrand factor), CD31/PECAM (platelet endothelial cell adhesion molecule), 
VE-cadherin as well as smooth muscle cell marker SMA to confirm that the 
cultures were not contaminated with SMC. Figure 10 demonstrates primary 
cultures and immunofluorescence staining of the EC. Endothelial markers 
appeared to be reduced in endothelium in aneurysms from patients with both TAV 
and BAV (Figure 10).  
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Figure 10. Characterization of the aortic endothelial cells from patients with 
aortic aneurysm with either tricuspid aortic valve (TAV) or bicuspid aortic 
valve (BAV) and controls (C). Upper panel represents typical aortic 
endothelial cell cultures from control and aneurysmal aortas. The SMA 
staining confirms the lack of medial SMC contamination in the endothelial 
cell cultures. VE-cadherin, vWF, and CD31/PECAM staining confirms 
endothelial nature of the isolated cells. Scale bar corresponds to 200 µm. 
 
We compared also the mRNA level of SMA, PECAM/CD31, VE-cadherin 
and vWF in EC derived from control aortas and from aneurysms. The expression 
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of SMA was elevated in both BAV- and TAV-derived EC (Figure 11A). Typical 
SMA microfilament staining was not observed in our endothelial cultures; thus, 
the elevation of SMA mRNA level was not due to contamination with SMC. 
Additionally, the protein level of SMA determined by Western blot was increased 
in aneurysmal EC (Figure 11B). Expression of the endothelial markers vWF and 
PECAM/CD31 was substantially decreased in EC from patients and confirms 
changes observed with immunocytochemical staining. The level of VE-cadherin 
mRNA was not changed (Figure 11A).  
The culture media from EC was analyzed for elastin, collagen I, and fibrillin 
content. Our data show that aortic EC as well as SMC are capable of synthesizing 
these proteins. Moreover, EC from TAA patients synthesize fragmented collagen 
I which suggest that EC contribute to the impaired matrix biosynthesis (Figure 
11C). 
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Figure 11. Expression of smooth muscle cell markers and endothelial cell 
markers in endothelial cells from patients with aortic aneurysm with either 
tricuspid aortic valve (TAV) or bicuspid aortic valve (BAV) and controls (C). 
mRNA level was determined by qPCR; protein level was determined by 
Western blot. The bands were normalized by β-actin. (A) mRNA in 
endothelial cells: (C, n= 5; TAV, n= 5; BAV, n= 5); (B) representative 
Western blot picture for SMA and vimentin protein level in endothelial cells; 
(C) collagen I protein level in endothelial cell culture medium. Groups are 
compared using Mann-Whitney non-parametric test; *p<0.05. 
 
3.6 Baseline level of Notch signaling pathway in aortic endothelial cells from 
patients with thoracic aortic aneurysm and healthy donors. 
Our findings demonstrated substantial phenotypic changes in endothelial 
cells derived from aortic wall of patients with TAA. Notch signaling pathway 
plays a critical role in cardiac outflow tract (OFT) development and loss of Notch 
pathway results in spectrum of OFT defects including aortic abnormalities (High 
et al., 2009). Notch1 has been shown to be required within endothelial cell lineage 
for proper OFT development (Koenig et al., 2016). Notch pathway has been 
reported to be decreased in the ascending aorta wall specimens of patients with 
BAV (Sciacca et al., 2013). 
We address the role of Notch signaling pathway in human aortic endothelial 
cells (HAEC) from patients with TAA and healthy donors. Initially, we assessed 
the levels of expression for key genes belonging to Notch pathway – NOTCH1, 
NOTCH2, NOTCH3, NOTCH4, DLL1, DLL4, JAG1 in endothelial cells of BAV- 
and TAV-TAA patients and healthy controls (Figure 12). Endothelial cells from 
both BAV- and TAV-TAA patients had significantly lower mRNA levels of 
NOTCH1, NOTCH3, NOTCH4 and DLL4 compared to controls. The level of 
NOTCH2 expression was significantly lower only in HAEC of TAV-TAA 
patients, whereas the expression levels of DLL1 and JAG1 were significantly 
higher in endothelium from TAV-TAA patients. The mRNA level of direct Notch 
target HEY1 was significantly elevated in both BAV- and TAV-TAA. Expression 
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of other direct Notch target gene HES1 was changed neither in BAV- nor TAV-
derived endothelial cells.  
SNAIL1 one of the master regulator of EMT and Notch1 induces elevation 
in its expression during endothelial-to-mesenchymal transition (EMT) (Nieto, 
2002; Timmerman, 2004). Its mRNA level was significantly higher in HAEC of 
BAV patients compared to TAV-TAA and control cells. However, the expression 
level of other main regulator of EMT SLUG (SNAIL2) was not different between 
BAV-TAA patients and controls. Our data suggest alterations of baseline Notch 
signaling in aortic endothelial cells of BAV- and TAV-TAA patients.  
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Figure 12. Expression level of Notch receptors, ligands and transcriptional 
targets in the aortic endothelial cells from the patients with thoracic aortic 
aneurysm associated with either tricuspid aortic valve (TAV, n= 9), or 
bicuspid aortic valve (BAV, n= 15), and controls (C, n= 15). mRNA level was 
determined by qPCR. Groups are compared using Mann-Whitney non-
parametric test; line represents the median; *p<0.05. 
 
 3.7 Experimental models for induction of endothelial-to-mesenchymal 
transition. 
Patients with BAV are at increased risk for the most of aortic pathologies, 
including ascending aortic aneurysm (Fedak et al., 2003, 2002; Gleason, 2005). 
Bicuspid aortic valve is a result of impaired valve formation during the 
endothelial-to-mesenchymal transition (EMT) (Kovacic et al., 2012), but the 
proper mechanisms of development defective valve remain unclear. We 
hypothesized that the altered baseline level of Notch pathway in BAV-TAA 
patients affects EMT.   
To establish an experimental model for estimating EMT efficiency in 
HAEC of BAV-TAA patients we induced EMT in human umbilical vein 
endothelial cells (HUVEC) and control HAEC either by introduction of Notch 
intracellular domain (NICD) with lentivirus or by the addition of TGF-β as it was 
described earlier (Niessen et al., 2008; Yang et al., 2008). Stimulated cells lost 
cobblestone morphology after addition of NICD-bearing virus or TGF-β 
suggesting loss of endothelial phenotype and transformation to mesenchymal 
cells.  
During cardiac EMT, endocardial cells undergo significant changes in gene 
expression including Notch-dependent induction of ACTA2 (αSMA), SNAIL1, and 
SLUG (Noseda, 2004). Previously in our laboratory additional screening of 11 
genes described as markers of EMT was made for their up or down regulation at 
EMT for HAEC and HUVEC after TGF-β or NICD-induction (Zeisberg and 
Neilson, 2009). Among responsive early EMT markers by qPCR were HEY1, 
HES1, FSPS100A4, SLUG which were up regulated after EMT induction. These 
genes were used in further study (Figure 13A). SMA was late responsive and 
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reliable marker of EMT in HAEC and HUVEC by qPCR as well as by 
immunofluorescent staining after 14 days of EMT induction (Figure 13B). HEY1 
and HES1 are among main Notch transcriptional targets (Andersson et al., 2011) 
and were up regulated at mRNA level in endothelial cells in NICD-induced 
cultures. Thus, both HAEC and HUVEC activate EMT program in response to 
either Notch1 intracellular domain activation or to TGF-β stimulation at 
approximately equal extent although activating slightly different level of 
responsive genes. This may reflect differences in the origin of the two endothelial 
lineages. 
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Figure 13. Induction of endothelial-to-mesenchymal transition (EMT) in 
endothelial cells derived from human aorta (HAEC) and human umbilical 
vein (HUVEC) by either introduction of Notch-intracellular domain (NICD) 
or by TGF-". (A) Expression of responsive genes 3 and 14 days after EMT 
induction estimated by qPCR; (B) SMA induction in HAEC and HUVEC 14 
days after EMT induction by immunocytochemical staining. Scale bar 
corresponds to 200 µm. 
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Notch is known as a complex and lineage-specific signaling with several 
receptors and ligands (Andersson et al., 2011), therefore we explored the 
efficiency of different Notch ligands to induce EMT in HAEC using “direct” and 
“co-culture” systems of EMT induction. In the direct system we modified HAEC 
with lentiviruses bearing one of the Notch ligands (Dll1, Dll4, Jag1, Jag2) and 
analyzed the expression of key early EMT markers (Figure 14). For induction of 
EMT in co-cultures HUVEC were transduced with a lentivirus bearing one of the 
ligands (Dll1, Dll4, Jag1, Jag2) and then co-cultured with HAEC. Figure 14 
shows that both types of induction activate genes responsible for EMT in HAEC 
but with different extent and with the activation of different sets of genes specific 
for each ligand. Dll1 and Jag1 had similar modes of EMT induction: direct 
introduction of Dll1 or Jag1 into HAEC caused up regulation of SLUG and 
FSPS100A4, whereas the same inducers used in co-culture caused only moderate 
up regulation of the same target genes. On the opposite, Dll4 and Jag2 induced 
significant up regulation of EMT markers only in co-culture but not at direct 
introduction into HAEC. Notch targets HEY1 and HES1 were significantly up 
regulated only in co-culture experiments for all four ligands studied, but were not 
up regulated when the same genes were directly introduced into HAEC. All 
together these our results reflect versatile function of different Notch components 
in EMT. Described experimental settings were used in further experiments with 
the cells from BAV patients.  
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Figure 14. Comparison between direct endothelial-to-mesenchymal transition 
(EMT) induction by Notch ligands and induction of EMT in co-culture. The 
expression of corresponding EMT markers was verified 3 days after the 
induction of EMT by qPCR.   
 
3.8 Efficiency of endothelial-to-mesenchymal transition in HAEC of BAV 
patients and healthy donors. 
To test the hypothesis that Notch signaling is impaired in aortic endothelial 
cells of BAV-TAA patients we analyzed EMT induction in models described 
above and compared effectiveness of EMT in HAEC from the patients with 
control cells by gain of mesenchymal markers and loss of endothelial markers. 
First we induced EMT in BAV-TAA cells and in controls either by 
introduction of NICD or addition of TGF-! (Figure 15). We observed 
significantly impaired NICD-induced activation of HEY1 and SLUG after 3 days 
of EMT induction by NICD in HAEC of BAV-TAA; HES1, FSPS100A4 and 
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ACTA2 also were not activated after 14 days in response to EMT induction by 
NICD in the cells of patients. Similarly, TGF-β-induced activation of the key 
EMT markers was significantly reduced in diseased HAEC (Figure 15A, B). The 
loss of endothelial markers was observed in both HAEC of patients and controls 
but was not different between 2 groups (Figure 15C).  
Up regulation of ACTA2 expression induced either by NICD or TGF was 
also impaired in the cells from patients. Figure 15D demonstrates failure to 
activate NICD and TGF-β –induced EMT program in the cells of BAV patients by 
SMA staining of the cells. Endothelial cells of patients failed to properly form 
actin fibers during EMT compared to controls. 
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Figure 15. Comparison of endothelial-to-mesenchymal transition (EMT) 
induction effectiveness between HAEC from the patients with thoracic aortic 
aneurysm associated with bicuspid aortic valve (BAV) and control HAEC 
(donor) by either NICD or TGF". (A) Expression of mesenchymal markers 3 
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days after the induction; (B) expression of mesenchymal markers 14 days 
after the induction; (C) expression of endothelial markers 7 days after the 
induction; (D) expression of SMA by immunocytochemical staining 14 days 
after the induction. Scale bar corresponds to 200 µm. mRNA level was 
determined by qPCR. The initial level of a given gene was normalized 
between different samples and the fold change was estimated. Groups are 
compared using Mann-Whitney non-parametric test; asterisks (*p<0.05) 
indicate differences between control donor and BAV groups. 
 
To be activated Notch signaling pathway requires cell-to-cell contacts when 
transmembrane receptor of one cell binds transmembrane ligand of adjacent, but 
not the same cell, to induce cleavage of NICD. Whereas ligands activate Notch on 
the surface of neighboring cells, several studies show that ligands block Notch 
activity within the same cell (Li and Baker, 2004). Therefore “co-culture” model 
of EMT induction, when not all cells express ligands, seems to be more correctly 
model the situation in vivo than “direct” model.  
We analyzed EMT induction in HAEC from donors and patients in co-
culture with the ligand-expressing cells using the set of four Notch ligands 
(Figure 16). We observed impaired ligand-induced upregulation of HEY1 and 
HES1 as well as SNAIL1 and SLUG in diseased cells after 3 days of EMT 
induction (Figure 16A). Expression of HEY1, FSPS100A4, SLUG and ACTA2 
also was not activated in HAEC of patients after 14 days of EMT induction 
(Figure 16B). Staining for SMA confirmed observations revealed in gene 
expression assay (Figure 16C). Our data confirm the findings obtained in direct 
EMT stimulation that the cells of BAV patients fail to activate EMT program in 
response to activation of Notch ligands. 
Previously in our laboratory DNA sequencing of blood samples from BAV-
TAA patients was performed to verify if any of the BAV-TAA patients had 
mutations in NOTCH1 gene. It has been defined that none of the patients included 
in current study had mutations in exons of NOTCH1, previously implicated in 
BAV formation (Freylikhman et al., 2014). 
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Figure 16. Comparison of endothelial-to-mesenchymal transition (EMT) 
induction effectiveness between HAEC from the patients with thoracic aortic 
aneurysm associated with bicuspid aortic valve (BAV) and control HAEC 
(donor) by co-culture with HUVEC expressing one of the ligands Dll1, Dll4, 
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Jag1 or Jag2. (A) Expression of EMT-responsive markers 3 days after the 
induction; (B) Expression of EMT-responsive markers 14 days after the 
induction; (C) expression of SMA by immunocytochemical staining. mRNA 
level was determined by qPCR. Groups are compared using Mann-Whitney 
non-parametric test; asterisks (*p<0.05) indicate differences between donor 
and BAV groups. Scale bar corresponds to 200 µm. 
 
3.9 Notch1-Jagged1 feedback loop in HAEC of BAV patients and healthy 
donors. 
Notch functions as a part of positive feedback loop in which Notch 
receptor activation promotes Notch ligand expression in surrounding cells thus 
relaying a signal, a process known as lateral induction (Ross and Kadesch, 2004). 
JAG1 has been shown to be a direct transcriptional Notch target (Manderfield et 
al., 2012). Therefore we tested if this feedback loop is active in the cells of BAV 
patients. We transduced HAEC with NICD-bearing lentivirus and verified up 
regulation of Notch genes in control donor cells and in the cells from the patients 
(Figure 17). Our data show that JAG1 expression induced by NICD was 
substantially reduced in the cells of BAV patients. 
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Figure 17. Lateral induction of Notch genes by NICD. HAEC from the 
patients with thoracic aortic aneurysm associated with bicuspid aortic valve 
(BAV, n=6) and control HAEC (donor, n=9) were transduced with NICD-
bearing lentivirus and the expression of Notch family genes was verified after 
72 h by qPCR. Groups are compared using the Mann–Whitney non-
parametric test; asterisks (*p<0.05) indicate differences between donor and 
BAV groups.  
 
 
3.10 The baseline level of several major signaling pathways in HAEC of TAA 
patients and healthy donors. 
NOTCH1 haploinsufficiency as well as NOTCH1 inactivation by siRNA in 
endothelial cells cause dysregulation in several major pathways, associated with a 
proper shear stress response, including antiosteogenic, antioxidant, 
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antiatherogenic and proinflammatory pathways (Theodoris et al., 2015; White et 
al., 2015). We observed obvious changes in expression of Notch related genes in 
HAEC of the patients with TAA, therefore we looked at the expression of key 
genes of the pathways highlighted in (Theodoris et al., 2015; White et al., 2015) 
and belonging to pathways that cross talk to Notch in order to better characterize 
HAEC from TAA patients (Table 4). 
 
Table 4. Genes of different pathways analyzed in the HAEC of the patients 
with TAA in comparison to the cells of healthy donors. 
Gene Pathway 
NOTCH1 
Notch ligands and receptors 
NOTCH2 
NOTCH3 
NOTCH4 
DLL1 
DLL4 
JAG1 
HEY1 
Notch targets HES1 
SNAIL1 
CDC20 Cell cycle CDCA2 
PDE2A Phosphodiesterase 2 
TXNRD1 Antioxidant 
RASSF4 Ras effector 
THSD1 Endothelial cell-cell interaction 
EFNB2 Arterial specificity 
GREM1 Anti-osteogenic DKK1 
CYP1B1 Anti-atherogenic 
COL15A1 Extracellular matrix 
TCF4 Wnt effector 
CXCL12 Pro-inflammatory 
BMP2 Pro-osteogenic 
MGP Inhibitor of vascular mineralization 
AXIN2 Wnt traget 
SOX7 Pro-osteogenic Wnt related 
POSTIN Pro-osteogenic 
TGFBR2 TGF-beta 
STAT1 Jak/STAT STAT6 
SMAD1 Wnt effector 
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SMAD6 
MMP2 
Metalloproteases and inhibitors 
 
MMP10 
MMP19 
MMP24 
TIMP1 
TIMP3 
 
 
We observed a decrease in expression of cell cycle genes CDC20 and 
CDCA2 in HAEC of TAV-TAA patients. mRNA level of TGFβ pathway related 
gene TGFBR2 was elevated only in endothelium from BAV-TAA patients 
(Figure 18). Surprisingly, expression of arterial marker and downstream Notch1 
target EFNB2 was not altered in the cells of the patients (Supplementary Figure 
1). Among about 30 genes of several pathways responsible for stress response in 
endothelium (Fernández Esmerats et al., 2016; Theodoris et al., 2015) we 
observed significant upregulation of proosteogenic BMP signaling effectors 
DKK1 and BMP2 in the cells of the patients; antagonizing BMP secreted factor 
GREM1 was downregulated in HAEC from TAV patients. Genes of Wnt, such as 
effector TCF4 and protein of anti-inflammatory IL-4 mediator STAT6 were 
significantly upregulated in the cells of the TAA patients. Expression of 
antiatherogenic CYP1B1 was in contrary decreased in both groups of the patients; 
expression of TIMP1 and TIMP3 was elevated in the HAEC of the patients. 
Expression of other genes represented in Table 4 is shown in Supplementary 
Figure 1.  
Our data suggest that HAEC of BAV- and TAV-TAA patients have 
dysregulated pathways responsible for a proper shear stress response. 
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Figure 18. Genes dysregulated in the endothelial cells from patients with 
thoracic aortic aneurysm with either tricuspid aortic valve (TAV, n= 9) or 
bicuspid aortic valve (BAV, n= 6) and control HAEC (C, n= 6). Groups are 
compared using Mann-Whitney non-parametric test; line represents the 
median; asterisks (*p<0.05) indicate differences between donor and patient 
groups. 
 
3.11 Cross-talk between Notch and WNT/!-catenin pathways. 
BMP2 has been shown to activate WNT/!-catenin signaling cascade, 
driving osteogenic mineralization of vascular progenitors (Shao et al., 2005). 
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Since we observed differential expression of effectors of WNT/β-catenin, such as 
BMP2, DKK1, STAT6 and TCF4 in the cells of the patients we estimated the level 
of the whole WNT/βcatenin signaling in the diseased and healthy cells. We 
measured TCF/LEF promoter activity indicating transcriptional activation of 
Wnt/β-catenin pathway. The TOPflash reporter construct, in which expression of 
the firefly luciferase gene is regulated by six tandem TCF binding sites upstream 
of a minimal TK promoter (Madden et al., 1997), was used to measure TCF 
activity (Figure 19A, B).  
Canonical Wnt signaling promotes endothelial survival, junction 
stabilization, proliferation and is essential for vessel stability (Dejana, 2010). The 
canonical Wnt signaling mechanism involves suppression of Gsk3 activity and 
subsequent stabilization of β-catenin. To verify how activated WNT/β-catenin 
operated in the HAEC of the TAA patients in comparison to healthy donors we 
overexpressed S33A mutated stabilized β-catenin in the cells via lentiviral 
transduction or added a specific inhibitor of Gsk3 activity, CHIR99021, to the 
culture medium (Figure 19). Firstly, TCF activity was significantly elevated in 
the HAEC of TAA patients even at a basal level indicating possible differences in 
WNT/β-catenin signaling between HAEC of the patients with TAA and healthy 
donors. Secondly, the diseased cells also demonstrated a significant increase of 
the TCF-dependent luciferase activity in response to inhibition of Gsk3 by 
CHIR99021, but not by the S33A β-catenin alone (Figure 19A). However, the 
fold activation was significantly lower in diseased cells comparing to control, 
possibly due to the high initial level of the signaling (Figure 19B). The level of 
AXIN2 expression, a direct WNT transcriptional target, reflects the same 
tendency, showing the failure of activation in response to WNT, either by S33A 
β-catenin or CHIR99021 (Figure 19C). Thus, the WNT/β-catenin pathway 
activity is substantially elevated in the endothelial cells of TAA patients.  
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Figure 19. Wnt activity in the endothelial cells from patients with thoracic 
aortic aneurysm with either tricuspid aortic valve (TAV) or bicuspid aortic 
valve (BAV) and control HAEC (donor). (A) Dotted graph represents the 
basal level of luciferase activity in the HAEC; (B) bar graphs represent fold 
change of luciferase activity in non-stimulated cells relative to the stimulated 
cells; (C) the mRNA level of direct WNT/"-catenin target AXIN2 after Wnt 
activation. Groups are compared using Mann-Whitney non-parametric test; 
line represents the median; asterisks (*p<0.05) indicate differences between 
donor and patient groups. 
 
 
WNT/!-catenin pathway has been reported to modulate endothelial 
Notch/Dll4 signaling in mouse development (Corada et al., 2010). To understand 
if the observed changes in Notch and Wnt activity in the endothelial cells of TAA 
patients were due to cross-talk between the pathways we assessed how activation 
of Wnt/!-catenin influences DLL4 expression in adult HAEC (Figure 20). We 
activated WNT/!-catenin in HAEC either by transduction of S33A !-catenin-
bearing lentivirus or by the addition of CHIR99021. Correspondingly, we 
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observed increase in AXIN2 expression; inhibition of Gsk3 activity had more 
prominent effect on AXIN2 expression than S33A !-catenin alone. Both direct 
S33A !-catenin introduction and inhibition of Gsk3 activity decreased expression 
of DLL4, with more prominent effect of CHIR99021. DKK1 expression also 
decreased after inhibition of Gsk3, but S33A !-catenin alone was not able to 
decrease DKK1 expression. Our data suggest that activity of WNT/!catenin itself 
could influence the level of Notch signaling by Dll4 in the adult HAEC (Figure 
20). Thus, cross-talk and balance between Notch, Wnt and Wnt inhibitor Dkk1 
ensure endothelial integrity in adult aortic endothelial cells. Correspondingly, 
DLL4 mRNA level was lower in the HAEC of the patients comparing to healthy 
cells (Figure 12). 
 
 
 
Figure 20. Cross-talk between Wnt and Notch pathways in adult human 
endothelial cells. Groups are compared using Mann-Whitney non-parametric 
test; asterisks (*p<0.05) indicate differences between non-stimulated 
(control) and stimulated cells. 
 
 
3.12 Shear-stress response in HAEC of patients with TAA and healthy donors.  
The above data suggest the dysregulation of BMP and WNT/!-catenin 
pathways in HAEC of patients with TAA. These pathways are known to be 
activated in response to cellular stress including shear stress (Theodoris et al., 
2015). To reveal the difference in the expression of genes associated with stress 
response between diseased and healthy aortic HAEC, we compared the shear 
stress response of HAEC from patients and control cells to the following two 
types of shear stress: laminar flow imitating steady blood flow in the aorta and 
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oscillatory flow imitating disturbed flow also seen in the aorta especially with 
BAV. Endothelial cultures before and after both types of flow experiments are 
shown in Figure 21. 
  
 
Figure 21. Control endothelial cell cultures prior and after exposure to 
oscillatory or laminar flow. Magnification 5x. 
 
We analyzed expression of Notch/BMP/WNT/!-catenin related genes in 
diseased and control HAEC. The response of normal HAEC to both types of flow 
is shown in Figure 22. Both types of flow show similar tendency in activation 
shear-stress responsive genes in control HAEC with more prominent activation by 
oscillatory flow.  
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Figure 22. Genes that were up or down regulated in response to oscillatory or 
laminar flow in control HAEC. Groups are compared using Mann-Whitney 
non-parametric test; asterisks (*p<0.05) indicate differences between non-
stimulated (static, n= 6) and flow-stimulated cells (oscillatory, n= 6; laminar, 
n= 5).  
 
A comparison between the activation of Notch/BMP/WNT/!-catenin related 
genes in cells of the patients and donors showed the most striking differences in 
the expression of DLL4, SNAIL1 and BMP2, DKK1, TCF4 as a result of exposure 
to oscillatory or laminar shear stress (Figure 23). DLL4 and SNAIL1 were not up 
regulated to the same level as in donor cells in both BAV and TAV HAEC in 
response to oscillatory flow. Whereas these genes were not activated in response 
to laminar flow only in TAV HAEC.  
DKK1 and BMP2, as well as Wnt effectors STAT6 and TCF4, were already 
elevated in non-stimulated HAEC of the patients (Figure 18). BMP2 and TCF4 
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expression was upregulated at both type of flow in control cells while we did not 
observe any fold change in BMP2 and TCF4 expression after flow in the diseased 
cells, possibly, due to elevated baseline level of these genes. DKK1 level dropped 
in response to flow in both control and diseased cells; but the absolute level of 
DKK1 was different between patient and controls in the flow-stressed cells and 
remained higher in the cells of the patients. On the contrary, we observed 
elevation of BMP2 expression by flow in donor cells while no change was 
observed in the flow-stimulated diseased cells (Figure 23). We conclude that 
stress response is attenuated in the endothelial cells of TAA patients. 
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Figure 23. Shear stress response in the endothelial cells from patients with 
thoracic aortic aneurysm with either tricuspid aortic valve (TAV, n= 9) or 
bicuspid aortic valve (BAV, n= 6) and control HAEC (C, n= 6). Dotted 
graphs represent relative mRNA level in the cells subjected to the flow 
estimated by qPCR. Bar graphs represent fold change of mRNA level in non-
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stimulated cells (static) to the level in the flow-stimulated 
(laminar/oscillatory) cells. Groups are compared using Mann-Whitney 
nonparametric test; line represents the median; asterisks (*p<0.05) indicate 
differences between control and patient groups. 
 
 
3.13 Expression of Notch receptors and ligands in cells from calcified and 
healthy valves. 
We used the cells isolated from the patients with calcific aortic stenosis with 
either tricuspid (TAV) or bicuspid (BAV) morphology of the aortic valve. The 
control samples (C) were isolated from healthy tricuspid valves because of the 
low occurrence of bicuspid aortic valve in the population. We measured the 
expression of key genes of the Notch pathway, namely NOTCH1-4 as well as 
Notch ligands JAG1, DLL1, DLL4 in human VIC and VEC (Figure 24). In VIC 
expression of NOTCH1, DLL1, and DLL4 were decreased in BAV compared to 
both TAV and controls whereas NOTCH2 was decreased with borderline 
significance. NOTCH3 expression was increased in TAV compared to both 
healthy valves and BAV (Figure 24A). Surprisingly, none of these parameters 
were altered in VEC in either BAV or TAV group comparing to control group 
(Figure 24B). Our data show dysregulation of Notch components at baseline 
expression level in interstitial cells from patients, mostly with BAV. 
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Figure 24. Expression level of Notch receptors and ligands in the valve 
interstitial cells VIC (A) and endothelial cells VEC (B) from the patients with 
calcific aortic stenosis with either tricuspid aortic valve (TAV, n= 17) or 
bicuspid aortic valve (BAV, n= 13) and from healthy control valves (C, n= 
11). mRNA level was determined by qPCR. Groups were compared using 
Mann-Whitney non-parametric test; line represents the median; *p<0.05.  
 
 
3.14 Induced calcification in interstitial cells from tri- and bicuspid aortic 
valves. 
We compared the sensitivity to osteogenic stimuli of VIC from the patients 
and healthy controls (Figure 25). Twenty-one day after stimulation with 
osteogenic medium calcification occurred in diseased VIC as shown by strong 
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Alizarin Red staining, but without any difference between VIC from BAV and 
TAV. No Alizarin Red staining was seen in VIC from healthy valves.  
Expression of genes that might be involved in calcification was measured 
in VIC by qPCR after stimulation with osteogenic medium: BMP2 (bone 
morphogenetic protein 2), RUNX2 (runt related transcription factor 2), POSTIN 
(periostin), CTNNB1 (beta-catenin), SOX9 (sex determining region Y0-box 9), 
OPN (osteopontin), SPRY1 (Sprouty1). RUNX2 and SPRY1 were lower in 
unstimulated VIC from BAV patients as compared to healthy controls. However, 
unstimulated VIC from TAV patients were not different from healthy controls. 
OPN expression was higher in non-stimulated VIC from TAV than in BAV and in 
controls. There were no differences between unstimulated cells derived from 
either BAV, TAV or controls regarding BMP2, POSTIN, CTNNB1, and SOX9.  
After 21 days of osteogenic induction RUNX2 and SPRY1 expression 
increased in all three groups comparing to non-stimulated cells, but without 
difference between groups. SOX9 was upregulated only in TAV after osteogenic 
stimulation. BMP2 was higher in TAV than in BAV and controls after osteogenic 
stimulation. POSTIN and CTNNB1 showed neither differences between groups 
nor changes after stimulation with osteogenic medium.  
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Figure 25. Sensitivity of VIC from the patients with calcific aortic stenosis 
with either bicuspid aortic valve (BAV, n= 13) or tricuspid aortic valve 
(TAV, n= 17) and from healthy control valves (C, n=11) to osteogenic 
stimulation. (A) Left panel shows representative image of VIC differentiation 
with calcification revealed by red color. Right panel represents digital 
quantification of calcium deposition. (B) mRNA expression by qPCR of 
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proosteogenic genes in the BAV, TAV and control groups of VIC. The groups 
were compared using Mann-Whitney non-parametric test, line represents the 
median. P-value for the differences between the groups is given only for the 
significant differences (*p<0.05). Asterisks indicate the significant differences 
(*p<0.05) of mRNA content between undifferentiated and differentiated cells 
for a given group (BAV, TAV or control, correspondingly). 
 
 
3.15 Notch-dependent initiation of osteoblast differentiation in interstitial cells 
from tri- and bicuspid aortic valves. 
As we observed Notch genes alterations in the VIC of BAV patients with 
aortic stenosis, we asked whether alteration in Notch signaling activity could 
differently influence osteogenic signaling in BAV and TAV derived VIC. 
To assess if the initial mechanisms of calcification in BAV and TAV-
derived VIC are dependent on Notch signaling we used co-culture of VIC with 
human umbilical endothelial cells (HUVEC). These co-culture experiments model 
the situation in vivo when endothelial cells communicate with mesenchymal cells 
via Notch signaling (Lilly, 2014; Lin and Lilly, 2014a). HUVEC, not VEC, were 
used because they give more uniform endothelial cell cultures. Notch was 
activated in HUVEC by transduction with lentiviruses bearing Notch Intracellular 
Domain (NICD). The next day the HUVEC were seeded on VIC (Figure 26A, 
left panel). HEY1, main Notch target, was elevated in co-cultures and this 
elevation was more prominent when Notch was activated in endothelial cells 
(Figure 26A, right panel). The day after start of co-culture we induced 
osteogenic differentiation by addition of osteogenic medium. The early expression 
of Notch target HEY1 and proosteogenic markers was measured in the co-cultures 
after three days of exposure to osteogenic medium in the absence (control) or 
presence of Notch activation (Figure 26B). Expression of HEY1 was similar in all 
three groups without Notch activation. However, when Notch was activated, 
HEY1 was the highest in the co-cultures that contained BAV-derived VIC. Co-
cultures with VIC from BAV patients demonstrated significantly higher 
expression of OPN, ALP and POSTIN after osteogenic stimulation. Activation of 
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Notch caused even higher elevation of OPN, ALP and POSTIN, which was 
significantly higher in the co-cultures containing BAV derived VIC. The 
expression of the other proosteogenic genes was not responsive to changes in 
Notch activity.   
Increased alkaline phosphatase 10 days after the initiation of osteogenic 
stimulation confirmed that Notch activation induced osteogenic phenotype more 
readily in BAV-derived co-cultures with more intensive staining of the co-
cultures containing VIC derived from BAV patients and activated Notch (Figure 
26B, lower panel).  
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Figure 26. Notch activity distinctly influences osteogenic differentiation of 
VIC of patients with calcified bicuspid aortic valve (BAV, n= 5) and tricuspid 
aortic valve (TAV, n= 5). (A) Activation of HEY1 expression in co-cultures of 
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VIC from normal valves with HUVEC with or without activation of Notch. 
(B) Upper panel: level of proosteogenic gene transcription (estimated by 
qPCR). The groups were compared using Mann-Whitney non-parametric 
test. P-value for the differences between the groups is given; *p<0.05. Lower 
panel: alkaline-phospatase staining. 
 
 
3.16 Notch-dependent endothelial-to-mesenchymal transition in endothelial 
cells from tri- and bicuspid aortic valves. 
Recently it has been shown that endothelial-to-mesenchymal transition 
(EMT) precedes the onset of calcification in valve cells (Hjortnaes et al., 2015).  
We studied Notch-dependent EMT activation in VEC derived from BAV and 
TAV patient and healthy valves. For Notch-induced EMT we used a previously 
described model with introduction of NICD into VEC by lentiviral transduction 
(Kostina et al., 2016). Expression of Notch-responsive genes HEY1 and SLUG, 
which activate the initial stage of EMT,  was measured after three days (Figure 
27). In VEC from BAV expression of both SLUG and HEY1 was higher than in 
TAV and healthy controls. After 10 days ACTA2 expression encoding  αSMA, the 
definitive EMT marker, was not different between BAV and TAV, but  was 
significantly less than in control cells. Immunocytochemical staining of control 
cells for αSMA showed well differentiated cells that undergone EMT and 
terminated by appearance of  true mesenchymal cells with nice actin fibers 
(Figure 27). At the same time endotelial cells from BAV and TAV patients failed 
to form actin fibers properly that suggested failure of EMT process. 
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Figure 27. EMT initiation in the VEC derived from the patients with calcified 
BAV and TAV or control cells derived from healthy valves (C). Gene 
expression was analysed by qPCR (upper panel). Immunocytochemical  
staining of the cells with antibody against !SMA (lower panel). Scale bar 
corresponds to 50 #m. The groups were compared using Mann-Whitney non-
parametric test. P-value for the differences between the groups is given; 
*p<0.05.  
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4. Discussion. 
Notch pathway is indispensable for heart development and maintenance of 
cardiovascular system during postnatal life. Mutations in Notch components are 
associated with a number of congenital defects of the left ventricular outflow 
tract, particularly with bicuspid aortic valve, but the mechanisms of realization of 
genetic mutations remain to be defined. This study provides the first direct 
functional evidence that primary aortic and valvular cells from patients with left 
ventricle outflow tract pathologies have impaired Notch signaling pathway 
comparing to healthy donors.       
 
4.1 Endothelial and smooth muscle cells in thoracic aortic aneurysm. 
Thoracic aortic aneurysm (TAA) may be associated with either bicuspid or 
tricuspid aortic valve (BAV or TAV, respectively). Whether BAV-related aortic 
dilatation is a consequence of a constant stress due to valve configuration or it is a 
consequence of a developmental mistake is widely discussed. Moreover, no 
additional defects are revealed in some patients and aneurysm develops at TAV 
background. Aortic wall integrity depends on individual functions of endothelial 
(ECs) and smooth muscle cells (SMC) regulated by their mutual communication. 
Healthy cellular properties are changed in the pathology, apparently due to altered 
intercellular interactions.  
We addressed phenotypic and functional properties of cellular components 
of the aortic wall from patients with TAA and from healthy donors (Malashicheva 
et al., 2016). We observed decreased SMC proliferation rate in both patient 
groups. Previously it has been demonstrated that the cells from BAV-TAA 
patients proliferate more slowly than those from healthy donors (Blunder et al., 
2012). Thus, in addition to other similar data our results indicate that SMC have 
reduced proliferative potential in TAA patients both with BAV and TAV. These 
data explain the observations that the SMC number in aortic wall samples in TAA 
patients is less than in healthy donors (El-Hamamsy and Yacoub, 2009). 
SMC from thoracic aneurysms demonstrated decreased expression of key 
SMC proteins such as SMA, SM22α and vimentin. These data suggest that the 
cells from the aneurysm aortic wall are in less differentiated state comparing to 
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normal aortic wall. This finding is in line with the studies that reported changes in 
SMC functionality during TAA formation (Della Corte et al., 2008; Forte et al., 
2013; Ignatieva et al., 2017). Of most importance, we revealed the primary 
changes of endothelial cells from TAA patients. Our findings are in agreement 
with a recent publication describing endothelial dysfunction in BAV patients (Ali 
et al., 2014; Jia et al., 2017).  
 Notch pathway is an important regulator of SMC (Boucher et al., 2012; 
Domenga et al., 2004; Liu et al., 2010). We revealed altered baseline level of 
Notch signaling in endothelial cells of TAA patients in comparison to endothelial 
cells of healthy persons. This observation is well in line with the findings that 
endothelial cells influence differentiation and functions of underlying SMC 
through Notch signaling (High et al., 2008; Lin and Lilly, 2014b; Pedrosa et al., 
2015). Endothelial-expressed Jag1 has been shown to induce differentiation and 
maturation of SMC via Notch3 activation during vessel wall constructing 
(Hoglund and Majesky, 2012; Liu et al., 2009). Expression of JAG1 was 
attenuated in EC of TAV-TAA that may reflect the impaired SMC differentiation 
and maturation resulted in TAA formation irrespectively of BAV. 
Cultured SMC from aneurysm patients demonstrated surprisingly high 
amounts of annexin V positive cells suggesting a high level of apoptosis in the 
aortic wall of aneurysm patients (Della Corte et al., 2008). Surprisingly, the SMC 
of TAA patients were relatively resistant to apoptosis induced by H2O2. Philippi 
and coauthors showed that SMC from aneurysms in BAV patients had the poorest 
resistance to oxidative stress, but they did not show a baseline level of apoptosis 
in their SMC cultures (Phillippi et al., 2009). Notch pathway has been reported to 
suppress apoptosis and promote cell survival (Baeten and Lilly, 2015; Li et al., 
2009; Sweeney et al., 2004; Wang et al., 2012). Apoptosis/proliferation rate is a 
very important parameter of a cellular population turnover. We suggest that both 
decreased proliferation rate and increased apoptosis contribute to the loss of cells 
in the aortic wall in aneurysms. 
Comparison of the content of some extracellular matrix proteins in aortic 
tissue samples, SMC lysates and supernatants from SMC and endothelial cells 
revealed that SMC are not the only cells that synthesize extracellular matrix 
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proteins in the aortic wall. Also endothelial cells are capable of synthesizing 
extracellular matrix proteins in aneurysms. Finally, the integrity of the 
extracellular matrix in the aortic wall of aneurysmal patients is influenced by 
changes in the ratio between different proteins. Both endothelial cells and SMC 
from aneurysm patients had synthesis of fragmented collagen I. The complex 
nature of biosynthesis of extracellular matrix proteins in the aneurysmal aortic 
wall is in agreement with other studies (LeMaire et al., 2005; Phillippi et al., 
2014; Rabkin, 2014). The ability of endothelial-derived Notch signaling to 
promote collagen synthesis and other markers in SMC has been demonstrated in 
several studies (Lilly and Kennard, 2008; Lin and Lilly, 2014b). This may be a 
recapitulation of the developmental program in early vessel development, wherein 
Notch induces ECM synthesis (Baeten and Lilly, 2017). Apparently, attenuated 
ECM protein content in SMC of TAA patients is affected by impaired Notch 
signaling in TAA ECs. 
Recent findings show that the gene profiles in TAA patients with BAV and 
TAV differ, which indicates the various etiologies for TAA (Folkersen et al., 
2011; Kjellqvist et al., 2013). Ignatieva et al. demonstrated that SMC from BAV 
and TAV patients form distinct clusters by expression of Notch-related and 
proosteogenic genes (Ignatieva et al., 2017). In addition, BAV-derived SMC were 
more responsive to Notch activation by ACTA2 transcription (Ignatieva et al., 
2017). Our findings regarding different extracellular matrix composition and the 
migration rate in TAV- and BAV-TAA support the idea that the mechanisms 
underlying the TAA development are distinct between the two patient groups 
(Balistreri et al., 2013; Phillippi et al., 2014).  
We suggest that the initial process of the vessel formation as well as further 
healing in response to constant mechanical stress in the aorta could be impaired in 
TAA patients via Notch-dependent events in particular through inactive feedback 
loop connecting ECs and SMC and their mutual influence on cellular functional 
state.  
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4.2 Notch pathway and endothelial-to-mesenchymal transition. 
The most known genetic link in BAV pathology is mutations in NOTCH1 
described in patients with BAV (Garg et al., 2005; McBride et al., 2008; McKellar 
et al., 2007). Although BAV has strong evidence of a genetic basis, successful 
identification of disease-causing variants has been limited. Several studies did not 
find considerable amount of mutations in Notch-related genes in a cohort of 
patients where previously NOTCH1 mutations had been described (Bonachea et 
al., 2014; Campens et al., 2015; Martin et al., 2014). 
 We have shown that aortic endothelial cells derived from the BAV patients 
with dilated aorta have impaired EMT induction (Kostina et al., 2016). This 
impairment could potentially reflect two aspects of the associated aortopathy. 
First aspect regards the failure to undergo EMT during embryonic development, 
which is necessary for the proper valve formation (Kovacic et al., 2012). 
Alternatively, because EMT is described as a stress-induced mechanism in aortic 
valve, the failure to activate EMT program could lead to valve calcification 
(Balachandran et al., 2011; Kovacic et al., 2012). A recent work has shown that 
Notch1 haploinsufficiency disrupts the appropriate endothelial response to shear 
stress. In contrast to wild-type endothelial cells, shear-exposed NOTCH1+/– 
endothelial cells showed derepression of latent pro-osteogenic and pro-
inflammatory gene networks and failed to up regulate anti-osteogenic and anti-
inflammatory factors that may be critical for preventing calcification of 
underlying interstitial cells (Theodoris et al., 2015). Similarly, our results suggest 
that BAV-derived aortic endothelial cells fail to up regulate Notch-induced EMT. 
We suggest that this reflects a common stress-defense mechanism, which is 
impaired in the diseased cells.  
We also observed significant down regulation of NOTCH4 and DLL4 in the 
diseased endothelial cells. Dll4 is the first Notch ligand expressed in the forming 
arteries in the mouse, and DLL4 expression precedes that of the genes encoding 
arterial Notch receptors, NOTCH1 and NOTCH4 (Chong et al., 2011). Our 
findings are well in line with recent reports describing fine tuning of Dll4/Notch4 
axis and its participation in arterial specification, implying that this axis might be 
disrupted in BAV-patients and this impaired arterial specification could contribute 
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to aortic aneurysm development often associated with BAV (Wu et al., 2014; 
Wythe et al., 2013). 
In a recent paper it has been shown that Notch4 agonistic antibody in mice 
accelerate the healing response increasing amount of SMC in the vessel (Pedrosa 
et al., 2015). Also this paper demonstrates the proangiogenic role of endothelial 
Jag1 in adult physiological angiogenesis and the synergistic roles of endothelial 
Jag1 and Dll4 on vascular maturation. We show that JAG1 expression induced by 
NICD was substantially reduced in the BAV-derived endothelial cells and this 
was associated with downregulation of smooth muscle cell contractile markers in 
SMC of the aneurysmal wall. We suppose that the response to constant shear 
stress in the aorta with BAV could be impaired in the BAV patients via Notch-
dependent events in particular through inactive feedback loop between Notch1 
and Jag1.   
In our experiments all the ligands (Dll1, Dll4, Jag1, Jag2) failed to up 
regulate EMT response in the cells of BAV-patients. However, both Dll1 and Dll4 
were able to up regulate SNAIL almost to its level in healthy cells. This result 
demonstrates the complexity of Notch signaling links and also represents Dll1 and 
Dll4 ligands as potential candidates for the up regulation the Notch system in the 
diseased cells as it has been already described in other pathologies (Rizzo et al., 
2015). However it is clear that the system is extremely dosage-dependent and 
fine-tuned, thus further studies of endothelial-SMC regulation are needed to 
understand its function (Xiao and Dudley, 2017).   
 
4.3 Endothelial shear-stress response.  
Recent findings suggest that Notch signaling in the valve endothelium is 
uniquely positioned to mediate the anti-calcific response to shear stress within the 
valve (Combs and Yutzey, 2009; Masumura et al., 2009; White et al., 2015). Our 
data support this idea for endothelial cells of the ascending aorta as well. It is 
clear, that signaling mechanisms do not operate in isolation but that they are 
integrated into signaling networks. The list of signaling pathways that modulate a 
given component of the Notch signaling system is already abundant and is likely 
to be expanded in the coming years (Andersson et al., 2011). In this study we also 
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show that endothelial cells from patients with TAA along with Notch have 
changed activity of several important shear stress response pathways such as 
Wnt/β-catenin and BMP comparing to the cells of healthy donors. In addition, we 
report attenuation of shear stress response in the ECs of the patients with TAA. 
Our data on increased expression of Wnt effectors GREM1 and DKK1 and 
proosteogenic BMP2 as well as decreased expression of CYP1B1 in the diseased 
cells are well in agreement with the data obtained on NOTCH1+/- iPS derived 
endothelial cells (Theodoris et al., 2015).  
We observed a strong elevation of Wnt/β-catenin signaling in the diseased 
ECs. In the vasculature, the Wnt/β-catenin pathway controls vascular stability 
through remodeling, junction assembly, and pericyte recruitment (Reis and 
Liebner, 2013). The sequential and parallel interactions between the BMP and 
Wnt signaling controls mineralization, with intracellular/extracellular fine-tuning 
of signal duration and strength (Bostrom et al., 2011). DKK1 expression, a Wnt/β-
catenin antagonist, was significantly elevated in the diseased cells. Activation of 
DKK1 has been associated with endothelial integrity (Li et al., 2016). 
Fluid shear stress is involved in stem cell and mesenchymal progenitor 
differentiation into vascular ECs and plays an important role in endothelial 
homeostasis (Obi et al., 2008; Resnick and Gimbrone, 1995; Wang, 2005; 
Yamamoto, 2004). In response to application of laminar or oscillatory shear stress 
a differential expression of DLL4, SNAIL, BMP2, DKK1 and TCF4 was observed 
between the patients and healthy donor ECs. This gave further support to the role 
of Notch, Wnt/β-catenin and BMP pathways in maintaining endothelial integrity 
and proper differentiation state of endothelial cells as has been reported by others 
(Corada et al., 2010; Dejana, 2010; Fernández Esmerats et al., 2016; Morini and 
Dejana, 2014; Rostama et al., 2014; Wu et al., 2014). DLL4 was up regulated in 
response to stress in healthy cells whereas its expression remain low in the patient 
cells. Activation of Notch, in particular DLL4 in response to flow, is an important 
factor for stress resistance (Jahnsen et al., 2015; Pedrosa et al., 2015), and this 
function seems to be compromised in the cells of TAA patients.  
DKK1 expression, in contrary, stayed at high level in the diseased cells and 
failed to be down regulated at stress suggesting attenuated regulation mechanism. 
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Activation of Wnt/β-catenin axis has already been described in calcified aortic 
valves, but not in aortic aneurysms (Bostrom et al., 2011). 
A cross talk between Wnt and Notch pathways has been shown to be 
important for the early endothelial patterning in vertebrate development (Corada 
et al., 2010; Dejana, 2010; Morini and Dejana, 2014). In our experiments, 
activation of Wnt/β-catenin by either inhibition of Gsk3 kinase or by introduction 
of proteolysis resistant S33 β-catenin mutant downregulated the expression of 
DLL4. This was in accordance with data obtained with patient cells where strong 
activation of Wnt/β-catenin was accompanied by downregulation of DLL4 and 
general loss of endothelial properties by the cells of the patients. Hence, fine-
tuned cross-talk between several pathways is responsible for the proper 
maintenance of endothelial state in the adult aorta and this cross-talk is attenuated 
in the diseased cells. Recent studies suggest that vascular endothelial growth 
factor (VEGF), ETS factors, Sox and Notch regulate DLL4 expression in complex 
cascades that may be further impacted by the canonical Wnt pathway (Birdsey et 
al., 2015; Corada et al., 2010; Dejana, 2010; Morini and Dejana, 2014; Yamamizu 
et al., 2010). Despite the fact that even subtle changes in DLL4 expression impair 
vascular development (Duarte, 2004; Krebs, 2004; Trindade et al., 2012), one of 
the challenges lying ahead is to define the temporal and spatial location of the 
regulatory mechanisms for fine-tuning of Dll4/Notch signaling in vivo during 
vascular development (Wu et al., 2014). 
 
4.4 Notch pathway and aortic valve calcification.  
The mechanisms behind heart valve calcification are not fully elucidated, 
but they have some similarities with bone ossification. The involvement of 
dysregulated Notch pathway in calcification is evident. Idiopathic calcific aortic 
valve disease is associated with hypomethylation of the long noncoding (lnc) 
RNA H19, which prevents p53 from binding to the promoter region of NOTCH1, 
suppressing transcription (Hadji et al., 2016). This supports recent data showing 
that the repression of NOTCH1 leads to calcific aortic valve disease, likely 
through myofibroblast and osteogenic differentiation (Merryman and Clark, 2016). 
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Therefore, our data on Notch-related gene expression in valve interstitial cells 
(VIC) and differences between patients with calcified aortic stenosis and healthy 
donors suggest that dysregulated expression of Notch genes might contribute to a 
change of phenotype in these cells (Kostina et al., 2017). 
We analyzed the effect of modulating Notch activity by introducing NICD 
in co-cultures of VIC and endothelial cells (ECs). NICD induced increased 
downstream signaling from Notch genes and increased expression of 
proosteogenic genes in co-cultures of ECs and VIC from BAV compared to TAV 
and controls. NICD induced stronger expression of Notch-responsive genes HEY1 
and SLUG in cultures with BAV-derived valve endothelial cells (VEC), whereas 
expression of key EMT marker ACTA2 was significantly less in diseased cells 
compared to control, and VEC of patients displayed failure of EMT process. 
During embryogenesis the endothelial cells of primordial valve cushions undergo 
EMT to become interstitial cells (Butcher and Markwald, 2007). EMT also occurs 
an adult valve (Frid, 2002). Inability of patient VEC to proper EMT may reflect 
both impaired VIC differentiation during valvulogenesis and attenuated renewal 
of VIC as part of physiologic valve remodeling. Moreover, insufficient EMT in 
diseased VEC may result altered stress response (Balachandran et al., 2011). 
Our data indicate that BAV-derived cells have increased sensitivity to Notch 
modulation. This may explain why BAV have higher occurrence of calcification 
and the process may also go faster. The presented data showing stronger 
predisposition to calcification in BAV induced by NICD, do suggest that the 
initiation mechanisms are Notch-dependent and may be different in BAV and 
TAV. However, our data indicate that the calcification of end-stage disease is 
similar in calcific BAV and TAV. This is in agreement with studies comparing 
transcriptomes and serum OPG and OPN level in BAV and TAV patients 
(Guauque-Olarte et al., 2016; Irtyuga et al., 2017; Padang et al., 2015; Yu et al., 
2009).  
OPN and POSTIN may be key early players in triggering osteogenic 
phenotype (Poggio et al., 2014; Zhang et al., 2017), although there are conflicting 
data regarding the role of OPN (Grau et al., 2012; Passmore et al., 2015; Zhang et 
al., 2017). Notch activation caused a substantial activation of OPN and POSTIN 
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transcription in VIC from BAV group comparing to cells from TAV and controls. 
The exact role of osteopontin in valvular calcification is not clear and its possible 
regulation by Notch deserves further research (Shen and Christakos, 2005; Xue et 
al., 2014). 
To date, aortic valve calcification based on the concept of diffuse 
calcification secondary to myofibroblast differentiation of VIC and ossification 
carried out by osteoblasts (Rutkovskiy et al., 2017). Apparently, the process of 
valve calcification, particularly BAV, is initiated by impaired Notch signaling in 
VIC and VEC followed by pathogenic VIC differentiation.  
 
 
The main feature of OFT is its embryonic complexity due to existing of 
multiple cellular contributors in OFT development, such as progenitors from SHF, 
CNC cells, endocardium and endocardium-derived mesenchyme (Hutson and 
Kirby, 2007). Notch signaling has been implicated in the regulation of cell-fate 
decisions of OFT contributors during development (High et al., 2007). Thus, OFT 
pathologies, even those appeared in postnatal life, might have embryonic origin, 
as initially impaired Notch signaling pathway affects cell-cell communications 
and further cell fate of OFT components. 
In summary, our data provide the evidence that Notch signaling pathway is 
attenuated in cellular components of aorta and aortic valve from patients with 
thoracic aortic aneurysm and calcified aortic valve stenosis, respectively. 
Impaired Notch pathway causes disrupted cell-cell communications and 
disturbance of aortic and aortic valve tissue homeostasis resulting in failure of 
aorta and aortic valve to perform their vital functions.  
These findings further underline the importance of Notch pathway in 
cardiovascular system development and maintenance. The obtained data open an 
additional clinical prospective for searching a therapeutic targets in order to 
prevent the development of thoracic aortic aneurysm and calcific aortic valve 
stenosis.   
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Conclusions 
 
1. Endothelial and smooth muscle cells from thoracic aortic aneurysms of 
the ascending aorta have downregulated specific cellular markers and altered 
functional properties, such as growth rate, apoptosis induction, and extracellular 
matrix synthesis. 
2. Notch-dependent endothelial-to-mesenchymal transition is attenuated in 
the aortic endothelial cells of patients with thoracic aortic aneurysm and bicuspid 
aortic valve. 
3. Shear-stress response is impaired in endothelial cells of the patients with 
thoracic aortic aneurysm due to altered Notch/BMP/WNTβ/-catenin network. 
4.  Early events of aortic valve calcification are Notch-dependent and differ 
in BAV and TAV. 
 
 
 
 
 
Limitations 
 
The current study has several limitations. First, the unavailability of healthy 
aortic wall from patients with BAV as the ideal comparative control group to 
BAV aneurysmal aortic wall and the unavailability of structurally normal BAV as 
comparative control to calcified BAV. Second, wide variability was observed 
within each subgroup on qPCR data. This may reflect the fact that each individual 
sample might be at a different stage of disease. Shear stress in vitro experiments 
with isolated ECs in the absence of SMC layer cannot reflect the complexity of 
signaling in the whole aortic wall due to cell-cell communication residing in 
different layers of aorta. Moreover, gene expression and cell behavior can be 
affected by physical and biochemical environment, and these factors are absent in 
cultured cells.  
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Application 
 
 
 
 
Supplementary Figure 1. Genes dysregulated in the endothelial cells from 
patients with thoracic aortic aneurysm with either tricuspid aortic valve 
(TAV, n= 9) or bicuspid aortic valve (BAV, n= 6) and control HAEC (C, n= 
6). Groups are compared using Mann-Whitney non-parametric test; line 
represents the median.   
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A B S T R A C T
Aims: Calciﬁc aortic valve disease is the most common heart valve disease in the Western world. Bicuspid and
tricuspid aortic valve calciﬁcations are traditionally considered together although the dynamics of the disease
progression is diﬀerent between the two groups of patients. Notch signaling is critical for bicuspid valve de-
velopment and NOTCH1 mutations are associated with bicuspid valve and calciﬁcation. We hypothesized that
Notch-dependent mechanisms of valve mineralization might be diﬀerent in the two groups.
Methods and results: We used aortic valve interstitial cells and valve endothelial cells from patients with calciﬁc
aortic stenosis with bicuspid or tricuspid aortic valve. Expression of Notch-related genes in valve interstitial cells
by qPCR was diﬀerent between bicuspid and tricuspid groups. Discriminant analysis of gene expression pattern
in the interstitial cells revealed that the cells from calciﬁed bicuspid valves formed a separate group from cal-
ciﬁed tricuspid and control cells. Interstitial cells from bicuspid calciﬁed valves demonstrated signiﬁcantly
higher sensitivity to stimuli at early stages of induced proosteogenic diﬀerentiation and were signiﬁcantly more
sensitive to the activation of proosteogenic OPN, ALP and POSTIN expression by Notch activation. Notch-acti-
vated endothelial-to-mesenchymal transition and the corresponding expression of HEY1 and SLUG were also
more prominent in bicuspid valve derived endothelial cells compared to the cells from calciﬁed tricuspid and
healthy valves.
Conclusion: Early signaling events including Notch-dependent mechanisms that are responsible for the initiation
of aortic valve calciﬁcation are diﬀerent between the patients with bicuspid and tricuspid aortic valves.
1. Introduction
Calciﬁed valve stenosis, most frequently in the aortic valve, is the
third leading cause of cardiovascular disease [1]. The only option for
treatment is heart surgery with implantation of valve prosthesis. The
mechanisms behind heart valve calciﬁcation are not fully elucidated,
but they have some similarities with bone ossiﬁcation.
Normal aortic valve leaﬂets have two cell types: valve interstitial
cells (VIC) and valve endothelial cells (VEC) [2]. It has been suggested
that VIC are the main functional units of the valve that undergo mi-
neralization [3]. However, the VEC may also participate in the
mineralization process [4–7]. The progressive valve ﬁbrosis and mi-
neralization are thought to be active rather than passive processes. A
main risk factor for development of calciﬁed aortic valve disease is
bicuspid anatomy of the aortic valve (bicuspid aortic valve, or BAV).
Only< 2% of the population has BAV [8], but they represent about
50% of the patients undergoing aortic valve replacement. Calciﬁcation
also occurs at an earlier age in BAV compared to individuals with the
normal tricuspid anatomy (tricuspid aortic valve, or TAV) [9–11]. The
average age of surgery for calciﬁed BAV is approximately 27 years
younger than in patients with TAV [12]. However, the cellular and
molecular mechanisms of valve calciﬁcation have been considered to be
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common for BAV and TAV [13–15].
Although the heritability of BAV is well known, the genetic causes
of BAV are not elucidated. NOTCH1 remains the only proven candidate
gene [16,17]. Notch is also a key signaling pathway during cardiac
valvulogenesis, ensuring cross talk between diﬀerent types of cells and
their physiological diﬀerentiation [18]. All Notch receptors (Notch1–4)
and ligands (Jag1 and 2 and Dll1, 3, and 4) are expressed in the vas-
cular system. Activation of Notch receptors requires binding to a
transmembrane ligand presented by neighboring cells. This binding
enables a series of successive cleavage events in the receptor, ultimately
resulting in intracellular release of the Notch Intracellular Domain
(NICD), which is the transcriptionally active form of Notch. NICD
translocates to the nucleus, where it regulates a broad range of target
genes, including those involved in calciﬁcation [18]. The data re-
garding the role of Notch in aortic valve calciﬁcation are controversial.
Notch1 may inhibit osteogenic calciﬁcation [19], however, opposite
data suggest that Notch1 sustains osteogenic calciﬁcation in human VIC
[20]. NOTCH1 haploinsuﬃciency promotes proosteogenic and in-
ﬂammatory gene expression [21].
In this work we sought to ﬁnd the diﬀerences of aortic valve cal-
ciﬁcation between bicuspid and tricuspid aortic valves and to explore if
there are Notch-dependent mechanisms of osteogenic transformation of
valve cells that diﬀer between the two groups of patients. We show that
the expression pattern of Notch genes is altered in the aortic valve cells
of patients with calciﬁc aortic stenosis compared to those of healthy
persons. The expression pattern is diﬀerent between VIC derived from
BAV and from TAV patients. We also show diﬀerent sensitivity to
proosteogenic stimuli in the cells of BAV versus TAV patients.
Collectively, our ﬁndings suggest that the mechanisms of the early
phase of aortic valve calciﬁcation are diﬀerent between BAV and TAV
patients and Notch pathway deregulation in BAV is important for this
process.
2. Materials and methods
The clinical research protocols were approved by the local Ethics
Committee of the Almazov Federal Medical Research Center and were
in accordance with the principle of the Declaration of Helsinki. All
patients gave informed consent. Valve interstitial cells (VIC) and valve
endothelial cells (VEC) were isolated from aortic valves explanted
during aortic valve replacement at the National Almazov Research
Centre. Patients with known infective endocarditis and rheumatic dis-
ease were excluded from the study. VICs and VECs from normal aortic
valves were isolated from healthy valves obtained from explanted
hearts from recipients of heart transplantation (n= 11). Due to the low
incidence of BAV in the population all healthy valves were TAV.
Clinical data regarding patients with aortic stenosis in BAV and TAV are
shown in Supplementary Table 1 (for qPCR) and Supplementary Table 2
(for plasma osteopontin analysis).
Human umbilical vein endothelial cells (HUVEC) were harvested
from umbilical cords at the National Almazov Research Centre.
2.1. Plasma osteopontin measurement
Peripheral venous blood was obtained at 08:00 on the morning of
surgery. Plasma samples were immediately frozen and kept at −70 °C
until assay. CRP and parameters of lipid metabolism were measured.
Osteopontin, a biomarker of calciﬁcation (OPN), was measured by the
human ELISA kit (BMS2066 еBiosciences, Vienna, Austria) according to
the manufacturer's instructions (pmol/l).
2.2. Isolation of primary cell cultures
Valve leaﬂets were washed in PBS and incubated for 10 min at 37°C
in 0.2% collagenase solution (Collagenase type IV, Worthington
Biochemical Corporation, USA). The valve was vortexed for one minute
to remove VECs, the supernatant was collected and centrifuged at 300g
for ﬁve minutes, and VECs were plated in Endothelial Cell Medium
(ECM) (ScienCell) on 0.2% gelatin (Sigma-Aldrich). Then the cells were
puriﬁed from VICs using magnetic cell separation (MACS) with CD31+
microbeads (CD31 MicroBead Kit, Miltenyi Biotec, Germany) according
to the manufacturer's instructions. Purity of the VECs was conﬁrmed by
immunocytochemistry with anti CD31 and anti vWF antibodies
(Abcam).
To isolate VICs the remaining valve tissue was incubated with 0.2%
collagenase solution for 24 h at 37°. Then the tissue was pipetted re-
peatedly to break up the tissue mass and spun at 300 g for ﬁve minutes.
The pellet containing VICs were resuspended in DMEM (Gibco) sup-
plemented with 15% FBS, 2 mM L-glutamine, and 100 units/ml peni-
cillin/streptomycin, and plated on T75 ﬂask.
To minimize variations between cultured cells at diﬀerent passages
all population analysis of gene expression by qPCR was done using the
cells at the same passages.
Human umbilical vein endothelial cells (HUVEC) were harvested
from umbilical vein by enzymatic dissociation. The vein was washed in
PBS, ﬁlled by 0.1% collagenase solution (Collagenase, Type II,
Worthington Biochemical Corporation, USA) and incubated in PBS at
37°C for 10 min. The cell suspension was centrifuged at 300g for ﬁve
minutes. The pellet of cells was suspended and seeded on 35 mm Petri
dish covered with 0.2% gelatin in ECM (ScienCell) [22]. Primary cells
between passages two and ﬁve were used for all experiments. All cul-
tures were maintained in humidiﬁed 5% CO2 at 37°C.
2.3. Induction of osteogenic diﬀerentiation
The osteogenic potential of VIC was tested by treatment with os-
teogenic medium (DMEM supplemented with 15% FBS (HyClone),
2 mM L-glutamine, 100 units/ml penicillin/streptomycin, 50 mg/ml
ascorbic acid, 0.1 mM dexamethasone and 100 mM b–glyceropho-
sphate) for 21 days. Calcium deposits were demonstrated by Alizarin
Red staining. Cells were washed with PBS, ﬁxed in 70% ethanol for
60 min, washed twice with distillated water and stained using Alizarin
Red solution (Sigma). The images of calcium phosphate deposition were
analyzed for the ratio of diﬀerentiated and undiﬀerentiated cell areas
with MosaiX software (Carl Zeiss microsystems, Germany).
2.4. Co-culture of endothelial cells and valve interstitial cells
VICs (120 × 103 cells) were plated in 12-well plates coated with
0.2% gelatin. At the same time HUVEC were seeded on a culture dish
covered with 0.2% gelatin and transduced with saturating concentra-
tion of NICD-bearing lentivirus. After 24 h the HUVEC were reseeded
and 120×103 HUVEC were added to VICs with fresh DMEM (Gibco)
supplemented with 15% FBS, 2 mM L-glutamine and 100 units/ml pe-
nicillin/streptomycin. After adhesion of HUVECs, the cell culture
medium was replaced by osteogenic medium. ALP staining was per-
formed using Sigma BCIP®/NBT kit (Sigma) 10 days after the initiation
of osteogenic diﬀerentiation. Cells were washed with PBS and in-
cubated with alkaline-phosphatase working solution for 10–15 min at
room temperature. ALP activity appeared as blue deposition and plates
were photographed with digital camera. At the same time calcium was
measured by Alizarin Red as described above.
2.5. Endothelial-to-mesenchymal transition (EMT) induction
For induction of EMT, 45 × 103 VECs were plated onto 12-well
plates and transduced overnight with saturating concentration of the
lentiviral concentrate encoding NICD. Early EMT markers such as
SNAIL1, SLUG, HES1, HEY1 were estimated by qPCR after 72 h of EMT
induction. αSMA (ACTA2) was late responsive and reliable marker of
EMT measured by qPCR as well as by ICH staining after 14 days of EMT
induction.
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2.6. Immunocytochemistry
After growing on cover slides, cells were ﬁxed for 20 min in 1%
paraformaldehyde and then for ﬁve minutes in methanol at −20 °C.
Fixed cells were permeabilized in 1% BSA/0.1% Triton X 100/PBS for
ﬁve minutes, followed by blocking in 1% BSA/PBS for 30 min.
Then cells were incubated for one hour with primary antibodies:
SMA (sc-32251, Santa Cruz). Secondary antibodies conjugated with
Alexa546 (Invitrogen) were used. DAPI was used to visualize nuclei.
Microphotographs were taken using an AxioObserver Microscope
(Zeiss) at 20× magniﬁcation with AxioVision software.
2.7. Immunoblotting
Cells were lysed with lysis buﬀer (50 mM Tris (pH 8), 150 mM NaCl,
1% Triton X-100, 1% sodium deoxycholate, and 5 mM EDTA), con-
taining protease inhibitors (Roche). Extracts were separated by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Primary antibodies αSMA (Abcam, USA), beta-actin (ab 6276,
Abcam) and calponin (Sigma-Aldrich) were used. Positive bands were
quantiﬁed by densitometry analyses using a gel documentation system
Fusion Fix (Vilber Lourmat) and Fusion-Capt software. Bands were
normalized using beta-actin staining.
2.8. qPCR
RNA from cultured cells was isolated using ExtractRNA (Eurogene,
Russia). Total RNA (1 μg) was reverse transcribed with MMLV RT kit
(Eurogen, Russia). Real-time PCR was performed with 1 μL cDNA and
SYBRGreen PCRMastermix (Eurogen, Russia) in the Light Cycler system
using speciﬁc forward and reverse primers for target genes.
Corresponding gene expression level was normalized to HPRT or
GAPDH from the same samples. Changes in target genes expression
levels were calculated as fold diﬀerences using the comparative ΔΔCT
method. All primers sequences will be presented at request.
2.9. Lentiviruses
Lentiviral production was performed as described previously [23].
In brief, 100-mm dishes of subconﬂuent 293T cells were cotransfected
with 15 μg pLVTHM-T7-NICD, 5.27 μg pMD2.G, and 9.73 μg packaging
pCMV-dR8.74psPAX2 by calcium-phosphate method. The following
day the medium was changed to fresh, and the cells were incubated for
24 h to obtain high-titer virus production. Produced lentivirus was
concentrated from supernatant by ultracentrifugation, resuspended in
1% BSA/PBS and frozen in aliquots at −80°C. The virus titer was de-
ﬁned by GFP-expressing virus; the eﬃciency of HUVEC and primary
endothelial cells transduction was 90–95% by GFP.
2.10. Statistics
Discriminant function analysis was performed to determine, which
continuous variables discriminate between groups of BAV, TAV and
controls. Continuous variables were qPCR gene expression data from
ΔΔCT estimation. A stepwise analysis enumerating steps, p-value sig-
niﬁcance level, and F-test were performed. A discrimination level was
evaluated by assessing Wilks' lambda. Signiﬁcance of an identifying
criterion was determined after drawing scatterplots of canonical values
and calculating classiﬁcation value and Mahalanobis squared distance.
Discriminant function analysis was performed with Statistica 7.0 soft-
ware. qPCR data on gene expression and plasma osteopontin content
was analyzed using Graph Pad Prism. Values are expressed as
means ± SD. Groups were compared using the Mann–Whitney non-
parametric test (qPCR) and Students's t-test (plasma osteopontin). A
value of P≤ 0.05 was considered signiﬁcant.
3. Results
3.1. Expression of Notch receptors and ligands in cells from calciﬁed and
healthy valves
We used the cells isolated from the patients with calciﬁc aortic
stenosis with either tricuspid (TAV) or bicuspid (BAV) morphology of
the aortic valve. The control samples (C) were isolated from healthy
tricuspid valves because of the low occurrence of bicuspid aortic valve
in the population. We measured the expression of key genes of the
Notch pathway, namely NOTCH1–4 as well as Notch ligands JAG1,
DLL1, DLL4 in human VIC and VEC. In VIC expression of NOTCH1,
DLL1, and DLL4 were decreased in BAV compared to both TAV and
controls whereas NOTCH2 was decreased with borderline signiﬁcance
(Fig. 1). NOTCH3 expression was increased in TAV compared to both
healthy valves and BAV. None of these parameters were altered in VEC
in either BAV or TAV group comparing to control group (Supplemen-
tary Fig. 1).
3.2. Induced calciﬁcation in interstitial cells from tri- and bicuspid aortic
valves
We compared the sensitivity to osteogenic stimuli of VIC from the
patients and healthy controls (Fig. 2). Twenty-one day after stimulation
with osteogenic medium calciﬁcation occurred as shown by strong
Alizarin Red staining, but without any diﬀerence between VIC from
BAV and TAV (Fig. 2A). Quite little Alizarin Red staining was seen in
VIC from healthy valves comparing to what was seen in the cells from
the BAV and TAV patients.
Expression of genes that might be involved in calciﬁcation was
measured in VIC by qPCR after stimulation with osteogenic medium:
BMP2 (bone morphogenetic protein 2), RUNX2 (runt related tran-
scription factor 2), POSTIN (periostin), CTNNB1 (beta-catenin), SOX9
(sex determining region Y0-box 9), OPN (osteopontin). There were no
diﬀerences between unstimulated cells derived from either BAV, TAV
or controls regarding BMP2, POSTIN, CTNNB1, and SOX9 in either non-
stimulated or stimulated cells (Supplementary Fig. 2). RUNX2 was
lower in unstimulated VIC from BAV patients as compared to healthy
controls, while OPN expression was higher in non-stimulated VIC from
TAV than in BAV and in controls. After 21 days of osteogenic induction
only RUNX2 expression increased in all three groups comparing to non-
stimulated cells, but without diﬀerence between groups (Fig. 2B).
3.3. Interstitial cells from bi- and tricuspid valves have diﬀerent levels of
markers of ﬁbrosis and smooth muscles
The aortic valve pathology includes mineralization of the valve and
also myoﬁbroblast-like transformation of VIC and valve ﬁbrosis [3].
The most common marker for myoﬁbroblasts is smooth muscle actin (α-
SMA). Calponin, a marker of fully diﬀerentiated smooth muscle cells,
has also been reported to be expressed in VIC of stenotic valves [24].
The content of αSMA and calponin estimated by Western blotting was
higher in VIC from calciﬁed BAV than from TAV (Fig. 3).
3.4. Bi- and tricuspid valves are two independent groups by gene expression
To identify if VIC from BAV and TAV patients form separate clusters
by gene expression we used multivariate discriminant function analysis
to discriminate groups by expression of the genes analyzed at the pre-
vious steps. Graphical result of the examined groups based on the dis-
criminant analysis (Fig. 4) shows that VIC from BAV and TAV groups
form independent and separate clusters. BAV group was more homo-
genous and well separated from TAV and control groups. VIC from TAV
patients were also distinct from healthy controls.
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3.5. Patients with calciﬁc aortic stenosis have elevated level of osteopontin
in blood
Increased levels of plasma osteopontin are associated with the
presence of aortic valve calciﬁcation and stenosis [25]. We compared
the level of osteopontin in the plasma of BAV and TAV patients and in
healthy controls (Fig. 5). Osteopontin concentration was signiﬁcantly
higher in both patient groups compared to control group, however,
there was no diﬀerence between BAV and TAV (Fig. 5). Interestingly,
many patients in both groups had the plasma level of osteopontin
overlapping with some healthy donors.
3.6. Notch-dependent initiation of osteoblast diﬀerentiation is stronger in
BAV
To assess if the initial mechanisms of calciﬁcation in BAV and TAV-
derived VIC are dependent on Notch signaling we used co-culture of
VIC with human umbilical endothelial cells (HUVEC). These co-culture
experiments model the situation in vivo when endothelial cells com-
municate with mesenchymal cells via Notch signaling [26,27]. HUVEC,
not VEC were used because they give more uniform endothelial cell
cultures. Notch was activated in HUVEC by transduction with lenti-
viruses bearing Notch Intracellular Domain (NICD). The next day the
HUVEC were seeded on VIC (Fig. 6A, left panel). HEY1, main Notch
target, was elevated in co-cultures and this elevation was more pro-
minent when Notch was activated in endothelial cells (Fig. 6A, right
panel). The day after start of co-culture we induced osteogenic diﬀer-
entiation by addition of osteogenic medium. The early expression of
Notch target HEY1 and proosteogenic markers was measured in the co-
cultures after three days of exposure to osteogenic medium in the ab-
sence (control) or presence of Notch activation (Fig. 6B and Supple-
mentary Fig. 3). Expression of HEY1 was similar in all three groups
without Notch activation. However, when Notch was activated, HEY1
was the highest in the co-cultures that contained BAV-derived VIC. Co-
cultures with VIC from BAV patients demonstrated signiﬁcantly higher
expression of OPN, ALP and POSTIN after osteogenic stimulation.
Fig. 1. Expression level of Notch receptors and ligands in aortic valve interstitial cells from the patients with calciﬁc aortic stenosis with bicuspid (BAV, n = 13) and tricuspid (TAV,
n = 17) aortic valves and from healthy control valves (C, n = 11). mRNA levels were analyzed by qPCR and normalized to GAPDH. Groups were compared using Mann-Whitney non-
parametric test; line represents the median; *p < 0.05.
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Activation of Notch caused even higher elevation of OPN, ALP and
POSTIN, which was signiﬁcantly higher in the co-cultures containing
BAV derived VIC. The expression of the other proosteogenic genes was
not responsive to changes in Notch activity (Supplementary Fig. 5).
Increased alkaline phosphatase 10 days after the initiation of os-
teogenic stimulation conﬁrmed that Notch activation induced osteo-
genic phenotype more readily in BAV-derived co-cultures (Fig. 6B) with
more intensive staining of the co-cultures containing VIC derived from
BAV patients and activated Notch.
3.7. Early endothelial-to-mesenchymal transition activation is more
prominent in endothelial cells from BAV
Recently it has been shown that endothelial-to-mesenchymal tran-
sition (EMT) precedes the onset of calciﬁcation in valve cells [4]. We
studied Notch-dependent EMT activation in VEC derived from BAV and
TAV patient and healthy valves. For Notch-induced EMT we used a
previously described model with introduction of NICD into VEC by
lentiviral transduction [23]. Expression of Notch-responsive genes
HEY1 and SLUG, which activate the initial stage of EMT, was measured
after three days (Fig. 7, left panel). In VEC from BAV expression of both
SLUG and HEY1 was higher than in TAV and healthy controls. After
10 days ACTA2 expression encoding αSMA, the deﬁnitive EMT marker,
was not diﬀerent between BAV and TAV, but was signiﬁcantly less than
in control cells. Immunocytochemical staining of control cells for αSMA
showed well diﬀerentiated cells that undergone EMT and terminated by
appearance of true mesenchymal cells with nice actin ﬁbers (Fig. 7,
right panel). At the same time endotelial cells from BAV and TAV pa-
tients failed to form actin ﬁbers properly that suggested failure of EMT
process.
4. Discussion
In this study we show diﬀerences in the initial proosteogenic events
between the valvular cells derived from the patients with aortic stenosis
associated with bicuspid aortic valve versus the cells derived from the
patients with tricuspid aortic valve. This is to our knowledge the ﬁrst
study showing that the mechanisms that underlie calciﬁcation of BAV
and TAV are diﬀerent. Furthermore discriminant analysis showed that
calciﬁed BAV had a distinctly diﬀerent genetic pattern compared to
calciﬁed TAV and noncalciﬁed controls.
4.1. Bicuspid valves and calciﬁcation
In the present study Notch-related genes NOTCH1, NOTCH3, DLL1,
DLL4 as well as proosteogenic RUNX2 showed a diﬀerent pattern of
expression in VIC derived from BAV patients compared to the cells from
TAV patients. Furthermore protein content of markers of smooth
muscle and ﬁbrosis (αSMA, vimentin, and calponin) were diﬀerent
between BAV and TAV derived cells.
There is accumulating evidence that dysregulated Notch is im-
plicated in calciﬁcation. NOTCH1 haploinsuﬃciency promotes
Fig. 2. Sensitivity of aortic valve interstitial cells from the patients with calciﬁc aortic stenosis with bicuspid (BAV, n = 13) and tricuspid (TAV, n = 17) aortic valves and from healthy
control valves (C, n = 11) to osteogenic stimulation. Aortic valve interstitial cells (VIC) were cultured in osteogenic medium for 21 days and then stained with Alizarin Red. (A) Left panel
shows representative image of VIC diﬀerentiation with calciﬁcation revealed by red color. Right panel represents digital quantiﬁcation of calcium deposition. (B) mRNA expression by
qPCR of proosteogenic genes in the BAV, TAV and control groups of VIC. The groups were compared using Mann-Whitney non-parametric test, line represents the median. P-value for the
diﬀerences between the groups is given only for the signiﬁcant diﬀerences (p < 0.05). Asterisks indicate the signiﬁcant diﬀerences (p < 0.05) of mRNA content between un-
diﬀerentiated and diﬀerentiated cells for a given group (BAV, TAV or control, correspondingly). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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proosteogenic gene expression in the cells from BAV patients [21].
Idiopathic calciﬁc aortic valve disease is associated with hypomethy-
lation of the long noncoding (lnc) RNA H19, which prevents p53 from
binding to the promoter region of NOTCH1, suppressing transcription
[28]. This supports recent data showing that the repression of NOTCH1
leads to calciﬁc aortic valve disease, likely through myoﬁbroblast and
osteogenic diﬀerentiation [29].
Fig. 3. Protein level of ﬁbrotic/smooth muscle markers in aortic valve interstitial cells from patients with calciﬁed bicuspid (BAV) and tricuspid valve (TAV). Left panel shows re-
presentative Western blots for protein level of αSMA and calponin. Right panel represents digital quantiﬁcation of protein level by densitometry of the corresponding bands. Bands were
normalized using beta-actin staining. BAV: n = 9, TAV: n = 10. The groups were compared using Mann-Whitney non-parametric test, line represents the median. P-value for the
diﬀerences between the groups is given.
Fig. 4. Partition of the groups based on the results of discriminant analysis of gene ex-
pression in aortic valve interstitial cells. Discriminant analysis was used to investigate
what parameters in gene expression could divide aortic valve interstitial cells (VIC) de-
rived from patients with bicuspid aortic valve (BAV) or with tricuspid aortic valve (TAV)
or healthy control (C) groups. Expression data on a set of the following genes was used:
NOTCH1, NOTCH2, NOTCH3, NOTCH4, DLL1, DLL4, JAG, BMP2, RUNX2, POSTIN,
CTNNB1, SOX9, OPN, VIM, SPRY1). Scatter plot demonstrates that VIC from BAV and
TAV groups form separated clusters by gene expression, while VIC from control group
overlap with both BAV and TAV group.
Fig. 5. Level of osteopontin in the plasma of patients with calciﬁed bicuspid (BAV) and
tricuspid (TAV) aortic valves and patients with healthy control valves (C). Groups were
compared using t-test.
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Notch-signaling is extremely dose sensitive due to the lack of a
signal ampliﬁcation step or utilization of secondary messengers to
transmit the signal from the cell surface to the nucleus [30]. By altering
the amount of ligands and receptors expressed in a cell, numerous
scenarios of Notch activation patterns can be generated. The tissue
speciﬁc context-dependent action of Notch is poorly understood, but
dysregulation in expression of Notch-related genes could contribute to
the development of cardiovascular pathology [31,32]. Therefore, our
data on Notch-related gene expression in VIC and diﬀerences between
BAV and TAV and controls suggest that dysregulated expression of
Notch genes might contribute to a change of phenotype in these cells.
4.2. Notch and initiation of calciﬁcation
We analyzed the eﬀect of modulating Notch activity by introducing
NICD in co-cultures of VIC and endothelial cells. NICD induced in-
creased downstream signaling from Notch and increased expression of
proosteogenic genes in co-cultures of endothelilal cells and VIC from
BAV compared to TAV and controls. NICD induced stronger expression
of Notch-responsive genes HEY1 and SLUG in cultures with BAV-de-
rived VEC. Our data indicate that BAV-derived cells have increased
sensitivity to Notch modulation. This may explain why BAV have
higher occurrence of calciﬁcation and the process may also go faster.
The presented data showing stronger predisposition to calciﬁcation
in BAV induced by NICD, do suggest that the initiation mechanisms
may be diﬀerent in BAV and TAV and that they are Notch-dependent.
However, our data indicate that the calciﬁcation of end-stage disease is
similar in calciﬁc BAV and TAV. This includes both data from cell
cultures as well as similar plasma levels of osteopontin from endstage
disease with BAV and TAV. This is in agreement with studies comparing
transcriptomes of BAV and TAV [33,34]. Both studies conclude that the
gene expression proﬁles of calciﬁed valve tissues are similar, but dif-
ferent from healthy control valves and both studies proposed that the
early mechanisms inducing valve calciﬁcation might be diﬀerent be-
tween BAV and TAV patients.
Fig. 6. Notch activity distictly inﬂuences osteogenic diﬀerentiation of valve interstitial cells (VIC) of patients with calciﬁed bicuspid (BAV) and tricuspid valve (TAV). VIC from TAV, BAV
and control groups were cocultured with human umbilical vein endothelial cells (HUVEC) in the presence of osteogenic medium. To test how activation of Notch inﬂuences proosteogenic
responce HUVEC were transduced with lentivirus bearing Notch1 intracellular domain and cocultured with VIC (n = 5 for each group). (A) Activation of HEY1 expression in co-cultures
of VIC from normal valves with HUVEC with or without activation of Notch. (B) Left panel. The cells were stimulated with osteogenic medium. Level of proosteogenic gene transcription
was estimated in by qPCR in the absence/presence of Notch-activation 3 days after inducing osteogenic diﬀerentiation. The groups were compared using Mann-Whitney non-parametric
test. P-value for the diﬀerences between the groups is given. Right panel. To assess the induction of proosteogenic phenotype alkaline-phosphatase activity was veriﬁed after 10 days of
osteogenic induction.
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4.3. Osteopontin and valve calciﬁcation
OPN was increased in patients with calciﬁed BAV and TAV without
any diﬀerence between groups. OPN and POSTIN may be key early
players in triggering osteogenic phenotype [35,36], although there are
conﬂicting data regarding the role of OPN [36–38]. Notch activation
caused a substantial activation of OPN and POSTIN transcription in VIC
from BAV group comparing to cells from TAV and controls.The co-
culture experiments show greater response of BAV VIC to NICD for
several genes including OPN. The exact role of osteopontin in valvular
calciﬁcation is not clear and its possible regulation by Notch deserves
further research.
4.4. Markers of ﬁbrosis and smooth muscle
Multiple mesenchymal markers are used to characterize EMT. αSMA
is a key factor often used to identify fully diﬀerentiated myoﬁbroblasts,
which are often termed ‘activated ﬁbroblasts’. αSMA not only exerts
traction forces that are central in the alteration of tissue architecture
during ﬁbrosis, but also plays an important role in myoﬁbroblast
diﬀerentiation and function [39].
αSMA content was increased in VICs from BAV compared to TAV
according to our data. Increased expression of αSMA has been shown to
directly reduce the clonal potential of human mesenchymal stem cells
and to guide their diﬀerentiation toward osteoblasts. It has been also
demonstrated, that αSMA not only identiﬁes osteoprogenitors in me-
senchymal populations [40,41], but may be part of the mechanism
driving diﬀerentiation [42]. In this regard high αSMA content in BAV-
derived VIC might also contribute to their higher predisposition to os-
teogenesis compared to TAV cells.
4.5. Limitations
The current study is limited by the unavailability of structurally
normal BAV as the ideal comparative control group to calciﬁed BAV.
The availability of healthy valves is in itself a diﬃculty, and to obtain a
material of healthy BAV is virtually impossible. Wide variability was
observed within each subgroup on qPCR data. This may reﬂect the fact
that each individual sample might be at a diﬀerent stage of disease.
Fig. 7. Endothelial-to-mesenchymal transition (EMT) initiation is more prominent in the valve endothelial cells (VEC) derived from the patients with calciﬁed bicuspid aortic valve (BAV)
compared to the cells derived from the patients with calciﬁed tricuspid aortic valve (TAV) or control cells derived from healthy valves (C). VEC were transduced with the lentivirus
bearing activated Notch intracellular domain (NICD), n = 5 for each group. SLUG and HEY1 expression was analyzed by qPCR 3 days after the induction of EMT; ACTA2 expression was
analyzed 10 days after the induction of EMT by qPCR (left panel) and by ICH staining of the cells with antibody against αSMA (right panel). Scale bar corresponds to 50 μm. The groups
were compared using Mann-Whitney non-parametric test. P-value for the diﬀerences between the groups is given.
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5. Conclusion
The present data demonstrated genetic diﬀerences between calciﬁ-
cation in BAV and in TAV with special reference to Notch signaling,
which may be particularly important in the initiation of calciﬁcation in
BAV. Gene expression in VIC from BAV, TAV, and healthy controls
represent diﬀerent clusters.
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associated with bicuspid aortic valve remain unclear. NOTCH1 mutations are associated with bicuspid aortic
valve and have been found in individuals with various left ventricular outﬂow tract abnormalities. Notch is a
key signaling during cardiac valve formation that promotes the endothelial-to-mesenchymal transition. We
address the role of Notch signaling in human aortic endothelial cells from patients with bicuspid aortic valve
and aortic aneurysm. Aortic endothelial cells were isolated from tissue fragments of bicuspid aortic valve-
associated thoracic aortic aneurysm patients and from healthy donors. Endothelial-to-mesenchymal transition
was induced by activation of Notch signaling. Effectiveness of the transition was estimated by loss of endothelial
and gain of mesenchymal markers by immunocytochemistry and qPCR. We show that aortic endothelial cells
from the patients with aortic aneurysm and bicuspid aortic valve have down regulated Notch signaling and fail
to activate Notch-dependent endothelial-to-mesenchymal transition in response to its stimulation by different
Notch ligands. Our ﬁndings support the idea that bicuspid aortic valve and associated aortic aneurysm is associ-
ated with dysregulation of the entire Notch signaling pathway independently on the speciﬁc gene mutation.
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Bicuspid aortic valve (BAV) is the most common congenital heart
malformation, occurring in 1% to 2% of the population [1]. It has been
suggested that the valve defect may arise during development of the
aortic valvular cusps and aortic media from neural crest cells [2,3].
BAV patients are at increased risk for aortic dilation, aneurysm, and
dissection [4–6]. However, the reasons that cause aortic dilation as
well as calciﬁcation in BAV patients remain unclear [7] and conservative
therapy is currently absent for this disease.
NOTCH1mutations are associated with BAV and have been found in
individuals with various left ventricular outﬂow tract abnormalities
such as hypoplastic left heart syndrome, coarctation of the aorta and
aortic valve stenosis, [8,9]. Notch is a key signaling pathway during
cardiac valve formation that via Snail1 activation, promotes theesearch Centre, Akkuratova, 2,
A.B. Malashicheva).endothelial-to-mesenchymal transition (EMT) of endocardial cells to
form the valve primordium (10). Combined loss of Notch1 downstream
targets, Hey1 and HeyL causes impaired EMT in mice [11].
Functional studies on the missense NOTCH1 mutations associated
with left ventricular outﬂow abnormalities have shown reduced recep-
tor signaling associated with defective epithelial-to-mesenchymal
transition in HMEC-1 microvascular endothelial cell line used as a
model [12]. Recently it has been shown that NOTCH1 haploinsufﬁciency
dramatically inﬂuences the capacity of human iPS-derived endothelial
cells to resist shear stress and this may explain the aortic pathology in
the case of NOTCH1 mutation [13]. All these highlights the role of
Notch signaling in endothelial cells in maintaining aortic wall integrity
and its resistance to continuous stress.
Multiple studies have demonstrated the high heritability of BAV in
humans [14–16]. Animal models of BAV also suggest a possible geno-
type–phenotype correlation related to cusp fusion phenotypes. Despite
tremendous advances in gene sequencing technology, the genetic
etiology of many congenital heart malformations, including BAV, re-
mains poorly understood [17,18]. We hypothesized that the entire
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BAV patients thus causing endothelial dysfunction and consequent
alteration of the aortic wall.
We address the role of Notch signaling in human aortic endothelial
cells (HAEC) from patients with BAV and aortic aneurysm (BAV/AoA).
We show that HAEC of the patients have down regulated Notch signal-
ing and fail to activate Notch-dependent EMT in response to its stimula-
tion by different Notch ligands and TGF-β. These ﬁndings support the
idea that BAV/AoA is associated with deregulation of the entire
Notch1 signaling pathway independently on the speciﬁc genemutation.
This might be especially important ﬁnding in terms of searching for a
possible therapeutic agent which is currently absent in BAV associated
aortopathies.
2. Methods
The clinical research protocol was approved by the local Ethics
Committee of the Almazov Federal Medical Research Center and was
in accordance with the principle of the Declaration of Helsinki. All
patients gave informed consent.
Samples of the aneurysmalwall of the ascending aortawere harvest-
ed during aortic surgery at the Almazov Federal Medical Research
Center. 12 specimenswere sampled frompatientswith ascending aortic
aneurysm associated with bicuspid aortic valve. All samples were from
aneurysms with a diameter of N5 cmmeasured by preoperative trans-
thoracic echocardiography. The patients are described in Table 1.
Control aortic specimens were obtained during organ harvesting from
organ transplant donors (n = 9) with the authorization of the law of
Russian Federation and in accordance with the Declaration of Helsinki.
Donors used as controls had no evidence of aneurysmal disease and
all had TAV. All tissues were sampled from the outer curvature of the
ascending aorta and the tissue was immediately dissected to separate
medial layers followed by either freezing or enzymatic digestion.
2.1. Isolation of primary cultures
Human umbilical vein endothelial cells (HUVEC) were harvested
from the human umbilical vein by enzymatic dissociation as previously
described [19]. Human aortic endothelial cells (HAEC)were isolated ac-
cording to [20] from tissue fragments of BAV-associated thoracic aortic
aneurysm (TAA) patients after surgery for aneurysm corrections.
Under sterile conditions tissue fragments were dissected away from
the adventitia. After washing in PBS, the tissue fragments were ﬁrst in-
cubated for 30 min at 37 °C in 0.1% collagenase solution (Collagenase,
Type 3, Worthington Biochemical Corporation, USA). Then endothelial
layer was removed mechanically by scraper, endothelial cells were
washed twice and plated onto fresh 3 cm2 culture dish covered 0.1% gel-
atin (Sigma) in EGM2 medium (Promocell) and incubated at 37 °C. On
the next day endothelial cells were washed by PBS and culture medium
was changed. Then the cells were puriﬁed from interstitial cells using
magnetic cell separation (MACS) with CD31+ microbeads (MiltenyiTable 1
Clinical characteristic in the study group.
Values are means ± S.E.M.; CSA/h, ascending aortic cross-sectional area to patient
height ratio
BAV (n= 12)
Male gender (%) 59
Age (years) 42–65
Aortic diameter (cm) 5.9 ± 0.2
Aortic CSA/h (cm2/m) 7.6 ± 0.6
Peak valve gradient (mmHg) 86 ± 11
Mean valve gradient (mmHg) 59 ± 9
Aortic valve area index (cm2/m2) 0.38 ± 0.02
Hypertension (%) 81Biotec) according to the manufacturer's directions. Purity of the endo-
thelial cells was conﬁrmed by ICH staining with anti CD31 and anti
vWF antibodies (Abcam). The CD31+ cells were used in experiments
at passages 2–5.
2.2. Genetic constructs and lentiviruses
Lentiviral packagingplasmidswere a generous gift of D. Trono (École
Polytechnique Fédérale de Lausanne, Switzerland); pLVTHMwas mod-
iﬁed by the addition of the T7 tag and chloramphenicol resistance gene
(cm), resulting in the pLVTHM-T7-cm vector. Open reading frame for
murine Notch intracellular domain (NICD) was ampliﬁed from reverse-
ly transcribed mouse ES cells mRNA, using the 5′-GGCGCGCCTCTGGA
TCCAGTGCTGCTGTCCCGCAAG-3′ and 5′-CCACTAGTGCGGCCGCTTATTT
AAATGCCTCTGGAATGTG-3′ primers; cDNA of murine Dll1, Dll4,
Jaggged1 and Jagged2 were kind gift from Prof. Shigeru Chiba (Univer-
sity of Tsukuba, Japan) andDr. Katsuto Hozumi (Tokai University School
of Medicine, Japan) [21]. The NICD PCR fragment was cleaved with AscI
and SpeI, then cloned in frame of the T7 tag, replacing the cmgenewith-
in pLVTHM-T7-cm. Similarly, theDll1was cloned at theAscI and SpeI re-
striction sites of pLVTHM-T7-cm, the Dll4 and Jag2 at AscI and EcoRI
restriction sites of pLVTHM-T7-cm, and the Jag1 into BamHI and EcoRI
restriction sites of the LeGO-G/BSD (Addgene). Lentiviral production
was performed as described previously [22]. The virus titer was deﬁned
by GFP-expressing virus; the efﬁciency of primary endothelilal cell
transductionwas 90–95%byGFP. The efﬁciency of transgene expression
with NICD-bearing virus and Dll4-bearing virus was veriﬁed by ICH-
staining with the antibodies to Notch1 and Dll4 correspondingly and
also was 90–95%.
2.3. EMT induction
For direct induction 50 × 103 HAEC were plated onto 6-well plates
and transduced with saturating concentration of the lentiviral concen-
trate encoding Dll1, Dll4, Jag1, Jag2 or NICD relatively (not shown).
For induction in co-culture 50 × 103 of HUVEC were plated onto 6-
well plates and transduced with Dll1, Dll4, Jag1or Jag2-bearing lentivi-
ruses respectively. After 24 h 50 × 103 HAEC were seeded onto HUVEC
in fresh EGM2. EMT was also induced by addition TGF-β1 (5 ng/ml) to
the culture media.
2.4. qPCR analysis
Total RNA (1 μg) was reverse transcribed with MMLV RT kit
(Eurogen, Russia). Real-time PCR was performed with 1 μL cDNA and
SYBRGreen PCRMastermix (Eurogen, Russia) in the Light Cycler system
using speciﬁc forward and reverse primers for target genes. Primer
sequences are available upon request. The thermocycling conditions
were as follows: 95 °C for 5 min, followed by 45 cycles of 95 °C for
15 s and 60 °C for 1 min. A ﬁnal heating step of 65 °C to 95 °C was per-
formed to obtain melting curves of the ﬁnal PCR products. Changes in
target genes expression levels were calculated as fold differences
using the comparative ΔΔCT method. The mRNA levels were normal-
ized to HPRTmRNA.
2.5. Immunocytochemistry
After growing on cover slides, cells were ﬁxed for 20 min in 1%
paraformaldehyde and permeablized in 1% BSA/0.1% Triton X-100/PBS
for three minutes, followed by blocking in 1% BSA/PBS for one hour.
Then cells were incubated for one hour with primary antibodies: SMA
(sc-32251, Santa Cruz). Secondary antibodies conjugated with r
Alexa546 (Invitrogen)were used. DAPI was used to visualize nuclei. Mi-
crophotographs were taken using an AxioObserver Microscope (Zeiss)
at ×20 magniﬁcation with AxioVision software.
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Genomic DNA was extracted from peripheral blood of all patients
used in the study with a FlexiGene DNA puriﬁcation Kit (Qiagen,
GmbH, Hilden, Germany). We applied a strategy of targeted mutation
screening for 10 out of 34 exons of theNOTCH1 gene as described earlier
[23]. Genomic DNA was extracted from peripheral blood using a
FlexiGene DNA puriﬁcation Kit (Qiagen, GmbH, Hilden, Germany).
Ampliﬁcation of exons 10, 11, 12, 13, 20, 23, 24, 29, 30, and 34 was
performed using primers (available upon request). Mutation screening
in patient and control groups was performed by direct sequencing of
ampliﬁed fragments with an ABI capillary sequencer (Applied
Biosystems, Foster City, CA, USA) using a BigDye Terminator v3.1 mix
(Applied Biosystems). Obtained sequences were analyzed and aligned
using BioEdit and Geneious software; new and rare variants were
checked against the 1000 Genomes and EVS databases.Fig. 1. Expression level ofmainNotch receptors and ligands in the endothelial cells from the pati
in control endothelial cells (C), n = 9. Groups are compared using the Mann–Whitney non-pa2.7. Statistics
Values are expressed asmeans±SEM. Groupswere compared using
theMann–Whitney non-parametric test. A value of P ≤ 0.05was consid-
ered signiﬁcant. Statistical analysis was performed by using R software
(version 2.12.0; R Foundation for Statistical Computing, Vienna,
Austria).
3. Results
3.1. The baseline level of Notch signaling is altered in the HAEC from BAV
patients
Notch signaling has been shown to be decreased in the ascending
aorta wall specimens of patients with BAV [24]. Initially, we assessed
the levels of expression for key Notch genes – NOTCH1-4, JAG1, DLL1,entswith thoracic aortic aneurysmassociatedwith bicuspid aortic valve (BAV), n=12 and
rametric test.
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Patient cells had signiﬁcantly lower mRNA levels of NOTCH1, NOTCH4
and DLL4 comparing to controls. However the mRNA level of direct
Notch targets HEY1 and SLUG, which is required for EMT during cardiac
morphogenesis [25] was not different between patients and controls.
SNAI1 (Snail) is one of themaster regulators of EMT and Notch1 induces
elevation in its expression during EMT [10,26]. Its mRNA level was
signiﬁcantly higher in the endothelial cells of BAV patients compared
to control cells. Our data suggest alterations of baseline Notch signaling
in aortic endothelial cells of BAV patients.
3.2. Experimental models for EMT induction
To establish an experimental model for estimating EMT efﬁciency in
HAECs of BAV/AoA patients we induced EMT in HUVECs and control
HAECs either by introduction of Notch intracellular domain (NICD)
with lentivirus or by the addition of TGF-β as it was described earlier
[25,27]. Stimulated cells lost cobblestone morphology after addition of
NICD-virus or TGF-β suggesting loss of endothelial phenotype and
transformation to mesenchymal cells (data not shown).
During cardiac EMT, endocardial cells undergo signiﬁcant changes in
gene expression including Notch-dependent induction of ACTA2
(αSMA), SNAII, and SNAIL2 [28]. We made additional screening of 11
genes previously described as markers of EMT [29]: PECAM1, VWF,
ACTA2, COL1A1, FOXC2, CDH2 (N-cadherin), TAGLN (SM22α), TWIST1,Fig. 2. Induction of endothelial-to-mesenchymal transition (EMT) in endothelial cells derived
Notch-intracellular domain (NICD) or by TGF-β. (A) expression of responsive genes 3 and 1
HAECs and HUVECs 14 days after EMT induction by ICH staining. Scale bar corresponds to 200FSPS100A4 (ﬁbroblast speciﬁc protein s100a4), SNAI2/SLUG, SNAI1/
SNAIL for their up or down regulation at EMT for HAECs and HUVECs
after TGF-β or NICD-induction. Among responsive early EMT markers
by qPCR were HEY1, HES1, FSPS100A4, SLUG, which were up regulated
after EMT induction (Fig. 2A). SMA was late responsive and reliable
marker of EMT in HAECs andHUVECs by qPCR aswell as by ICH staining
after 14 days of EMT induction. HEY1 and HES1 are among main Notch
transcriptional targets [30] and were up regulated at mRNA level in
endothelial cells in NICD-induced cultures. Loss of endothelial markers
such as PECAM1, VWF was quite weak (data not shown). Thus, both
HAECs and HUVECs activate EMT program in response to Notch1 intra-
cellular domain activation and to a relatively lesser extent in response to
TGF-β stimulation.
3.3. EMT is impaired in HAEC of BAV patients
To test the hypothesis that Notch signaling is impaired in aortic
endothelial cells of BAV/AoA patients we compared effectiveness of
EMT in HAECs from the patients with control cells by gain of mesenchy-
mal markers and loss of endothelial markers.
Firstwe induced EMT in BAV/Ao cells and in controls by introduction
of NICD or addition of TGF-β (Fig. 3). We observed signiﬁcantly
impaired NICD-induced activation of HEY1 and SLUG after 3 days of
EMT induction by NICD;HES1, FSPS100 and ACTA2 alsowere not activat-
ed in response to EMT–induction by NICD in the cells of patients.from human aorta (HAEC) and human umbilical vein (HUVEC) by either introduction of
4 days after EMT induction; (B) SMA (alpha-smooth muscle actin, ACTA1) induction in
μm.
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icantly reduced. The loss of endothelial markers was not different
between 2 groups (Fig. 3C).
Up regulation of ACTA2 expression induced by NICD or by TGF was
also impaired in the cells from patients. Fig. 3D demonstrates failure
to activate NICD and TGF-β–induced EMT program in the cells of BAV
patients by SMA staining of the cells.
Notch is known as a complex and lineage-speciﬁc signaling with
several receptors and ligands [30], therefore we analyzed EMT induc-
tion in HAECs from donors and patients in co-culture with the ligand-
expressing cells using the set of four Notch ligands (Fig. 4). Our data
conﬁrm the ﬁndings obtained in EMT stimulation with NICD that the
cells of BAV patients fail to activate EMT program in response to activa-
tion of Notch ligands.
To verify if any of the BAV/Ao patients had mutations in NOTCH1
gene we sequenced DNA from the patient blood samples. We applied
a strategy of targeted mutation screening for 10 out of 34 exons of the
NOTCH1 gene as described previously [23]. The choice of these speciﬁcFig. 3. Comparison of EMT induction effectiveness betweenHAECs from the patients with thorac
by either NICD or TGFβ. (A) Expression of mesenchymal markers estimated by qPCR 3 days afte
the induction; (C) Expression of endothelial markers 7 days after the induction (D) Expression
initial level of a given genewas normalized between different samples and the fold changewas
the differences between non-stimulated and stimulated samples.exons was based on previously published reports on the implication of
NOTCH1mutations in cardiac malformations, including BAV [8,31–33].
We deﬁned that none of the patients included in the study had
mutations in these exons of NOTCH1.3.4. Notch1-Jagged1 feedback loop is inactivated in HAECs of BAV patients
Notch functions as a part of positive feedback loop in which Notch
receptor activation promotes Notch ligand expression in surrounding
cells thus relaying a signal, a process known as lateral induction [34].
Jagged1 has been shown to be a direct transcriptional Notch target
[35]. Therefore we tested if this feedback loop is active in the cells
of BAV patients. We transduced HAECs with NICD-bearing lentiviruses
and veriﬁed up regulation of Notch genes in control donor cells and
in the cells from the patients (Fig. 5). Our data show that JAG1 expres-
sion induced by NICD was substantially reduced in the cells of BAV
patients.ic aortic aneurysm associatedwith bicuspid aortic valve (BAV) and control HAECs (donor)
r the induction; (B) Expression of mesenchymal markers estimated by qPCR 14 days after
of SMA by ICH staining 14 days after the induction. Scale bar corresponds to 200 μm. The
estimated. Arrows (*) indicate differences between control (C) and BAV groups. P indicates
Fig. 4. Comparison of EMT induction effectiveness betweenHAECs from the patients with thoracic aortic aneurysm associatedwith bicuspid aortic valve (BAV) and control HAECs (donor)
by co-culturewithHUVECs expressing one of the ligands Dll1, Dll4, Jag1 or Jag2. (A) Expression of EMT-responsivemarkers estimatedby qPCR3 days after the induction; (B) Expression or
EMT-responsive markers estimated by qPCR 14 days after the induction; (C) expression of SMA by ICH staining. *P b 0.05, Mann–Whitney non-parametric test. Scale bar corresponds to
200 μm.
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The etiology of a bicuspid aortic valve accompanied by aortic dilation
remains poorly understood.Whether this is a consequence of a constant
stress due to valve conﬁguration or it is a consequence of a developmen-
tal mistake is widely discussed. A role of the endothelial cells in the
developing of aneurysms is largely unknown, although a recent study
suggests that aneurysms from BAV patients may be associated with
endothelial dysfunction [36]. The most known genetic link in BAV
pathology is mutations in NOTCH1 described in patients with BAV [8,9,
31–33]. Although BAV has strong evidence of a genetic basis, successful
identiﬁcation of disease-causing variants has been limited. It has
been suggested by many researchers that the mutations not only in
NOTCH1 itself but also in related genes could be responsible for left ven-
tricular outﬂow malformations. However, several recent papers do not
support such a correlation [16,37,38]. Surprisingly, the authors did not
ﬁnd considerable amount of mutations in Notch-related genes in a
cohort of patients where previously NOTCH1 mutations had been
described.
Our study provides the ﬁrst direct functional evidence that primary
endothelial cells derived from aortas of BAV/AoA patients haveattenuated Notch signaling, irrespectively of NOTCH1 mutation. We
have shown that aortic endothelial cells derived from the BAV patients
with dilated aorta have impaired EMT induction. This impairment
could potentially reﬂect two aspects of the associated aortopathy. First
aspect regards the failure to undergo EMT during embryonic develop-
ment, which is necessary for the proper valve formation [39]. Alterna-
tively, because EMT is described as a stress-induced mechanism in
aortic valve, the failure to activate EMT program could lead to valve cal-
ciﬁcation [39]. A recent work has shown that Notch1 haploinsufﬁciency
disrupts the appropriate endothelial response to shear stress. In contrast
to wild-type endothelial cells, shear-exposed NOTCH1+/− endothelial
cells failed to up regulate anti-osteogenic factors that may be critical
for preventing calciﬁcation of underlying interstitial cells [13]. Similarly,
our results suggest that BAV-derived aortic endothelial cells fail to up
regulate Notch-induced EMT. We suggest that this reﬂects a common
stress-defense mechanism, which is impaired in the diseased cells.
We also observed signiﬁcant down regulation of Notch4 and Dll4 in
the diseased endothelial cells (Fig. 1). Dll4 is the ﬁrst Notch ligand
expressed in the forming arteries in the mouse, and Dll4 expression
precedes that of the genes encoding arterial Notch receptors, Notch1
and Notch4 [40]. Our ﬁndings are well in line with recent reports
Fig. 5. Lateral induction of Notch genes by Jag1. HAECs from the patients with thoracic aortic aneurysm associatedwith bicuspid aortic valve (BAV), n= 6 and control HAECs (donor), n=
9, were transducedwith lentivirus bearing Jag1 and the expression of Notch family genes was veriﬁed after 72 h by qPCR. Groups are compared using theMann–Whitney non-parametric
test.
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al speciﬁcation [41,42], implying that this axis might be disrupted in
BAV-patients and this impaired arterial speciﬁcation could contribute
to aortic aneurysm development often associated with BAV.
In a recent paper it has been shown that Notch4 agonistic antibody
in mice accelerate the healing response increasing amount of SMC in
the vessel [43]. Also this paper demonstrates the proangiogenic role of
endothelial Jagged1 in adult physiological angiogenesis and the syner-
gistic roles of endothelial Jag1 and Dll4 on vascular maturation. We
show that JAG1 expression induced by NICD was substantially reduced
in the BAV-derived endothelial cells and this was associated by down
regulation of smooth muscle cell contractile markers in SMC of the
aneurysmal wall. We suppose that the initial process of the vessel for-
mation as well as further healing in response to shear stress is impaired
in the BAV patients via Notch-dependent events in particular through
inactive feedback loop between Notch1 and Jagged1.
In our experiments all the ligands (Dll1, Dll4, Jag1, Jag2) failed to up
regulate EMT response in the cells of BAV-patients. However, both Dll1
and Dll4 were able to up regulate SNAIL almost to its level in healthy
cells. This result demonstrates the complexity of Notch signaling links
and also represents Dll1 and Dll4 ligands as potential candidates for
the up regulation the Notch system in the diseased cells as it has been
already described in other pathologies [44]. However it is clear that
the system is extremely dosage-dependent and ﬁne-tuned, thus further
studies of endothelial-SMC regulation are needed to understand its
function.The list of signaling pathways that modulate a given component of
the Notch signaling system is already abundant and is likely to be
expanded in the coming years [30]. One of the challenges lying ahead
is to deﬁne the temporal and spatial location of the regulation in vivo
and to determine the relative importance of all the interacting signaling
pathways that impinge on Dll4/Notch activity. In addition, very little is
known about the complex genetic program triggered by Notch activa-
tion and how it changes in time and with relation to the cellular status.
Notch is clearly of central importance for physiological and pathological
angiogenesis and a deeper knowledge of its molecular regulation in dif-
ferent contexts will allow the development of better therapeutic
strategies.
In summary, our data provide the evidence that Notch signaling
pathway is attenuated in BAV/AoA-derived endothelial cells resulting
in non-effective EMTprocess. This ﬁnding further underlines the impor-
tance of Notch pathway in cardiovascular system development and
maintenance. The obtained data open an additional clinical perspective
for searching a therapeutic target in order to prevent the development
of aortic aneurysm/stenosis associated with bicuspid aortic valve.
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Thoracic aortic aneurysm develops as a result of complex series of events that alter the cellular structure and the composition of
the extracellular matrix of the aortic wall.The purpose of the present work was to study the cellular functions of endothelial and
smooth muscle cells from the patients with aneurysms of the thoracic aorta. We studied endothelial and smooth muscle cells from
aneurysms in patients with bicuspid aortic valve and with tricuspid aortic valve. The expression of key markers of endothelial
(CD31, vWF, and VE-cadherin) and smooth muscle (SMA, SM22훼, calponin, and vimentin) cells as well extracellular matrix and
MMP activity was studied as well as and apoptosis and cell proliferation. Expression of functional markers of endothelial and
smooth muscle cells was reduced in patient cells. Cellular proliferation, migration, and synthesis of extracellular matrix proteins
are attenuated in the cells of the patients. We show for the first time that aortic endothelial cell phenotype is changed in the thoracic
aortic aneurysms compared to normal aortic wall. In conclusion both endothelial and smooth muscle cells from aneurysms of
the ascending aorta have downregulated specific cellular markers and altered functional properties, such as growth rate, apoptosis
induction, and extracellular matrix synthesis.
1. Introduction
Thoracic aortic aneurysms have altered cellular composition
and degeneration of the extracellular matrix in the aortic
wall. There are several different etiologies of thoracic aor-
tic aneurysm such as monogenic syndromes (Marfan and
Loeys-Dietz syndromes), aneurysm associated with bicuspid
aortic valves, and idiopathic aneurysms.The pathogenesis of
aneurysm formation in the monogenic syndromes has been
extensively studied [1], whereas the molecular and cellular
mechanisms of the other forms, which constitute themajority
of thoracic aortic aneurysms, remain largely unknown.
Most studies of the cell and molecular biology of thoracic
aortic aneurysm have used entire wall specimens [2–6].
Consequently, the biology of the different cell types in the
aneurysmal wall remains largely unknown. Single studies
comparing smooth muscle cells (SMCs) from aneurysm
patients with the cells from patients with acute aortic dissec-
tion revealed differences in expression of some SMC specific
genes. In addition, SMCs fromaneurysmswere demonstrated
to have significantly shorter telomeres, reduced metabolic
activity, and impaired proliferation and migration rates [7].
Comparison of SMC derived from either bicuspid aortic
valve (BAV) or normal tricuspid aortic valve (TAV) in
thoracic aortic aneurysms showed expression difference in
several markers including osteopontin and tissue inhibitor
of metalloproteinase 3 which may reflect different etiologies
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of TAV- and BAV-associated aneurysms [5–10]. However
all above-mentioned studies did not address the functional
properties of endothelial cells. As a consequence, a possible
role of the endothelium in the developing of aneurysms
is largely unknown, although a recent study suggests that
aneurysms at least from BAV patients may be associated with
endothelial dysfunction [11].
Endothelial cells have a substantial influence on smooth
muscle cell differentiation [12]. Recent studies show that
endothelial cells could directly influence smooth muscle cell
phenotype [13, 14]. The major role of mature differentiated
vascular smooth muscle cells is to maintain blood vessel
tone and to regulate blood pressure through constriction
or relaxation. This is achieved through the expression of a
complement of regulatory and contractile genes that provide
the machinery for this response [15]. The differentiated
contractile phenotype is largely characterized by expression
of coordinately regulated smooth muscle-specific markers
that include smooth muscle (SM) 훼-actin (ACTA2), and
SM22훼 (TAGLN) and some other proteins [15].
We sought to investigate if SMCs from aortic tissue of
the patients with thoracic aneurysm undergo phenotypic
and functional change such as growth, apoptosis, and extra-
cellular matrix synthesis and whether this change is also
accompanied by endothelial cell changes in the cells of the
patient tissues compared to the cells from healthy tissue. Our
data demonstrate downregulation of smoothmuscle aswell as
endothelial cell specific markers in the patient cells and also
changes in functional state of both SMC and endothelial cells.
2. Materials and Methods
The clinical research protocol was approved by the Local
Ethics Committee of the Almazov Federal Medical Research
Center and was in accordance with the principle of the
Declaration of Helsinki. All patients gave informed consent.
Samples of the aneurysmal wall of the thoracic aorta
were harvested during aortic surgery at the Almazov Federal
Medical Research Center. Thirty specimens were sampled
from patients with BAV (푛 = 17) or TAV (푛 = 13) (Table 1).
Patientswith connective tissue disorderswere excluded. Con-
trol aortic specimens were obtained from organ transplant
donors (푛 = 11) and all had TAV. Donors were all men with
mean age 48 ± 11. All tissues were sampled from the outer
curvature of the thoracic aorta.
2.1. Primary Cultures. To obtain SMC cultures the cells were
isolated as previously described [16]. The cells were used in
experiments at passages 2–5. Human aortic endothelial cells
(HAEC) were isolated from tissue fragments of patients after
surgery for aneurysm corrections. Under sterile conditions
tissue fragments were dissected away from the adventitia.
After washing in PBS, the tissue fragments were first incu-
bated for 30min at 37∘C in 0.1% collagenase solution (Col-
lagenase, Type 3, Worthington Biochemical Corporation,
USA). Then endothelial layer was removed mechanically by
scraper, and endothelial cells were washed twice and plated
onto fresh 3 cm2 culture dish covered with 0.1% gelatin
(Sigma) in EGM2 medium (Promocell) and incubated at
37∘C. The next day endothelial cells were washed by PBS
and culture medium was changed. The cells were used in
experiments at passages 2–4.
2.2. Cell Migration Assay. Cell migration was determined
using a “scratch” wound assay as described previously [17].
SMCs were grown to confluence on 6-well plates; after the
cells formed a monolayer, the medium was exchanged for
serum free medium containing 10mM hydroxyurea and
10 ng/mLPDGF BB growth factor to inhibit proliferation and
to stimulate migration and the cell monolayer was scraped
with a 200P pipette tip to create a cell-free zone.The number
of cells which migrated into the wounded area was counted
after six and 24 hours. Experiments were performed in
duplicate and then repeated three times.
2.3. Apoptosis Assay. For estimation of apoptosis SMCs were
seeded at a density of 10 × 103 cells/cm2, and 10 × 10−3 M
hydrogen peroxide (H2O2) was added to the culture medium
48 hours later. After two hours the cells were removed
and labeled with FITC-conjugated annexin V (Sigma). The
number of annexin V labelled cells was estimated by flow
cytometry using Calibur II (BD).
2.4. Reverse Transcription-PCR. Total RNA was extracted
from SMCs or endothelial cells using Trizol reagent (Invit-
rogen) according to the instructions of the manufacturer.
Reverse transcription was performed using kits (Eurogen,
Russia). Real-time PCR was performed in the LightCycler
system with SYBR Green detection (Fermentas) using spe-
cific primers.The mRNA levels were normalized to GAPDH
or HPRT mRNA. Changes in target genes expression levels
were calculated as fold differences using the comparativeΔΔCT method. The primer sequence is available upon
request.
2.5. Immunoblotting. Proteins were extracted from medial
tissues or SMCs. Specimens were homogenized in a lysis
buffer (50mM Tris (pH 8), 150mM NaCl, 1% Triton X-
100, 1% sodium deoxycholate, and 5mM EDTA), containing
protease inhibitors (Roche). Extracts were separated by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Primary antibodies used are SM22훼 (ab14106,
Abcam), SMA, vimentin (M072529, DAKO), beta-actin (ab
6276, Abcam), collagen I, fibrillin, and elastin. Positive bands
were quantified by densitometry using a gel documentation
system Fusion Fix (Vilber Lourmat) and Fusion-Capt soft-
ware. Bands were normalized using beta-actin stainings.
2.6. Immunocytochemistry. Primary antibodies used are
SMA (sc-32251, Santa Cruz), SM22alpha (ab14106, Abcam),
vimentin (sc-6260, Santa Cruz), VE-cadherin (MAB938,
RandD), von Willebrand factor (ab20435, Abcam), and
calponin (ab700, Abacam). Secondary antibodies conjugated
withAlexa488 orAlexa546 (Invitrogen) were used. DAPIwas
used to visualize nuclei. Microphotographs were taken using
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Figure 1: Expression of smooth muscle cell (SMC) markers in SMC from patients with aortic aneurysm with either tricuspid aortic valve
(TAV) or bicuspid aortic valve (BAV) and controls (C) determined by immunohistochemical staining of vimentin, 𝛼-smooth muscle actin
(SMA), and SM22𝛼 (magnification ×20).
AxioObserver Microscope (Zeiss) at ×20 magnification with
AxioVision software.
2.7. Zymography. MMP activity was assayed by a modified
gelatin zymography method [18]. Activity and content of
MMP-2 and MMP-9 were expressed in QuantiScan arbitrary
units.
2.8. Statistical Analysis. Values are expressed as means ± SD.
Groups were compared using the Mann-Whitney nonpara-
metric test. A value of 𝑃 ≤ 0.05 was considered significant.
3. Results
3.1. Expression of Smooth Muscle Cell Markers in Smooth
Muscle Cells from Aneurysms of the Thoracic Aorta. SMCs
from aneurysms of the thoracic aorta and from control aortas
were analyzed regarding the expression of SMC markers
like 𝛼-smooth muscle actin (SMA), vimentin, and SM22𝛼.
Figure 1 shows typical immunofluorescent staining of SMC
fromcontrol aortas and fromaneurysms in patientswithBAV
and TAV. Both TAV- and BAV-derived SMCs appeared to
have decreased level of SMA, vimentin, and SM22. However,
there were no visible differences between SMC from patients
with BAV and TAV.
At both mRNA and protein level expression of SMA and
vimentin was reduced both in the BAV- and TAV-derived
SMC and in the aortic media (Figure 2). However, although
SMA was lower in aortic media of aneurysms from patients
with BAV than in controls, it was still higher than in patients
with TAV. SM22 expression was decreased only in SMC and
aortic media from patients with TAV. In aneurysms from
patients with BAV the expression of SMA was higher than in
TAV patients both in SMC and in aortic media (Figure 2).
3.2. Expression of Endothelial Markers in Endothelial Cells
fromAneurysms of theThoracic Aorta. Figure 3 demonstrates
primary cultures of endothelial cells and ICC staining of the
cells including staining for SMA to confirm that the cultures
were not contaminated with SMC. Endothelial markers
appeared to be reduced in endothelium in aneurysms from
patients with both TAV and BAV (Figure 3).
We compared also the mRNA level of SMA, CD31/
PECAM, VE-cadherin, and vWF in endothelial cells derived
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Figure 2: Expression of smooth muscle cell (SMC) markers in SMC from patients with aortic aneurysm with either tricuspid aortic valve
(TAV) or bicuspid aortic valve (BAV) and controls (C). mRNA level was determined by qPCR; protein level was determined byWestern blot.
The diagrams represent the results of densitometry.The bands were normalized by 훽-actin. (a) mRNA level in SMC, C: 푛 = 10; TAV: 푛 = 13;
BAV: 푛 = 11. (b) Protein level in SMC, C: 푛 = 10; TAV: 푛 = 13; BAV: 푛 = 11. (c) Protein level in aortic media, C: 푛 = 11; TAV: 푛 = 13; BAV:푛 = 17.
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Table 1: Clinical characteristics in the study groups.
TAV (푛 = 13) BAV (푛 = 22)
Male gender (%) 46 59
Age (years) 71.3 ± 2.53 (range 55–84)∗ 62.1 ± 1.87 (range 42–79)∗†
Aortic diameter (cm) 5.6 ± 0.18∗ 5.9 ± 0.16∗
Aortic CSA/h (cm2/m) 6.6 ± 0.6∗ 7.6 ± 0.6∗
Peak valve gradient (mmHg) 83 ± 9 86 ± 11
Mean valve gradient (mmHg) 55 ± 7 59 ± 9
Aortic valve area index (cm2/m2) 0.39 ± 0.02 0.38 ± 0.02
Hypertension (%) 84∗ 81∗
Medication
Angiotensin receptor blockers (%) 38∗ 18
Statins (%) 0 41∗†
Aspirin (%) 31 14
Values are means ± SEM. ∗푃 < 0.05 compared with donors; †P<0.05 compared with TAV; CSA/h, ascending aortic cross-sectional area to patient height ratio.
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Figure 3: Characterization of the aortic endothelial cells from patients with aortic aneurysm with either tricuspid aortic valve (TAV) or
bicuspid aortic valve (BAV) and controls (C). Upper panel represents typical aortic endothelial cell cultures from control and aneurysmal
aortas. The SMA staining confirms the lack of medial SMC contamination in the endothelial cell culture. Vascular endothelial-cadherin
(VE-cadherin), von Willebrand factor (vWF), and CD31/PECAM staining confirm endothelial nature of the isolated cells.
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Figure 4: Expression of smooth muscle cell (SMC) markers and endothelial cell markers in endothelial cells from patients with aortic
aneurysm with either tricuspid aortic valve (TAV) or bicuspid aortic valve (BAV) and controls (C). mRNA level was determined by qPCR;
protein level was determined byWestern blot.The diagrams represent the results of densitometry.The bands were normalized by 훽-actin. (a)
mRNA and protein level in endothelial cells: controls: 푛 = 5; TAV: 푛 = 5; BAV: 푛 = 5; (b) representative Western blot picture for SMA and
vimentin protein level in endothelial cells.
from control aortas and from aneurysms. The expression
of SMA mRNA was elevated in both TAV- and BAV-
derived endothelial cells (Figure 4). Typical SMA microfila-
ment staining was not observed in our endothelial cultures
(Figure 3); thus the elevation of SMAmRNA levelwas not due
to contamination with SMC. Expression of the endothelial
markers vWF andCD31/PECAMwas substantially decreased
in endothelial cells from aneurysms (Figure 4); the level of
VE-cadherin mRNA was not changed.
3.3. Proliferation and Migration of Cells from Aneurysms.
Specific degenerative processes associated with reduced cel-
lularity are observed in the aneurysm wall [19]. To evaluate
the possible contribution of SMC and endothelial cells to
these changes, we compared cell proliferation and migration
in healthy donors and patients with aneurysms of the thoracic
aorta. SMC proliferation rate (Figure 5(a)) in both BAV and
TAV aneurysm was lower compared to healthy donors, but
without any difference between the two types of aneurysms.
Endothelial cells from aneurysm patients had also lower
proliferation than controls, but endothelium from patients
with BAVhad lower proliferation rate than endothelium from
aneurysms of patients with TAV (Figure 5(b)).
SMCmigration ratewas higher in aneurysmpatients with
TAV, but not in BAV patients compared to controls (Figures
5(a) and 5(b)).
3.4. Apoptosis in Smooth Muscle Cells from Aneurysm Walls.
Reduced cell number has been shown in aortic tissue of
thoracic aortic aneurysm patients [20] and may reflect
increased apoptotic level in the vessel wall cells. Indeed, the
number of cells that are positive for DNA double strand
breaks (an apoptotic marker) is increased in the media of
the wall of thoracic aneurysms [20]. Therefore we studied
apoptosis in SMC cultures from aneurysm patients and
controls (Figure 6(a)).The number of annexinVpositive cells
was significantly higher in SMC cultures from patients with
both BAV and TAV.
Oxidative injury might be a cause of increased wall
weakness in both abdominal and thoracic aortic aneurysm
[21].The ability of oxidative stress to cause apoptosismight be
altered in SMC from aneurysms. To test this hypothesis H2O2
was added to SMC. We measured apoptosis as a residual
between the percentage of annexinV positive cells afterH2O2
treatment and the amount of annexin V positive cells in
normal cultures (“baseline”). H2O2-induced apoptosis was
reduced in SMC from aneurysms compared to SMC from
nonaneurysm aortic walls (Figure 6(b)).
3.5. Matrix Metalloproteases and Matrix Protein Content. To
evaluate SMC contribution to extracellular matrix protein
synthesis (elastin, fibrillin, and collagen I) in the aortic wall
we estimated the protein content in aortic media specimens
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Figure 5: Proliferation and migration characteristics of SMC and endothelial cells from patients with aortic aneurysm with either tricuspid
aortic valve (TAV, 푛 = 5) or bicuspid aortic valve (BAV, 푛 = 5) and controls (C, 푛 = 5).The cells were seeded at an equal density and counted
each two days for proliferation assay.The migration was estimated via scratch-assay (see Section 2). Migrated cells were counted after 6 h and
24 hours. (a) SMC proliferation. (b) Endothelial proliferation. (c) SMC migration.
and in SMC protein extracts (Figure 7). The elastin and
fibrillin content was reduced in aortic media from aneurysms
in both BAV and TAV patients (Figure 7(a)).
Collagen I content was higher in aortic media from both
types of aneurysm patients but was not significantly changed
in SMC from aneurysm patients. However, the amount of
collagen I was higher in SMC of aneurysms from patients
with TAV only (Figure 7(a)).
The culture media from endothelial cells were analyzed
for elastin, collagen I, and fibrillin content (Figure 7(b)).
Our data show that aortic endothelial cells are capable
of synthesizing these proteins and synthesizing fragmented
collagen I.
MMP expressionmay be increased in thoracic aneurysms
[2, 22], but their role in the etiology of aneurysms is not
clarified. The exact type of cells in the aortic wall that
synthesizes MMPs is still unknown [23]. We did not detect
increase in MMP2 or MMP9 activity in total aneurysm
medial tissue samples (Figure 8), whereas MMP-9 activity
was significantly increased in SMCs and SMC culture media
from aneurysm patients with both BAV and TAV.
4. Discussion
The functional studies of the cells from TAA patients are still
rare. However the ultimate target of any therapy approach is
a cell, whose healthy properties are changed in the pathology.
That is why, it is important to know not only a set of genes
changed at a definite pathology, but also cellular properties
that are the cause of a pathology and thus to find a possible
8 International Journal of Vascular Medicine
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Figure 6: Apoptosis level in cultured SMC from patients with aortic aneurysm with either tricuspid aortic valve (TAV) or bicuspid aortic
valve (BAV) and controls (C). (a)The level of “baseline” SMC apoptosis in culture.The diagram shows the percentage of annexin V positive
SMC in vitro estimated by flow cytometry.The lower panel shows representative plots from the analysis of live SMC in culture. C: 푛 = 5; TAV:
n=5; BAV: 푛 = 5. (b) Apoptosis induction by H2O2.The diagram shows the residual between the percentage of annexin V positive cells after
H2O2 treatment and the level of annexin V positive cells in untreated cultures.The lower panel shows representative plots from the analysis
of SMC treated with H2O2. C: 푛 = 5; TAV: 푛 = 5; BAV: 푛 = 5. Arrows mark annexin V positive cells.
tool for a correction. This study aimed to characterize two
major aortic cellular populations, SMC and EC, from TAA
patients and healthy donors.
In the present study we demonstrated that both SMC
and endothelial cells from thoracic aortic aneurysms have
impaired functional properties in terms of proliferation, con-
tractile and extracellular protein expression, and apoptosis
with significant difference between BAV- and TAV-associated
aneurysms. Of most importance, we revealed the primary
changes of endothelial cells. Our findings are in agreement
with a recent publication describing endothelial dysfunction
in BAV patients [11].
SMC from thoracic aneurysms demonstrated decreased
expression of key SMC proteins such as SMA and SM22훼
both at mRNA and at protein level. Endothelial cells from
thoracic aneurysms also demonstrated downregulation of
specific markers and impairment in growth. Our data sug-
gests that the cells from the aneurysm aortic wall are in less
differentiated state comparing to normal aortic wall. This
observation is well in line with the findings that endothelial
cells influence differentiation and functions of underlying
SMC [13, 14]. Thus, endothelial changes may contribute to
impairment of the aortic wall structure built by SMC.
Cultured SMC from aneurysm patients demonstrated
surprisingly high amounts of annexin V positive cells sug-
gesting a high level of apoptosis in the aortic wall of aneurysm
patients [3]. This may also be partly a consequence of the
cell culture, but nevertheless there were differences between
the different groups. Surprisingly the SMCs were relatively
resistant to apoptosis induced by H2O2. This may be an
important finding, but we have no good explanation. Philippi
and coauthors showed that SMC from aneurysms in BAV
patients had the poorest resistance to oxidative stress [10],
but they did not show a baseline level of apoptosis in their
SMC cultures but counted the viability of the cells under
oxidative stress. Apoptosis/proliferation rate is a very impor-
tant parameter of a cellular population turnover. We suggest
that both decreased proliferation rate and increased apoptosis
contribute to the loss of cells in the aortic wall in aneurysms.
The mechanisms of apoptosis resistance/susceptibility in
aortic SMC populationmay be important in the development
of aneurysms.
We compared the content of some extracellular matrix
protein in aortic tissue samples, SMC and supernatants from
SMC and endothelial cells.The observed results suggest that
SMC are not the only cells that synthesize extracellularmatrix
International Journal of Vascular Medicine 9
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Figure 7: Matrix protein level in SMC and endothelial cells from patients with aortic aneurysm with either tricuspid aortic valve (TAV) or
bicuspid aortic valve (BAV) and controls (C) determined byWestern blot. (a) Matrix protein level in SMC.The diagrams represent the results
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proteins in the aortic wall. Also endothelial cells are capable
of synthesizing extracellular matrix proteins in aneurysms
and the extracellular matrix composition is different between
aneurysms frompatients with TAVandBAVTAA. Finally the
integrity of the extracellularmatrix in thewall of aneurysms is
influenced by changes in the ratio between different proteins.
Fibrillin content was different between aneurysms from TAV
and BAV patients. Both endothelial cells and SMC from
aneurysm patients had synthesis of fragmented collagen I.
The complex nature of biosynthesis of extracellular matrix
proteins in the aneurysm wall is in agreement with other
recent studies [22, 23].
The role of different MMP in thoracic aneurysm patho-
genesis has been discussed [22, 23]. There are a number of
papers describing mainly the elevated gene expression levels
for someMMPs in the aneurysmwall [2, 22–24]. In our study
we analyzed the enzyme activity of MMP2 and MMP9. The
activity for MMP2 and MMP9 was elevated in SMC and in
supernatants from SMC cultures. This is in accordance with
previously reported elevated gene expression of MMP2 and
MMP9 in the wall of thoracic aneurysms [22, 23].
This study has several important limitations. The study
is heterogeneous because from every tissue sample it is not
possible to get SMC and endothelial cell cultures; the cells
are in culture for limited amount of passages that limits
the possibilities to study them. For the endothelial cells it
is difficult to get cultured cells and it is not possible to get
enough cells frommany patients for different kind of analysis.
Another limitation is that we have studied only two types
of cells whereas the aorta consists of more types of cells
including stem cells, macrophages, and fibroblasts. A very
important limitation is that gene expression and cell behavior
in dilatative aortopathy can be affected by hemodynamics as
well as by physical and biochemical environment, other than
by their interaction with the genetic background and these
factors are absent in cultured cells.
Further research of the cell alterations in the wall of
thoracic aneurysms might lead to a deeper understanding
10 International Journal of Vascular Medicine
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of pathogenesis and pathology and thus to find a potential
therapeutic tool.
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ABSTRACT   
Cellular and molecular mechanisms of thoracic aortic aneurysm are still not clear and therapeutic 
approaches are mostly absent. The role of endothelial cells in aortic wall integrity is emerging 
from recent studies. Although Notch pathway ensures endothelial development and integrity, and 
NOTCH1 mutations have been associated with thoracic aortic aneurysms, the role of this 
pathway in aneurysm remains elusive. The purpose of the present work was to study functions of 
Notch genes in endothelial cells of patients with sporadic thoracic aortic aneurysm.  
Aortic endothelial cells were isolated from aortic tissue of patients with thoracic aortic aneurysm 
and healthy donors. Gene expression of Notch and related BMP and WNT/β-catenin pathways 
was estimated by qPCR; WNT/β-catenin signaling was studied by TCF-luciferase reporter. To 
study the stress-response the cells were subjected to laminar shear stress and the expression of 
corresponding genes was estimated by qPCR.  
Analyses of mRNA expression of Notch genes, Notch target genes and Notch related pathways 
showed that endothelial cells of aneurysm patients have dysregulated Notch/BMP/WNT pathways 
compared to donor cells. Activity of Wnt pathway was significantly elevated in endothelial cells 
of the patients. Cells from patients had attenuated activation of DLL4, SNAIL1, DKK1 and BMP2 
in response to shear stress.   
In conclusion endothelial cells of the patients with thoracic aortic aneurysm have dysregulated 
Notch, BMP and WNT/β-catenin related signaling. Shear stress-response and cross-talk between 
Notch and Wnt pathways that normally ensures aortic integrity and resistance of endothelial cells 
to stress is impaired in aneurysmal patients.  
 
 
Keywords: thoracic aortic aneurysms, endothelial cells, Notch, Wnt, shear stress  
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INTRODUCTION   
Thoracic aortic aneurysm (TAA) is a life threatening condition, which is manifested by 
progressive enlargement of the thoracic aorta due to destructive changes in the aortic wall. 
Therapeutic agents that may influence the process are absent to date and the only therapeutic 
decision is elective surgical intervention (Davis et al., 2014). The etiologies underlying TAA are 
diverse and range from degenerative or hypertensive associated aortic enlargement to less 
common genetic disorders, such as Marfan syndrome, Ehlers-Danlos, and other syndromic 
connective tissue diseases (Verstraeten et al., 2017).   
Non-syndromic TAA may occur in the presence of a tricuspid (TAV) or a bicuspid aortic 
valve (BAV), and several lines of evidence suggest that the mechanism behind aneurysm 
development is distinct between the two patient groups (Folkersen et al., 2011; Kjellqvist et al., 
2013; Malashicheva et al., 2016). So far, a few genes such as NOTCH1 (Garg et al., 2005; 
McBride et al., 2008; McKellar et al., 2007; Mohamed et al., 2006) and GATA5 (Padang et al., 
2012) have been associated with non-syndromic forms of BAV/TAA. It is widely accepted that 
NOTCH1 mutations are associated with BAV and calcific aortic valve disease (Garg et al., 2005; 
McBride et al., 2008; Mohamed et al., 2006).    
Vascular smooth muscle cells (VSMC) have been considered as the main target of 
degeneration in the aortic wall, however, endothelial cells (ECs) have been implicated in 
maintaining the differentiation state of VSMC of the vessel wall (High et al., 2008; Kostina et al., 
2016; Malashicheva et al., 2016). We have previously shown that primary endothelial cells 
derived from aortas of BAV/TAA patients have attenuated Notch signaling, irrespective of 
NOTCH1 mutation (Kostina et al., 2016), and this may reflect an impaired common stress-
response mechanism in the diseased cells. Recently we and others reported NOTCH1 gene 
variants and mutations in patients with aortic stenosis with TAV (Ducharme et al., 2013; Irtyuga 
et al., 2017). However, no evidence has so far been presented for the defective function of Notch 
pathway in the ECs of aneurismal patients with a normal tricuspid valve.     
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In the present study we have analysed the expression of the Notch pathway in primary 
ECs from TAA patients with TAV. We show that Notch signaling is attenuated also in 
TAV/TAA cells. We observed over activation of Wnt and BMP signaling in the aortic ECs of 
TAA patients and show that the proper Notch, BMP2 and Wnt/β-catenin cooperation that is 
required for appropriate response to shear stress is impaired in aortic ECs of TAA patients.   
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MATERIALS AND METHODS  
Patients 
The clinical research protocol was approved by the local Ethics Committee of the 
Almazov Federal Medical Research Centre and was in accordance with the principle of the 
Declaration of Helsinki. All patients gave informed consent.   
Samples of the aneurysmal wall of the thoracic aorta were harvested during aortic surgery 
because of thoracic aortic aneurysm with aortic diameter more than 5 cm at the Almazov Federal 
Medical Research Centre. Nine specimens were sampled from patients with thoracic aortic 
aneurysm with tricuspid aortic valve (n = 9) (Table 1). Patients with connective tissue disorders 
were excluded. Control aortic specimens were obtained from organ transplant donors (n = 5) and 
all had TAV. All tissues were sampled from the outer curvature of the thoracic aorta.  
 
Primary cultures  
Human aortic endothelial cells (HAEC) were isolated from tissue fragments of patients 
after surgery for aneurysm corrections as described (Kostina et al., 2016). The cells were used in 
experiments at passages 2–5.  
  
In vitro flow model 
HAECs were plated on gelatin-coated teflon-bordered cell culture slides (75x25x10 mm, 
Flexcell International Corp.) and cultured for 40 hours with 5% CO2 at 37°C. The culture slides 
were then inserted into a parallel plate Streamer device (Flexcell International Corp., 
Hillsborough, NC, US) and exposed to laminar flow of 12 dynes/cm2 for 6 hours with 5% CO2 at 
37°C. A Masterflex L/S peristaltic pump was used to generate flow, and the frequency was 
determined by the Osci-Flow flow controller (Flexcell Internationl Corp.). Cells cultured under 
static conditions were used as controls. Total RNA was isolated using Qiagen miRNeasy Mini Kit 
(Qiagen, Hilden, Germany), according to manufacturer’s instructions and quantified using 
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NanoDrop ND-1000 (NanoDrop Technologies). In total, cells from n= 8 TAA patients and n= 5 
donors were used. 
 
qPCR analysis  
Total RNA (1 µg) was reverse transcribed with MMLV RT kit (Eurogen, Russia). Real-
time PCR was performed with 1µL cDNA and SYBRGreen PCR Mastermix (Eurogen, Russia) 
in the Light Cycler system using specific forward and reverse primers for target genes. Primer 
sequences are available upon request. Changes in target genes expression levels were calculated 
as fold differences using the comparative ∆∆CT method. The mRNA levels were normalized to 
HPRT mRNA.   
  
Genetic constructs and lentiviruses  
Lentiviral packaging plasmids were a generous gift of Didier Trono (École Polytechnique 
Fédérale de Lausanne, Switzerland); pLVTHM was modified by the addition of the T7 tag and 
chloramphenicol resistance gene (cm), resulting in the pLVTHM-T7-cm vector. The pCS2 
vector containing stabilized β–catenin resistant to proteolysis due to S33A mutation was kindly 
provided by Ralf Kemler, MPI Freiburg.  S33A β-catenin gene was amplified by PCR using the 
following primers:  
 
Asc-Bcat GGCGCGCCCATGGCTACTCAAGCTG  
Nde-Bcat GGAATTCCATATGTTACAGGTCAGTATCAAACC  
 
The PCR product was cleaved with AscI and NdeI, then cloned in frame of the T7 tag 
replacing the cm gene within pLVTHM-T7-cm resulting in the pLVTHM-b-catenin-S33A 
plasmid for lentiviral system. Lentiviral production was performed as described previously 
(Kostina et al., 2016). The virus titer was defined by GFP-expressing virus; the efficiency of 
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primary endothelial cell transduction was 90–95% by GFP. The efficiency of transgene 
expression with S33A β-catenin bearing virus verified by ICH staining with the antibodies to β-
catenin and it was 90–95%.  
 
Promoter activity assay  
To estimate canonical Wnt activity we used lentiviral TOP flash reporter construct and 
measured TCF activity  (Addgene 24307). In the construct the expression of the firefly luciferase 
gene is regulated by seven tandem TCF binding sites upstream of a minimal TK promoter 
(Korinek et al., 1997) and the level of TCF/LEF promoter activity indicates the transcriptional 
activation of WNT/β-catenin pathway. Cell lysis was performed using Luciferase Assay System 
(Promega) according to the manufacturer recommendations. Luciferase activity was measured 
with Synergy2 (BioTek, США). Samples were normalized by protein content using Pierce BCA 
Protein Assay Kit (Thermo Scientific).  
  
Statistics  
Values are expressed as means ± SEM. Groups were compared using the Mann–Whitney 
non-parametric test. A value of P≤0.05 was considered significant. Statistical analysis was 
performed by using R software (version 2.12.0; R Foundation for Statistical Computing, Vienna, 
Austria).  Principal component analysis (PCA) was performed to determine, which continuous 
variables discriminate between groups of TAA and donors. Continuous variables were qPCR 
gene expression data from 2^-ΔΔCT (RQ) estimation. PCA and the analysis of differential gene 
expression were performed using Phantasus tool (https://genome.ifmo.ru/phantasus/) with 
integrated limma instrument (Ritchie et al., 2015). 
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RESULTS  
Alteration in Notch signaling in ECs of TAV patients  
We measured the expression levels of key genes belonging to Notch pathway, namely– 
NOTCH1-4, JAG1, DLL1, DLL4 in human aortic endothelial cells (HAEC) of TAA patients and 
healthy controls (donors) (Fig. 1). This revealed a significantly lower level of mRNAs for 
NOTCH1, NOTCH2, NOTCH4 and DLL4, but significantly higher levels of NOTCH3 and DLL1 
expression in TAA patients as compared to donor controls.  Our data suggest alterations of 
baseline Notch signaling in aortic ECs of TAA patients.  
 
 
 
Fig. 1 Expression levels of Notch receptors and ligands in the aortic endothelial cells from the 
patients with thoracic aortic aneurysm (TAA), n=9 or control cells (donor), n=5. Groups are 
compared using Mann-Whitney nonparametric test; line represents the median; * p<0.05 
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Next we estimated the expression of key genes of several major pathways including 
antiosteogenic, antioxidant, antiatherogenic and proinflammatory pathways (Fig. 1, 
Supplementary fig.1). The mRNA levels of direct Notch target HEY1 and TGF-β/BMP effector, 
BMP2, were significantly up regulated while GREM1 was down regulated in the cells of the 
patients (Fig. 1A).  WNT/β-catenin effectors, TCF4, DKK1 and STAT6 were also upregulated in 
the patients. PCA analysis shows that HAEC from the patients are different by gene expression 
profiles from the cells derived from aortic tissues of healthy persons. Our data suggest that 
HAEC of TAA patients have dysregulated Notch/BMP/WNT pathways comparing to donor cells.  
10  
  
 
Fig. 2 Genes dysregulated in the aortic ECs from the patients with thoracic aortic aneurysm 
(TAA), n=9 or control cells (donor), n=5.A. Notch target genes (HEY1, HES1, SNAIL) as well as 
the expression of genes belonging to pathways that cross talk to Notch such as TGF-β/BMP 
(BMP2, GREM1, TGFRB2) and WNT/β-catenin (TCF4, DKK1, STAT6) pathways is shown. 
Groups are compared using Mann-Whitney non-parametric test; line represents the median; * 
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p<0.05. B. PCA analysis showing differences in gene expression between HAEC from healthy 
and diseased aortas. See also suppl. Fig.1. 
  
12  
  
 
Cross-talk between Notch and Wnt/β-catenin pathways  
BMP2 has been shown to activate WNT/β-catenin signaling cascade, driving osteogenic 
mineralization of vascular progenitors (Shao et al., 2005). Since we observed differential 
expression of effectors of WNT/β-catenin, BMP2, DKK1, STAT6 and TCF4, we estimated the 
level of the WNT/βcatenin signaling in the diseased and healthy cells using TOP flash using 
TOPflash reporter construct (Fig. 3).  
To verify how activated WNT/β-catenin operated in the HAEC of the TAA patients in 
comparison to healthy donors we overexpressed S33A mutated stabilised β-catenin in the cells 
via lentiviral transduction or added a specific inhibitor of Gsk3 activity, CHIR99021, to the 
culture medium (Fig. 3). Firstly, TCF activity was significantly elevated in the HAEC of TAA 
patients even at a basal level indicating possible differences in WNT/β-catenin signaling between 
the HAECs of the two groups. Secondly, the diseased cells also demonstrated a significant 
increase of the TCF-dependent luciferase activity in response to inhibition of Gsk3 by 
CHIR99021 (Fig. 3a), but not by the S33A β-catenin alone. However, the fold activation was 
significantly lower in diseased cells comparing to control (Fig. 3b), possibly due to the high 
initial level of the signaling. The level of AXIN2 expression, a direct WNT transcriptional target, 
(Fig. 3c) reflects the same tendency, showing the failure of activation in response to WNT, either 
by S33A β-catenin or CHIR99021. Thus, the WNT/β-catenin pathway activity is substantially 
elevated in the HAECs of TAA patients.  
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Fig. 3 Wnt activity in the HAEC of patients with TAA. Wnt was activated by a lentiviral 
transduction of proteolysis resistant S33A mutant of β-catenin into the cells or by addition of 
specific Gsk3 inhibitor CHIR99021. Wnt-activity was estimated with TOPFlash reporter 
construct as well as by the expression of AXIN2. (A) Dotted graph represents the basal level of 
luciferase activity in the HAEC; (B) bar graphs represent fold change of luciferase activity 
(mRNA level) in non-stimulated cells relative to the stimulated cells. (C) The mRNA level of 
direct WNT/ β-catenin target AXIN2 after the introduction of mutant β-catenin into the cells or by 
addition of specific Gsk3 inhibitor CHIR99021. HAEC from the patients with thoracic aortic 
aneurysm (TAA), n= 9; control HAEC (donor), n=6; line represents the median. Groups are 
compared using Mann-Whitney non-parametric test. * p<0.05 
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WNT/β-catenin pathway has been reported to modulate endothelial Notch/Dll4 signaling 
in mouse development (Corada et al., 2010). We assessed how activation of WNT/β-catenin 
influences DLL4 expression in adult HAEC (Fig. 4). We activated WNT/β-catenin in HAEC 
either by transduction of S33A β-catenin-bearing lentivirus or by the addition of CHIR99021. 
Correspondingly, we observed increase in AXIN2 expression; inhibition of Gsk3 activity had 
more prominent effect on AXIN2 expression than S33A β-catenin alone. Both direct S33A β-
catenin introduction and inhibition of Gsk3 activity decreased expression of DLL4 and NOTCH4. 
DKK1 expressionwas also decreased after inhibition of Gsk3, but S33A β-catenin alone was not 
able to decrease DKK1 expression. Our data suggest that activity of WNT/βcatenin itself could 
influence the level of Notch signaling by Dll4 and NOTCH4 in the adult HAECs. 
Correspondingly, DLL4 and NOTCH4 mRNA level was lower in the HAECs of the patients 
comparing to healthy cells (Fig. 1).   
  
15  
  
 
 
 
  
Fig. 4 Cross-talk between Wnt and Notch in adult human aortic endothelial cells (HAECs). Cells 
were transduced with S33A mutant β-catenin-bearing lentivirus or cultured in the presence of 
Gsk3 inhibitor CHIR99021. Groups are compared using Mann-Whitney non-parametric test. * 
p<0.05 for the difference between control and stimulated cells 
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Shear stress response is impaired in the endothelial cells of the patients with thoracic aortic 
aneurysm  
The above data suggest the dysregulation of BMP and WNT/ β-catenin pathways in ECs 
of the TAA patients. These pathways are known to be activated in response to cellular stress 
including shear stress (Theodoris et al., 2015). To reveal the difference in the expression of genes 
associated with stress response between diseased and healthy aortic ECs, we compared the shear 
stress response of HAECs from patient and donor cells to laminar flow that is the relevant blood 
flow in the aortas with a tricuspid valve. A comparison between the activation of 
Notch/BMP/WNT/β-catenin related genes in cells of the patients and donors (Fig. 5, 
Supplementary fig. 2) showed the most striking differences in the expression of DLL4, SNAIL1 
and BMP2, DKK1 as a result of exposure to laminar shear stress (Fig. 5A). In patient cells DLL4 
and SNAIL1 were not up regulated to the same level as in donor cells. On the other hand, BMP2 
was up regulated in control cells, whereas the diseased cells had already elevated BMP2, and 
flow did not elevate it any further. DKK1 level dropped in response to flow in both control and 
diseased cells; but the absolute level of DKK1 was different between patient and controls in the 
flow-stressed cells (Fig. 5A) and remained higher in the cells of the patients.   
On the contrary, DKK1 and BMP2, as well as Wnt effectors, STAT6 and TCF4, were 
already elevated in non-stimulated ECs of the patients (Fig. 2). We observed elevation of BMP2 
expression by flow in donor cells while no change was observed in the flow-stimulated diseased 
cells. Absolute level of DKK1 expression was significantly higher in the diseased versus healthy 
cells in both non-stimulated (Fig. 2) and flow-stressed cells (Fig. 5A). PCA analysis of gene 
expression profiles (Fig. 5B) shows that HAEC derived from the patients and healthy donors 
form separate clusters by gene expression in response to shear stress.  We conclude that stress 
response was attenuated in the HAECs of TAA patients.  
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Fig. 5 Shear stress response in the HAEC of the patients with thoracic aortic aneurysm. A. Dotted 
graphs represent relative mRNA level in the cells subjected to the flow. Bar graphs represent fold 
change of mRNA level in non-stimulated level (static) to the level in the flow-stimulated (laminar) 
cells. Endothelial cells from the patients with thoracic aortic aneurysm (TAA), n=9; control cells 
(donor), n=5. Groups are compared using Mann-Whitney nonparametric test; line represents the 
median; **, * p<0.05. B. PCA analysis showing differences in gene expression between HAEC 
from healthy and diseased aorta in response to shear stress. See also suppl. Fig.2. 
 
 
 
 
DISCUSSION   
In this study, we show that ECs from TAA patients are impaired in several important 
pathways such as Notch, BMP and WNT/β-catenin compared to the cells of healthy donors. We 
also report attenuation of shear stress response in the aortic ECs of the patients with TAA.   
Notch pathway is indispensable for endothelial differentiation and maintenance during 
adult life (Briot et al., 2016). We have recently shown that ECs from BAV/TAA have impaired 
Notch-dependent EMT irrespective of NOTCH1 mutations (Kostina et al., 2016). Here we indeed 
show that the expression of different components of the Notch pathway is altered in of 
TAV/TAA patients.  
Due to the absence of signal amplification step or utilization of secondary messengers to 
transmit the signal from the cell surface to the nucleus, Notch signaling is extremely dose 
sensitive. Strict dosage dependence of Notch during development has been reported in human 
and other mammals (Krebs et al., 2004) and a tight regulation of both signal sending and 
receiving cells is crucial for optimal outcome in physiological settings. By altering the amount of 
available ligands and receptors, different scenarios for Notch activation could be generated 
(Luxán et al., 2016). Therefore, our data proposes that dysregulation of Notch pathway in the EC 
may play a role in the development of TAA.  
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Moreover, Notch signaling in the endothelium of the vessel mediates the differentiation 
of underlying SMC, ensuring integrity of the vessel wall (Pedrosa et al., 2015). This is 
compatible with our earlier reports in which we demonstrated a decreased expression of 
contractile markers in aortic SMC of TAA patients (Malashicheva et al., 2016), but the 
connection between dysregulation of endothelial Notch and SMC contractile phenotype in TAA 
patients requires further elucidations.   
We observed a strong elevation of WNT/β-catenin signaling in the diseased ECs. This 
pathway controls vascular stability through remodelling, junction assembly, and pericyte 
recruitment (Reis and Liebner, 2013). The sequential and parallel interactions between the BMP 
and WNT/β-catenin signaling controls mineralization, and intracellular/extracellular fine-tuning 
of signal duration and strength (Boström et al., 2011). We show a significantly elevated 
expression of WNT/β-catenin antagonist, DKK1, in the diseased cells. Activation of Dkk1 has 
been associated with endothelial integrity (Li et al., 2015). Our data is in accordance with 
previously published report (Malashicheva et al., 2016) and is suggestive of an overall 
attenuation of endothelial integrity and function in the cells of TAA patients.    
Fluid shear stress is involved in stem cell and mesenchymal progenitor differentiation into 
vascular ECs  and plays an important role in endothelial homeostasis (Resnick and Gimbrone, 
1995). The aortic wall is subjected to constant mechanical stress and the ability of the vessels to 
resist this stress is important for proper vascular function. In response to application of laminar 
shear stress, a differential expression of DLL4, SNAIL, BMP2 and DKK1 was observed between 
the patients and healthy donor ECs. This gave further support to the role of Notch, WNT/β-
catenin and BMP pathways in maintaining endothelial integrity as has been reported by others 
(Corada et al., 2010; Dejana, 2010; Rostama et al., 2015; Wu et al., 2014). DLL4 was up 
regulated in response to shear stress in healthy cells whereas its expression remained low in the 
patient cells. Activation of Notch, in particular DLL4 in response to flow, is an important factor 
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for stress resistance (Pedrosa et al., 2015) and this function seems to be compromised in the cells 
of TAA patients.   
A cross talk between Wnt and Notch pathways has been shown to be important for the 
early endothelial patterning in vertebrate development (Corada et al., 2010; Dejana, 2010; Morini 
and Dejana, 2014). In our experiments, activation of WNT/β-catenin either by inhibition of Gsk3 
kinase or by introduction of proteolysis resistant S33 β-catenin mutant, down regulated the 
expression of DLL4. This was in accordance with data obtained with patient cells where strong 
activation of WNT /β-catenin was accompanied by down regulation of DLL4 and NOTCH4 and 
general loss of endothelial properties. Hence, fine-tuned cross-talk between several pathways is 
responsible for the proper maintenance of endothelial state in the adult aorta and this cross-talk is 
attenuated in the diseased cells. Recent studies suggest that vascular endothelial growth factor 
(VEGF), ETS factors, Sox and Notch regulate DLL4 expression in a complex cascades that may 
be further impacted by the canonical WNT/β-catenin pathway (Corada et al., 2010; Morini and 
Dejana, 2014). Despite the fact that even subtle changes in DLL4 expression impairs vascular 
development (Pedrosa et al., 2015), the regulatory mechanisms for the fine-tuning of Dll4/Notch 
signaling during vascular development in vivo still remain to be defined (Wu et al., 2014).  
This study has two major limitations. Firstly, the number of patients used in the study was 
not large. Secondly, the in vitro experiments with isolated ECs in the absence of an SMC layer 
cannot reflect the complexity of signaling in the whole aortic wall due to cell-cell communication 
residing in different layers of aorta as well as cells entering these layers via systemic connection. 
Nevertheless, we suggest that our findings are relevant for finding potential targets to ameliorate 
endothelial integrity.   
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Table 1 Clinical characteristics in the study groups  
Values are means±S.E.M.  CSA/h, ascending aortic cross-sectional area to patient height ratio.  
TAV (n=9)  
   
Male gender (%)  46  
Age (years)  71.3±2.53 (range 55–84)  
Aortic diameter (cm)  5.6±0.18  
Aortic CSA/h (cm2/m)  6.6±0.6  
Peak valve gradient (mmHg)  83±9  
Mean valve gradient (mmHg)  55±7  
Aortic valve area index (cm2/m2)  0.39±0.02  
Hypertension (%)  
 
Medication  
84  
 Angiotensin receptor blockers (%) 38  
  Statins (%)  
 
0  
  Aspirin (%)  
  
 
 
31  
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SUPPLEMETARY FIGURES 
Supplementary figure 1. Differential expression of genes related to major antiosteogenic, 
antioxidant, antiatherogenic and proinflammatory pathways in the human aortic endothelial cells 
derived from either healthy donors (donor) or patients with thoracic aortic aneurysms (TAA). 
RNA was isolated from the cells and mRNA level for indicated genes was analyzed. 
28 
Supplementary figure 2.  Differential expression of genes related to major antiosteogenic, 
antioxidant, antiatherogenic and proinflammatory pathways in the human aortic endothelial cells 
derived from either healthy donors (donor) or patients with thoracic aortic aneurysms (TAA) after 
shear stress. The cells were subjected to shear stress, subsequently RNA was isolated from the 
cells and mRNA level for indicated genes was analyzed. 
